Engineering and characterization of single chain antibody fragments (scFvs) specific to key enzymes in polyamine biosynthesis and manipulation of polyamine pathway by constitutive expression of recombinant ODC and SDE enzymes in transgenic tobacco by Nölke, Greta
 
 
 
 
 
“Engineering and characterization of single chain antibody 
fragments (scFvs) specific to key enzymes in polyamine 
biosynthesis and manipulation of polyamine pathway by 
constitutive expression of recombinant ODC and SDE enzymes in 
transgenic tobacco” 
 
 
 
 
 
Von der Fakultät für Mathematik, Informatik and Naturwissenschaften der Rheinisch-
Westfälischen Technischen Hochschule Aachen zur Erlangung des akademischen Grades 
einer Doktorin der Naturwissenschaften genehmigte Dissertation 
 
 
 
 
vorgelegt von 
 
 
Master of Science 
Greta Nölke 
aus  
Korce (Albanien) 
 
 
 
 
 
 
 
Berichter: Universitätsprofessor Dr. rer. nat. R. Fischer 
                     Universitätsprofessor Dr. rer. nat. F. Kreuzaler 
 
 
 
Tag der mündlichen Prüfung: 20. September 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Für Daniel   
 
 Contents 
 I
I Introduction ............................................................................................................ 1 
I.1 Characteristics and biosynthesis of polyamines ..................................................... 1 
I.1.1 Polyamines and their cellular localisation..................................................... 1 
I.1.2 Polyamines in animal cells ............................................................................ 2 
I.1.3 Exogenous polyamines - implications for growth and health ....................... 3 
I.1.4 Polyamine function in plants ......................................................................... 4 
I.1.5 Polyamine biosynthesis pathway................................................................... 5 
I.1.6 Ornithine decarboxylase................................................................................ 7 
I.1.7 Molecular and genetic approaches for modulating the levels of 
polyamines in plants...................................................................................... 9 
I.2 Engineering of recombinant antibodies by phage display technology................. 10 
I.2.1 General structure of antibodies.................................................................... 10 
I.2.2 Immunoglobulin genetics ............................................................................ 13 
I.2.3 Selection of recombinant antibodies by phage display ............................... 14 
I.2.4 Antibody libraries........................................................................................ 15 
I.2.5 Expression of antibody genes in plants: immunomodulation ..................... 17 
I.3 Aim of this thesis.................................................................................................. 19 
II Material and Methods........................................................................................... 22 
II.1 Material................................................................................................................. 22 
II.1.1 Chemicals and consumables........................................................................ 22 
II.1.2 Enzymes and reaction kits ........................................................................... 22 
II.1.3 Primary antibodies, secondary antibodies and substrates ........................... 22 
II.1.4 Bacterial strains ........................................................................................... 23 
II.1.5 Plants and animals ....................................................................................... 24 
II.1.6 Phage ........................................................................................................... 24 
II.1.7 Vectors......................................................................................................... 24 
II.1.8 Oligonucleotides.......................................................................................... 25 
II.1.9 Buffers, media and solutions ....................................................................... 28 
II.1.10 Matrices and membranes............................................................................. 29 
II.1.11 Equipment and applications ........................................................................ 29 
II.2 Methods ................................................................................................................ 31 
II.2.1 Recombinant DNA technologies................................................................. 31 
II.2.1.1 Competent cells for RbCl-mediated transformation ................................ 31 
II.2.1.2 Transformation of E. coli by heat-shock .................................................. 32 
 Contents 
 II
II.2.1.3 Preparation of electrocompetent E. coli ................................................... 32 
II.2.1.4 Transformation of E. coli by electroporation ........................................... 32 
II.2.1.5 Preparation of electrocompetent Agrobacterium cells ............................. 32 
II.2.1.6 Transformation of Agrobacterium by electroporation ............................. 33 
II.2.1.7 Determination of the efficiency of recombinant bacteria 
transformation .......................................................................................... 33 
II.2.1.8 Culturing of E. coli and glycerol stock preparation ................................. 33 
II.2.1.9 Growth of recombinant A. tumefaciens and preparation of glycerol 
stocks........................................................................................................ 33 
II.2.1.10 Isolation of plasmid-DNA from E.coli..................................................... 34 
II.2.1.11 Agarose gel electrophoresis of DNA........................................................ 34 
II.2.1.12 Preparative agarose gel electrophoresis ................................................... 34 
II.2.1.13 PCR amplification .................................................................................... 34 
II.2.1.14 DNA sequencing ...................................................................................... 36 
II.2.1.15 Sequence analysis..................................................................................... 36 
II.2.2 Generation and characterisation of transgenic plants.................................. 36 
II.2.2.1 Transient assay in tobacco leaves by vacuum infiltration........................ 36 
II.2.2.2 Preparation of recombinant Agrobacteria ................................................ 36 
II.2.2.3 Vacuum infiltration of intact leaves ......................................................... 37 
II.2.2.4 Recombinant agrobacterium-mediated stable transformation of 
tobacco plants ........................................................................................... 37 
II.2.2.5 Growth of N. tabacum cv. Petite Havana SR1 ......................................... 38 
II.2.2.6 Preparation of total soluble proteins from plant leaves ............................ 38 
II.2.2.7 Extraction of RNA from transgenic plants............................................... 39 
II.2.2.8 Northern-blot analysis .............................................................................. 39 
II.2.3 Expression and purification of recombinant proteins.................................. 40 
II.2.3.1 Expression and purification of polyamine-GST fusion proteins from 
E. coli ....................................................................................................... 40 
II.2.3.2 Expression and purification of ODC and PAO proteins .......................... 40 
II.2.3.3 Large scale expression of scFv in pSyn and purification of soluble 
scFv by IMAC.......................................................................................... 41 
II.2.4 Protein analysis............................................................................................ 42 
II.2.4.1 Quantification of proteins......................................................................... 42 
II.2.4.2 SDS-PAA gel electrophoresis and Coomassie brillant blue staining....... 42 
II.2.4.3 Immunoblot analysis ................................................................................ 43 
II.2.4.4 Dot blot analysis....................................................................................... 44 
II.2.5 Immunization of mice ................................................................................. 44 
 Contents 
 III
II.2.5.1 Determination of antisera titers by ELISA............................................... 44 
II.2.6 Construction of phage displayed scFv libraries .......................................... 45 
II.2.6.1 Isolation of total RNA from spleen cells.................................................. 45 
II.2.6.2 First strand cDNA synthesis..................................................................... 45 
II.2.6.3 Construction of scFv libraries .................................................................. 45 
II.2.6.4 BstNI fingerprinting ................................................................................. 45 
II.2.7 Phage displayed antibody selection............................................................. 46 
II.2.8 Characterisation of phage displayed scFv fragments .................................. 46 
II.2.8.1 Soluble expression of scFv fragments and direct ELISA......................... 46 
II.2.8.2 Capture ELISA of selected scFv fragments ............................................. 47 
II.2.8.3 Biotinylation of scFv ................................................................................ 47 
II.2.8.4 Competition ELISA of biotinylated scFv fragments................................ 47 
II.2.8.5 Electrophoretic mobility shift assay (EMSA) .......................................... 47 
II.2.8.6 Gel Filtration ............................................................................................ 48 
II.2.8.7 Characterisation of scFv fragments by BIACORE .................................. 48 
II.2.9 Determination of ODC activity ................................................................... 48 
II.2.10 Extraction of polyamines from tobacco plants............................................ 49 
II.2.10.1 Analysis of free polyamine levels from stable transformed tobacco ....... 49 
III Results .................................................................................................................. 51 
III.1 Cloning of human ornithine decarboxylase (ODC) a key enzyme in 
polyamine biosynthesis ........................................................................................ 51 
III.2 Expression and purification of ADC, ODC and PAO from bacterial cultures..... 52 
III.3 Cloning of ODC in bacteria expression vector pET22b and purification of the 
expressed protein via IMAC................................................................................. 53 
III.4 Generation and characterization of transgenic plants........................................... 54 
III.4.1 Engineering of constructs for targeting of human ODC to different 
plant cell compartments............................................................................... 54 
III.4.1.1 Cloning of ODC into plant expression vector pSSH1.............................. 54 
III.4.1.2 Transient expression of ODC in different plant cell compartments......... 56 
III.4.2 Generation and screening of stable transformed tobacco plants 
expressing human ODC............................................................................... 58 
III.4.3 Generation of transgenic tobacco plants co-expressing human ODC and 
chimeric mouse/human SDE enzymes ........................................................ 60 
III.5 Polyamine analysis ............................................................................................... 61 
III.5.1 Polyamine levels in stable transformed plants overexpressing ODC.......... 61 
III.5.2 Polyamine levels in transgenic plants co-expressing apoplasmic ODC 
and SDE enzymes........................................................................................ 63 
 Contents 
 IV
III.6 Enzymatic activity of ODC in stable transformed plants overexpressing 
human ODC.......................................................................................................... 64 
III.7 Immunization of mice with recombinant ADC, ODC and PAO.......................... 66 
III.8 Construction of phage displayed libraries ............................................................ 67 
III.8.1 Isolation of total RNA from mouse spleen cells ......................................... 67 
III.8.2 cDNA synthesis and PCR amplification of variable heavy and light 
chain fragments ........................................................................................... 68 
III.8.3 Construction of phagemid-scFv libraries .................................................... 70 
III.9 Selection and characterisation of specific scFvs .................................................. 73 
III.9.1 Solid phase panning of libraries HA1LA2 and HO1LO2 against  
recombinant fusion proteins ADC and ODC-GST...................................... 73 
III.9.2 Screening and characterisation of scFv-fragments against ODC-GST  
fusion protein............................................................................................... 74 
III.9.3 Sequence analysis of scFv fragments specific to ODC clones.................... 76 
III.9.4 Screening and characterisation of scFv-fragments against ADC-GST 
fusion protein............................................................................................... 78 
III.9.5 Sequence analysis of selected scFv-ADC clones ........................................ 80 
III.10 Characterization of biological and physical features of the ODC-specific scFv 
antibodies.............................................................................................................. 83 
III.10.1 Cloning and expression of scFvODC1, scFvODC3, scFvODC7 and 
scFvODC15 in E. coli ................................................................................. 83 
III.10.2 Stability of affinity purified scFvODCs ...................................................... 84 
III.10.3 Reactivity of ODC-specific scFvs with ODC-GST and GST ..................... 85 
III.10.4 Epitope mapping of scFvODC1, scFvODC3 and scFvODC7 by surface 
plasmon resonance ...................................................................................... 87 
III.10.5 Comparative analysis of binding activity of scFvODC1 preincubated  
with ODC-GST............................................................................................ 88 
III.10.6 Electrophoretic mobility shift assay (EMSA) ............................................. 90 
III.10.7 In vitro effect of scFvODC1 and scFvODC3 on the enzymatic activity  
of bacterial purified ODC-GST................................................................... 91 
III.10.8 Transient expression of scFvODC1, 3, 7 and 15 in vacuum-infiltrated 
tobacco leaves.............................................................................................. 93 
III.10.9 Functional analyses of the cytosolic expressed scFvODC1 and  
scFvODC3................................................................................................... 94 
III.10.10 Generation and screening of stable transformed plants overexpressing 
scFvODCs ................................................................................................... 97 
III.11 Cloning and expression of scFvADC3 and scFvADC7 in E.coli......................... 99 
III.11.1 Reactivity of purified scFvADC3 and scFvADC7.................................... 100 
III.12 Epitope mapping of scFvADC3 and scFvADC7................................................ 101 
III.13 Transient expression of scFvADC3 in tobacco plants ....................................... 102 
 Contents 
 V
IV Discussion........................................................................................................... 104 
IV.1 Generation and characterization of transgenic plants......................................... 105 
IV.2 Enzymatic activity and polyamine analyses of stable transformed plants 
overexpressing human ODC .............................................................................. 106 
IV.3 Polyamine analyses of transgenic tobacco plants co-expressing apoplasmic  
ODC and SDE enzymes ..................................................................................... 108 
IV.4 Generation and Characterization of scFv-fragments specific to ADC, ODC  
and PAO ............................................................................................................. 109 
IV.4.1 Expression and purification of recombinant antigens ............................... 110 
IV.4.2 Immunization of mice with ADC, ODC-GST and PAO-GST inclusion 
bodies......................................................................................................... 111 
IV.4.3 Phage displayed antibody selection........................................................... 112 
IV.4.4 Expression and purification of scFvs in E. coli......................................... 115 
IV.4.5 Characterization of engineered scFvs........................................................ 116 
IV.4.6 Generation of stable transformed tobacco plants overexpressing ODC-
specific scFvs ............................................................................................ 119 
IV.5 Conclusion and future prospects ........................................................................ 121 
V Summary............................................................................................................. 123 
VI References .......................................................................................................... 125 
VII Appendices ......................................................................................................... 145 
 
Chapter I Introduction 
 1
I Introduction 
I.1 Characteristics and biosynthesis of polyamines 
I.1.1 Polyamines and their cellular localisation 
The polyamines represent a group of naturally occurring compounds ubiquitous in all 
living cells of prokaryotes, eukaryotes, plants and animals. They play essential roles in a 
wide range of biological processes, including cell growth and differentiation (Pegg, 1986; 
Tabor and Tabor, 1984). Inhibition of polyamine synthesis results in growth arrest and 
eventually, cell death (Seidenfeld et al., 1986; Snyder et al., 1989; Anehus et al., 1984a; 
Quemener et al., 1994; Aziz et al., 1996). In vivo polyamines occur either in their free 
form (positively charged), or bound as conjugates with hydroxycinnamic acids (Tiburcio et 
al., 1990; Evans et al., 1989) and many types of proteins including numerous enzymes 
whose activities are directly modulated by polyamine binding (Corley et al., 1983, Datta et 
al., 1987, Igarashi et al., 1989). Chemically polyamines are organic aliphatic cations with 
two (putrescine), three (spermidine) or four (spermine) amino groups that are fully 
protonated at physiological pH. Unlike inorganic molecules or ions, the positive charges on 
polyamines are spaced out at intervals and, despite the hydrocarbon chains being flexible, 
have steric as well as cationic properties. The structure of the three most commonly 
occurring natural polyamines, putrescine, spermidine, and spermine, together with those of 
1,3-diaminopropane and cadaverine (1,5-diaminopropane), are shown in Figure I-1. 
 
Putrescine NH3+-CH2-CH2-CH2-CH2-NH3+ 
Cadaverine NH3+-CH2-CH2-CH2-CH2-CH2-NH3+ 
Spermidine NH3+-CH2-CH2-CH2- NH+-CH2-CH2-CH2-NH3+ 
Spermine NH3+-CH2-CH2-CH2- NH+-CH2-CH2-CH2- NH+-CH2-CH2-CH2-NH3+ 
1,3-diaminopropane NH3+-CH2-CH2-CH2-NH3+ 
Figure I-1 Structure of polyamines. 
 
The diamine putrescine and the polyamines spermidine and spermine are found at 
concentrations from micromoles to millimoles in almost any living cell (Tabor and Tabor, 
1984; Pegg and McCann, 1982; Russell, 1980). Intracellular polyamine concentrations 
vary throughout the cell cycle. An increase in polyamine synthesis is a very early event in 
cell proliferation and takes place before any increase in protein or nucleic acid synthesis 
(Morgan, 1998) is detectable. 
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Understanding the biological role of polyamines in plants is hampered by the lack of 
knowledge about their tissue- and subcellular distribution (Kumar et al., 1997). The 
difficulties experienced in attempting to identify and measure the amounts of polyamines 
in biological materials are related with their size, the concentrations in which they are 
present and that their only reactive centers are the amino groups. In mature plant tissues 
polyamines are associated primarily with the cell wall, bound to polyuronic acids and 
lignin (Goldberg and Perdrizer, 1984). They are localized in the vacuole (Pistocchi et al., 
1988; Jokela et al., 1997), mitochondria and chloroplast (Slocum, 1991a). The polyamines 
have also been detected in thylakoid membranes of spinach, associated with the light 
harvesting complex and photosystem II (Kotzabasis et al., 1993). In normal secretory cell 
systems, the polyamines are concentrated in cytoplasmic structures (Hougaard, 1992). 
Ultrastructural studies using immunogold labelling have shown that polyamines, primarily 
spermine and to a lesser extent spermidine, are concentrated in regions of high density 
chromatin in the interphase nucleus (Roch et al., 1997). The polyamine transport across the 
plasmalemma is energy–dependent and influenced by calcium through a cascade pathway 
involving protein kinase and phosphatase activities (Antognoni et al., 1995). 
 
I.1.2 Polyamines in animal cells 
Polyamines, primarily putrescine, spermidine and spermine, play critical roles in cell 
proliferation (Pegg, 1986; Piacenza et al., 2001), including tumor growth (Hobbs and 
Gilmour, 2000), differentiation, maintenance and neoplastic transformation.  
In mammalian cells, polyamines play an important role in promoting S-phase progression 
and also facilitate the G1-S transition. Several studies have indicated the role of 
polyamines in inducing and prevention of apoptosis (Dypbukt et al., 1994, Takahashi et 
al., 2000; Piacenza et al., 2001; Thomas and Thomas, 2001). Polyamines induce bends and 
transitions in DNA from B to Z and/or A isoforms (Thomas et al., 1995; Korolev et al., 
2001), and promote associations or cause release of a variety of DNA binding proteins 
(Bryans et al., 1996). They may play a critical role in stabilisation of histone interactions in 
formation of the nucleosome and higher chromatin structures (Ballestar et al., 1996; Basu 
et al., 1999; Hobbs and Gilmour, 2000). The specific interactions of polyamines with a 
number of different types of ion channels have also been reported (Williams, 1997). 
Overexpression of ornithine decarboxylase (ODC), a key enzyme in polyamine 
biosynthesis, leads to greater overall protein phosphorylation (Shore et al., 1997), 
suggesting that high intracellular polyamine concentration might have major impact on 
signalling pathways. 
The polyamines have been observed to enhance transcription of a number of genes, 
including protooncogenes (Celano et al., 1989). Rapidly growing cells such as tumor cells 
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and regenerating cells produce greater amounts of polyamines than normal tissue 
(Nishioka et al., 1996; Takahashi et al., 2000), therefore polyamines can be possible 
biomarkers of tumor progression (Nishioka et al., 1995). Many studies indicate that the 
polyamine pathway is a molecular target for therapeutic intervention in several types of 
cancer. Cells are able to take up polyamines from the diets and from the polyamines 
produced by the intestinal mucosa and bacteria (Leveque et al., 1998). Thus, complete 
control of polyamines may require a polyamine free diet and inhibition of uptake from 
gastrointestinal sources (Quemener et al., 1994; Kumar et al., 1997; Thomas and Thomas, 
2001). Inhibitors of polyamine biosynthesis, polyamine analoges as well as oligonucleotide 
polyamine analog combinations are promising drug candidates for chemoprevention and/or 
treatment of cancer (Thomas and Thomas, 2001). 
The polyamines have a significant importance in human health. They have important 
neurophysiological functions (Williams et al., 1991; Williams, 1994; Carter, 1994) and 
roles in both post-natal brain development and in mature brain function (Slotkin, and 
Bartolome, 1986; Morrison et al., 1995). Polyamines also enhance the survival of 
sympathetic neurons (Gilad and Gilad, 1988). Studies have indicated participation of 
polyamines in the cortical development especially in the layer formation (Ichikawa et al., 
1997). Abnormal polyamine activity is involved in the neurodegenerative processes 
occurring in the brain of patients with Alzheimer’s disease (Morrison and Kish, 1995). 
 
I.1.3 Exogenous polyamines - implications for growth and health 
Exogenous polyamines play an important role in the growth process of body tissues and 
organs. Every organ of the body requires polyamines for growth, renewal and metabolism. 
The polyamine content of an organ correlates with its metabolic activity. The gut 
epithelium has one of the highest cell turnover and hence the highest metabolic activity of 
the body. Polyamines are essential for the maintenance of the high metabolic activity of the 
normally functioning and healthy gut. Although every cell has capacity to synthesise 
polyamines (Jänne et al., 1978; Pegg, 1986; Tabor and Tabor, 1984), the body also relies 
on a continuous supply of polyamines from food, most of which are not retained by the gut 
tissues, but distributed in different organs of the body. Thus the polyamine requirements 
that cannot be met by biosynthesis have to be satisfied by exogenous polyamines derived 
from food. Food varies widely in its polyamine content and distribution. Cereal grains 
represent the primary diet for most people in the world, yet having low levels of all 
polyamines (Bardoz et al., 1993). Rice is probably the most important, accounting for most 
of the energy uptake for up to 50% of the world’s population (Christou, 1994). However, it 
contains very low levels of nutrients such as iron, calcium and polyamines (Bardocz et al., 
1993). 
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The importance of different polyamine sources for growth and health changes with the 
physiological or pathological states of the person. With age, cell proliferation slows and 
the activity of ODC decreases. Therefore, dietary polyamines might be more important 
later in life than in growing individuals, whose polyamine requirement can be satisfied to a 
larger extend by more active biosynthesis. In contrast, to inhibit unwanted growth, such as 
neoplastic proliferation of any of the tissues, the uptake of polyamines should be 
minimised to slow down the growth and progression of the tumour (Molinoux et al., 1991; 
Sarah and Seiler, 1991). Thus, manipulation of polyamine biosynthetic pathway by 
combining genetic engineering and antibody approach could lead to the establishment of 
transgenic food plants with altered polyamine levels, increasing their nutritional and health 
values. 
 
I.1.4 Polyamine function in plants 
Molecular analysis of polyamine biosynthesis in plants was initiated in 1990 when Bell 
and Malmberg isolated the first ADC cDNA from oat. The polyamines have been 
demonstrated to play important roles in many plant metabolic processes by virtue of their 
polybasic nature (Rajam, 1997; Galston and Kaur-Sawhney, 1990). In addition to their 
involvement in plant growth and development, they play a role in plant stress tolerance 
(Young and Galston, 1983; 1984; Besford et al., 1993; Borrell et al., 1996), senescence 
(Drolet et al., 1986; Carbonell and Navarro, 1989), modulation of enzyme activity, and 
stabilization of nucleic acids and cell membranes (Tiburcio et al., 1989; Evans and 
Malmberg, 1989; Bajaj and Rajam, 1995, 1996; Sharma and Rajam, 1995; Zheliaskova et 
al., 2000). Polyamine levels in plant cells increase in response to various stresses (Galston 
and Kaur-Sawhney, 1990). The localisation of ADC in the chloroplast indicates the role of 
polyamine biosynthesis in the maintenance of photosynthetic activity during senescence 
responses induced by osmotic stress (Borrell et al., 1995). The polyamines also protect 
cells and cell compartments from oxidative damage (Drolet et al., 1986; Balasundaram, et 
al., 1993). They play a role in controlling the flux between primary and secondary 
metabolism (Lamberts et al., 1959). Many plants form toxic alkaloids from polyamines 
(Guggisberg and Hesse, 1983; Burtin and Michael, 1997), and the principal alkaloid of 
tobacco is nicotine. 
At their physiological concentrations polyamines control the currents through the plant ion 
channels, namely through the tonoplast FV and SV channels (Dobrovinskaya et al., 1999). 
Polyamines have been implicated in somatic embryogenesis (Feirer et al., 1984; Minocha 
and Minocha, 1995), flowering (Caffaro et al., 1994; Caffaro and Vicente, 1994; Tarenghi 
and Martin-Tanguy, 1995; Havelange et al., 1996), floral development (Kaur-Sawhney et 
al., 1990; Rastogi and Sawhney, 1990; Perez-Amador and Carbonell, 1995), root growth 
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and differentiation of lateral roots (Sharma et al., 1997). Putrescine enhances xylogenesis 
of xylem cells in Helianthus tuber (Phillips et al., 1988) and it influences cambial activity 
in gymnosperms (Königshofer, 1991). 
 
I.1.5 Polyamine biosynthesis pathway 
The biosynthetic pathways for polyamines have been well documented. The initial key 
enzymes in polyamine biosynthesis are arginine decarboxylase (ADC; EC 4.1.1.19) and 
ornithine decarboxylase (ODC; EC 4.1.1.17). ADC catalyses the decarboxylation of L-
arginine to the diamine putrescine, via agmatine and N-carbamoylputrescine. This is one of 
the main pathways of putrescine synthesis in plants (Tiburcio et al., 1990) (Figure I-2) and 
in some bacteria. In contrast to the pathway in animals and most fungi in which the sole 
route to putrescine biosynthesis is the direct decarboxylation of L-ornithine in a reaction 
catalysed by ODC. However, there are several preliminary reports of ADC activity in 
animals (Li et al., 1994; Morrissey et al., 1995; Gilad et al., 1996; Regunathan and Reis, 
2000) and in various fungi (Khan and Minocha, 1989). 
In a step common to most organisms, spermidine is formed from putrescine by addition of 
an aminopropyl group donated by decarboxylated S-adenosylmethionine. This reaction is 
catalysed by spermidine synthase (SDE), an aminopropyl-transferase. Spermine is formed 
by addition of the second aminopropyl moiety to spermidine, catalyzed by a different 
aminopropyl transferase namely, spermine synthase (SME) (Tiburcio et al., 1990). 
Polyamines are oxidatively deaminated by the action of amine oxidases including the 
copper diamine oxidase (DAO; EC 1.4.3.6), and the flavoprotein polyamine oxidase (PAO; 
EC 1.5.3.3). Putrescine can be oxidised to pyrroline in a reaction catalized by DAO. The 
diamine oxidase is characterised by its substrate specificity toward diamines. The 
polyamine oxidase oxidises spermidine and spermine at their secondary amino groups to 
1,3-diaminopropane and pyrroline or 1-(3-1-aminopropyl)-pyrroline (Smith, 1988; 
Tiburcio et al., 1997). 1,3-Diaminopropane can be converted into alanine (Terano and 
Suzuki, 1978), whereas pyrroline can be further catabolized to gamma-aminobutiric acid 
(GABA) (Flores and Filner, 1985). GABA is subsequently transaminated and oxidised to 
succinic acid, which is incorporated into the Krebs cycle. This pathway ensures the 
recycling of carbon and nitrogen from putrescine and spermidine (Flores and Filner, 1985). 
Although one or both of the pathways may be active in different plant tissues, their relative 
contribution to the biosynthesis of putrescine in higher plants is controversial (Tiburcio et 
al., 1990). The activity of ADC is considered to be responsible for putrescine biosynthesis 
upon stress (Smith, 1990) or nutrient deficiency and in tissues undergoing cell elongation 
and morphogenesis (Flores and Galston, 1982; 1984; Pandit and Ghosh, 1988; Slocum and 
Weinstein, 1990; Besford et al., 1993; Borrell et al., 1995, 1996). The rise in putrescine 
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titers, observed in rapidly proliferating plant cells is due to ODC activity (Cohen et al., 
1982; Hiatt et al., 1986). ODC and ADC are responsible for different physiological 
processes in plant development (Kwak and Lee, 2001).  
Figure I-2 Schematic representation of the polyamine biosynthetic pathway and its 
interrelationship with the ethylene pathway.  
SAMDC, the key enzyme for both pathways is indicated in blue. The target enzymes are indicated 
in red. Abbreviations: OTC, ornithine transcarbamylase; ADC, arginine decarboxylase; SAMDC, S-
adenosylmethionine decarboxylase; ACC, 1-aminocyclopropane-1-carboxylic acid, ODC, ornithine 
decarboxylase; SDE, spermidine synthase; SME, spermine synthase; DAO, diamine oxidase, PAO, 
polyamine oxidase, AIH, agmatine iminohydrolase; GABA, gamma-aminobutiric acid. 
 
S-adenosynmethionine decarboxylase (SAMDC) is a further key enzyme in the 
biosynthesis of the polyamines spermidine and spermine from putrescine and its activity 
has been shown to be rate limiting in this pathway (Slocum et al., 1984; Tabor and Tabor, 
1984; Slocum, 1991; Pegg and McCann, 1992). SAMDC influences the rate of ethylene 
biosynthesis (Apelbaum et al., 1985) as the polyamine and ethylene pathways are 
biosynthetically related by sharing a common precursor, SAM (Biondi et al., 1990; Kushad 
and Dumroff, 1991). 
Many studies indicated that ODC activity is regulated at the transcriptional, translational 
and post-translational levels (Hayashi and Murakami, 1995). The protein levels and/or 
enzymatic activity of plant ADC and SDE are regulated post-translationally (Coleman et 
al., 1993; Schröder and Schröder, 1995; Malmberg and Cellino, 1994; Borrell et al., 1996; 
Primikiros and Roubelakis-Angelakis, 2001). The intracellular free polyamine pools do not 
only dependent on polyamine synthesis, but also on several other processes including: 1.) 
the activities of enzymes that regulate the synthesis of arginine and ornithine, like arginase 
(L-arginine aminohydrolase; EC 3.5.3.1) and ornithine transcarbamylase (EC 2.1.3.3) 
which can supply ornithine from arginine and vice versa, respectively; 2.) the catalysis of 
argininosuccinate citrulline
OTC
arginasearginine
agmatine N-carbamoylputrescine
ornithine
putrescine
DAO
pyrroline GABA
spermidine
methionine
S-adenosylmethionine
SAM synthase
5-methylthioadenosine
5-methylthioadenosine
decarboxylated
SAM
spermine
SME diaminopropane ß-alanine
ornithine cycle
ADC
AIH
ODC
1-(3-aminopropyl)-pyrroline
SAMDC PAO
PAO
SDE
ACC
ethylene
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polyamines by the respective catabolic enzymes (oxidative deamination); 3.) the 
interconvertion of free putrescine, spermidine and spermine to their soluble and insoluble 
forms; 4.) the size of the intracellular polyamine pools; 5.) polyamine transport (Tiburcio 
et al., 1990; Slocum and Flores, 1991; Bagni and Torrigiani, 1992); 6.) the rate of 
conversion of free putrescine to spermidine and spermine (Bouchereau et al., 1999; 
Primikirios et al., 1999). 
 
I.1.6 Ornithine decarboxylase 
Ornithine decarboxylase (ODC) (EC 4.1.1.17), a key enzyme of polyamine biosynthesis is 
one of the most highly regulated eukaryotic enzymes. ODC is an extremely labile enzyme 
present in low concentration. cDNA clones of ODC have been obtained from a number of 
species (McCann and Pegg, 1992; Michael et al., 1996; Alabadi and Carbonell, 1998; 
Kwak and Lee, 2001). The homology among eukaryotic ODC genes is greater than 90% 
suggesting that their structural and catalytic properties are similar. In contrast, the 
similarity to bacterial ODC genes is low.  
Eukaryotic ODCs require pyridoxal 5′-phosphate (PLP) as a cofactor and the amino acid 
residues Lys69 and Cys360 are critical at the active site of ODC (Jackson et al., 2000). Lys69 
in the mouse ODC is important for PLP binding (Heby and Persson, 1990). The Cys360 is 
the key residue that binds difluoromethylornithine (DFMO) a specific ‘suicide’ inhibitor of 
ODC (Metcalf et al., 1978). The enzyme forms a homodimer (Figure I-3), with Lys69 of 
one of the subunits forming an active site in trans with Cys360 of the other subunit (Tobias 
and Khahana, 1993; Coleman et al., 1993). Most ODC genes code for about 460 amino 
acids, except the bacterial and Leishmania enzymes, which are 40% bigger. 
Mammalian ODC has an extremely short intracellular half-life of 15 min to 1 h (Ghoda et 
al., 1989; Hölttä and Pohjanpelto, 1986; Isomaa et al., 1983; McConlogue et al., 1986). 
Turnover of ODC is extremely rapid and highly regulated, and is accelerated when 
polyamine levels increase (Satriano et al., 1998; Babal et al., 2001). The polyamine-
mediated degradation of ODC is associated with the antizyme (AZ), an ODC inhibitory 
protein induced by polyamines (Fong et al., 1976; Heller et al., 1976; Matsufuji et al., 
1995). AZ binds to the N-terminal region of the monomeric subunit of ODC inducing 
conformational changes that expose the C-terminal region to the 26S proteosome-
dependent degradation (Li and Coffino 1992; 1993; Murakami et al., 2000) without 
ubiquitylation (Murakami et al., 1992; 1999). The carboxyl terminal domain of mouse 
ODC contains a specific amino acid sequence PEST (residues 423-449) which makes the 
enzyme sensitive to cellular proteases (Rogers et al., 1986; Rechsteiner, 1987). Deletion of 
some or all of the 36 residues at the carboxyl end of the mouse enzyme does not alter 
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enzyme activity, but greatly increases the stability of the protein (Ghoda et al., 1989; Lu et 
al., 1991). 
 
 
 
Figure I-3 Crystal structure of human ODC homodimer with the PLP as cofactor. 
The two subunits are coloured yellow and red. The localization of the putative antizyme-binding 
element is coloured blue, the protease-sensitive loops are light green, and the basal PEST 
degradation motifs (residues 376-427) are dark green (Almrud et al., 2000). 
 
Trypanosoma ODC does not have a PEST sequence, but its stability was reduced when 
fused to the C-terminus of mouse ornithine decarboxylase and expressed in Chinese 
hamster ovary cells (Ghoda et al., 1990). Thus, the degradation pathway of ODC proceeds 
as a sequence of multiple distinct processes, including recognition, sequestration, 
unfolding, translocation, and ultimate degradation mediated by the 26S proteasome 
(Murakami et al., 2000). The plant ODC does not posses the C-terminal extension found in 
the mammalian enzyme, suggesting that the plant ODC may have a longer half life 
(Michael et al., 1996). 
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In normal mammalian cells (non proliferating cells) ODC activity is low and only 100-200 
molecules of the enzyme are present (Pegg et al., 1982a). ODC activity is closely 
associated with the cellular proliferation and the enzyme is essential for normal cell growth 
(Pegg, 1988; Pegg and McCann, 1992). The human ODC promoter is directly regulated by 
the product of c-myc (Bello-Fernandes et al., 1993; Wagner et al., 1993; Iyengar et al., 
2001) and overexpression of human ODC in NIH3T3 cells resulted in cell transformation 
(Auvinen et al., 1992; Moshier et al., 1993). This and other studies (Packham and 
Cleveland, 1994; Guo et al., 1999) have indicated that ODC is a proto-oncogene crucial for 
regulation of cellular growth and transformation. Inhibition of ODC activity has been 
shown to be associated with a decrease in polyamine levels, DNA synthesis and 
carcinogenesis in various cancer types. 
 
I.1.7 Molecular and genetic approaches for modulating the levels of 
polyamines in plants 
In recent years, several genes encoding polyamine biosynthetic enzymes have been cloned 
from different plants. Availability of cloned genes for polyamine biosynthesis enzymes 
provides a unique opportunity to manipulate cellular polyamine metabolism.  
In early experiments, DeScenzo and Minocha (1993) and Bastola and Minocha (1995) 
expressed a mammalian ODC gene in carrot and transgenic tobacco under the control of 
plant specific promoters. This caused a 2.5-fold increase in cellular putrescine levels. 
Putrescine levels were also increased in tobacco roots (Hamill et al., 1990) by expressing 
transgenic yeast ODC. Transgenic cells of poplar (Populus nigra x maximowiczii) 
expressing a mouse ODC gene showed elevated activity of mouse ODC and increased 
levels of polyamines (Bhatnagar et al., 2001). 
An increase in cellular levels of spermidine has been achieved by introduction of a human 
SAMDC cDNA into tobacco plants. In these transgenic plants, putrescine levels were 
significantly reduced, whereas the spermidine content was two to three times higher 
compared to control plants (Noh and Minocha, 1994). Transgenic tobacco plants 
containing sense and antisense constructs of the potato SAMDC cDNA under the control 
of the cauliflower mosaic virus (CaMV) 35S promoter have been generated (Kumar et al., 
1996). Reduction in the levels of SAMDC transcripts in the antisense plants were observed 
resulting in stunted phenotypes with highly branched stems, short internodes, small and 
chlorotic leaves and inhibited root growth. Attempts to produce transgenic plants with the 
sense SAMDC construct were unsuccessful, suggesting that a constitutive overexpression 
of the enzyme may be lethal (Kumar et al., 1996). 
Overexpression of oat ADC cDNA in tobacco caused a 65-fold increase in agmatine 
accumulation but no concomitant changes in putrescine levels (Burtin and Michael, 1997). 
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Inducible overexpression of oat ADC in transgenic tobacco led to an accumulation of ADC 
mRNA, increased ADC activity and changes in polyamine levels (Masgrau et al., 1997). 
Biochemical analysis of cellular polyamines resulted in up to fourfold increase in 
putrescine levels in transgenic callus and regenerated rice plants (Capell et al., 1998; 
Noury et al., 2000). 
Transgenic rice cell lines, engineered with the pea diamine oxidase cDNA in antisense 
orientation under the control of two different promoters (Bassie et al., 2000), have 
demonstrated for the first time the down regulation of DAO catabolic enzyme involved in 
polyamine metabolism accompanied by concomitant increase in putrescine and spermidine 
concentrations.  
Although plant PAO genes have been cloned and characterised from a few plant species 
(Federico and Angelini, 1991; Tavaldoraki et al., 1998) no results for overexpression of 
this enzyme in transgenic plants have been reported. 
Thus, with the ability of the key genes involved in the biosynthetic pathways and catabolic 
processes, it has become possible to manipulate the polyamine metabolism using antisense 
and sense transgenic approaches (Taylor et al., 1992; Bastola and Minocha, 1995; Koc et 
al., 1995; Kumar et al., 1997; Malmberg et al., 1998). However, alternative approaches 
based on antibodies stabilizing or destabilizing key enzymes in polyamine biosynthesis 
have not been addressed so far. 
 
 
I.2 Engineering of recombinant antibodies by phage display 
technology 
I.2.1 General structure of antibodies 
Human immunoglobulins are a group of structurally and functionally similar glycoproteins 
that confer humoral immunity in humans (Spiegelberg, 1974). Five classes (isotypes) of 
immunoglobulins (IgG, IgA, IgM, IgD, and IgE) have been distinguished, each of which 
has a distinct heavy-chain C region encoded by a distinct C-region gene. The isotype of an 
antibody determines the effector mechanisms that it can engage on binding antigen. 
The general structure of an antibody (immunoglobulin) is that of a bifunctional molecule, 
comprising two antigen binding domain on one side of the molecule and an effector 
domain on the other side. The antigen binding domains are highly diverse and are 
produced by somatic recombinations and mutaions, which create the variable domain of 
the antibody molecule. The effector functions are part of the constant region of the 
antibody. The antibodies are multichain proteins, consisting of two pairs of light chains 
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(either κ or λ isotype) and two pairs of heavy chains (isotype γ, ε, δ, α, or µ) organized into 
three structural units as presented in Figure 1-4. Two of these units called Fab for 
Fragment antigen binding are identical and enable the binding to an antigen. The other unit 
has no antigen binding activity and was originally observed to crystallize readily, and for 
that reason was named the Fc fragment for Fragment crystalline. The Fc fragment interacts 
with effector systems such as the complement system. The light chain (L) is formed by two 
domains of about 100 residues in length, called the variable (VL) and the constant (CL) 
domain. The heavy chain (H) contains a variable domain (VH) and three or four constant 
(CH1, CH2, CH3, CH4) domains, depending on the isotype (Alberts et al., 1989). Each 
domain is formed by two β sheets packed face to face and linked together by conserved 
disulfide bridge and by interstrand loops (Lesk and Chothia, 1982). Disulfide bridges are 
an important component of the IgG structure. Intrachain disulfide bonds stabilize domain 
folding and interchain disulfide bonds stabilize the interaction of H and L chains and the 
interaction of H chains (Burton., 2001). The antigen binding sites of most antibodies are 
formed by six loops called ‘complementary determining regions’ (CDRs) (Kabat et al., 
1977; Kabat, 1978), three from the VL domain (L1, L2, L3) and three from the VH domain 
(H1, H2, H3) (Al-Lazikani et al., 1997). The CDR with the greatest variation in terms of 
length and sequence is the heavy-chain CDR3 (HCDR3) (Sanz, 1991). Comparison of the 
crystal structures of a number of antibodies suggests that CDRs, with the exception of 
HCDR3, adopt a limited number of confirmations or ‘canonical structures’. In each 
antibody, 3-5 residues of the CDR loops contribute contact sites to the antigen interaction. 
The regions of variable domains outside these loops are called framework. They are highly 
conserved in sequence and their conformation can be predicted using standard homology 
modelling techniques (Morea et al., 1998; Morea et al., 2000). 
By limited proteolytic digestion, it is possible to obtain smaller antibody fragments 
containing only a subset of the domains of a complete antibody, of which they maintain 
either the antigen binding ability (F(ab')2 , Fab, Fv) or the effector unit (Fc) (Winter and 
Milstein, 1991). Recent improvements in heterologous gene expression and the 
development of phage display technologies permit the design and expression of 
recombinant antibodies (rAb) with multiple specificity such as: scFv fragment, bispecific 
scFv, diabody (Holliger et al., 1993; Holliger and Winter, 1997; Hudson, 1999; Breitling 
and Dübel, 2000) (Figure 1-4). 
As antibodies are very large molecules, the use of small fragments can be advantageous for 
research and in vivo applications, due to their ability to penetrate tissues and faster 
clearance from tissues and serum (Yokota et al., 1992; Cumber et al., 1992). Recombinant 
antibody fragments have been fused with a range of molecules including enzymes for 
prodrug therapy, toxins for cancer therapy, viruses for gene therapy, ligands to guide them 
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to specific cellular targets (Michael et al., 1996; Douglas and Curiel 1997; Brinkmann, 
2000). 
 
Figure I-4 Schematic presentation of IgG molecule and antibody fragments 
 
The recombinant antibody fragment most commonly used in research and therapy is the 
single chain antibody fragment (scFv) (Bird et al., 1988; Huston et al., 1988; Skerra and 
Plückthun, 1988). ScFv fragments (~30 kDa) contain the complete antigen binding site of 
an antibody. In scFv fragments, the VH and VL domains are covalently linked by a flexible 
peptide linker (Whitlow et al., 1993) (usually 15-20 amino acids long, e.g. of the sequence 
(Gly4Ser)3, or 218 linker) (Whitlow et al., 1993). If no reorientation of the two domains 
occurs they should have the same monomeric binding affinity as the parental monoclonal 
antibody as experimentally demonstrated in a number of cases (e. g. Bird et al., 1988; 
Glockshuber et al., 1990; Huston et al., 1991). The hydrophobic interaction between the 
VH and VL domains is not very strong. This can lead to dimer formation where the VH of 
one molecule interacts with the VL of another and vice versa. Consequently, most scFv 
fragments are found in two forms: monomer and dimer (Kortt et al., 1994; Chames and 
Baty, 2000). This tendency to dimerize has been exploited to create bivalent or bispecific 
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diabodies (Holliger and Winter 1997; Perisic et al., 1994; Plückthun and Pack, 1997) and 
triabodies (Iliades et al., 1997). 
Single-chain fragments can be expressed in a variety of hosts (Verma et al., 1998), 
including bacteria (Plückthun et al., 1996), yeast (Fischer et al., 1999a) and plants 
(Shimada et al., 1999; Fischer et al., 1999b; Fischer et al., 1999c; Smith and Glick 2000). 
Single-chain fragments have found broad applications in medicine (Huston et al., 1993; 
Hudson, 1999) and have also great potential in biotechnology (Harris, 1999). The unique 
and highly specific antigen-binding ability might, for example, be exploited to block 
specific enzymes, bacteria or to detect environmental pollutents present in very low 
concentrations (biosensors) (Wörn and Plückthun, 2001). 
 
I.2.2 Immunoglobulin genetics 
In humans, antibody gene loci have been well characterized (Berek and Milstein, 1988; 
Tomlinson et al., 1995; Cook and Tomlinson, 1995). There are approximately 50 
potentially functional heavy-chain germ-line sequences (VH gene segments) that are 
organized into seven families. The largest family is VH3 with 22 genes, followed by VH1 
and VH4. VH5 has only two members and VH6 only one. The relative expression of these 
families is VH3>VH1, VH4>VH6>VH5>VH2. There are about 40 Vκ and about 30 Vλ human 
light chain germ-line genes, organized into six κ and ten λ families (Schable and Zachau, 
1993). In human antibodies, the κ to λ ratio is typically of the order 3:2. 
In mice, there are more than 100 heavy chain germ-line sequences organized into 15 or 
more families, and a similar number of κ light-chain sequences (Coutinho et al., 1992). 
The expression of λ chains in mice is far less than in humans, with only two potentially 
functional genes in most strains. In Balb/c mice, light chains are expressed with a typically 
κ:λ ratio of about 20:1. 
Antibody diversity is generated by somatic recombination in B lymphocytes, whereby V 
gene segments are linked to other gene segments (Dreyer and Bennett, 1965; Schroeder et 
al., 1995a). For the heavy chain, one of 27 diversity (D) gene segments is linked to one of 
6 joining (JH) gene segments. In turn, this D-JH fusion is linked to a VH gene segment to 
produce a VH rearrangement VH-D-JH segment that contains the complete coding region for 
the heavy chain variable domain. Later, the constant domain coding segment is joined by 
RNA splicing that determines the isotype of expressed antibody. For the κ chain, a Vκ gene 
segment is joined to one of 5 Jκ segments; for the λ light chain, a Vλ segment is joined to 
one of 4 Jλ segments. Additional diversity is generated during recombination by imprecise 
joining at the junctions of some of the gene segments. The greatest diversity is therefore 
typically seen at and between these two junctions, which structurally correspond to the 
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heavy-chain CDR3 region. Finally during an in vivo immune response, the interaction of B 
cells with antigen often results in additional diversity in antibody genes. 
 
I.2.3 Selection of recombinant antibodies by phage display 
Phage display is a powerful technique for rapid selection of high affinity recombinant 
antibody fragments from large repertoires to any protein of interest (Barbas et al., 1991; 
Hogenboom et al., 1998). The development of phage display vectors (Smith, 1985) has 
allowed expression and presentation of antigen-binding antibody fragments on the surface 
of filamentous phages. In 1990, McCafferty and colleagues demonstrated in a model 
experiment that it was possible to select antibody fragments from a large population of 
non-binding proteins by filamentous bacteriophages. A protein, in this case an antibody 
fragment, is located on the surface of a phage particle by cloning the antibody fragment 
into the phage genome, fused with a coat protein (pIII, pIV or pVIII). Upon expression, the 
coat protein fusion will be incorporated into new particles that are assembled in the 
bacterium. Expression of the fusion product and its subsequent incorporation into the 
mature phage coat results in the binding structures being present on the phage surface, 
while its genetic material resides within the phage particle. This relation between genotype 
and phenotype allows enrichment of specific phages (Barbas, 1993; Burton and Barbas, 
1994; Hoogenboom, 1997), which are selected on immobilised targets by a simple in vitro 
selection procedure called ‘biopanning’. Phages that display a relevant binding structures 
will be retained, while non-adherent phage will be washed away. Bound phages are 
recovered from the surface and used for reinfection of bacteria.  
The success of ligand phage display hinges on the combination of this display and 
enrichment method with the synthesis of large combinatorial repertoires on phage 
(Hoogenboom et al., 1998; Chames and Baty, 2000). Large libraries displaying peptide and 
proteins have been made using pIII as fusion partner (Smith and Scott, 1993; Winter et al., 
1994), leading to the development of a number of techniques for selecting the molecule(s) 
desired from such libraries (Clackson and Wells, 1994; Hoogenboom, 1997). Peptides and 
proteins have also been fused to the amino-terminal part of the major capsid protein pVIII 
(Iannolo et al., 1995; Malik et al., 1996). Recently, heavy and light-chain variable regions 
have been fused to the amino terminus of pVII and pIX and displayed on phages showing 
that this two minor coat proteins can also been used for display (Gao et al., 1999).  
Initially, phage vectors that carried all the genetic information required for the phage life 
cycle were used (McCafferty et al., 1990; Clackson et al., 1991). Display of antibodies on 
smaller filamentous particles called phagemids (Bass et al., 1990; Breitling et al., 1991) 
advanced antibody engineering. The phagemid genome contains the filamentous phage 
intergenic region with its origin of replication for viral and complementary strand synthesis 
Chapter I Introduction 
 15
as well as the hairpin packaging signal. The phagemid also contains an origin for plasmid 
replication and a resistance marker. The phagemid can maintain itself as a plasmid and 
function as a bacterial expression vector if desired. Infection of the bacteria with a 
filamentous helper phage activates the phage origin of replication, resulting in single 
stranded phagemid DNA being encapsulated into filamentous phage-like particles using 
helper phage proteins. A helper phage, such as M13KO7 has a defective packaging signal 
so that the majority of phages produced contain the phagemid single-stranded DNA 
(Russel et al., 1986). Bacteria can be infected with this phage selected via their antibiotic 
resistance. The phagemid DNA can then be propagated again by infection of the bacteria 
with helper phage. In phagemids, the scFv may be fused at the N-terminus of the mature 
gene III protein (McCafferty et al., 1990; Hoogenboom et al., 1991) or at the N-terminus 
of truncated pIII lacking the first two N-terminal domains (Garrard et al., 1991; Barbas et 
al., 1991). Phagemids have higher transformation efficiency and they are suited for 
generating very large repertoires. They may also be formatted for direct secretion of the 
unfused antibody fragment without subcloning (Hoogenboom et al., 1991). Many 
phagemids utilize the lacZ promoter to drive expression of the antibody-pIII fusion 
(Barbas et al., 1991; Breitling et al., 1991; Hoogenboom et al., 1991; Orum et al., 1993). 
The use of a lacZ promoter with an additional transcriptional terminator (Krebber et al., 
1996) or of the phage shock promoter (psp) (Rakonjac et al., 1997) allow display of 
relatively toxic products and reduce expression-mediated library bases. 
 
I.2.4 Antibody libraries 
There are two basic types of phage antibody libraries. One is the antibody library derived 
from spleen mRNA of immunized donors the other derived from non-immunized donors. 
With the first library the phage antibody repertoire is enriched for antigen-specific 
antibodies, because some have undergone affinity maturation by the immune system 
(Clackson et al., 1991; Lorimer et al., 1996; Chowdhury et al., 1998). This method yields 
antibodies with higher affinity than these from hybridomas (Chester et al., 1994). For 
immune libraries it is preferable to use a donor with a high serum antibody titer to the 
antigen of interest. More specific antibodies reflect higher levels of specific mRNA. 
Therefore, the likelihood of combining heavy and light chain fragments specific for the 
protein of interest is greater. The construction of immune libraries from a variety of species 
has been reported, including mouse, human, chicken, rabbit and camel (Hoogenboom et 
al., 1998).  
The other type of phage display library are ‘single-pot’ libraries that depend on the source 
of immunoglobulin genes and are further discriminated in ‘naïve’ and ‘synthetic’ antibody 
libraries. The naïve library offers the possibility to select high–affinity antibodies of any 
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desired specificity without the need for immunization (Burton, 2001). V-genes are 
amplified from B-cell cDNA using VL and VH family specific oligonucleotides (Marks et 
al., 1991). The heavy and light chains are randomly combined and cloned to encode a 
combinatorial library of scFv or Fab antibody fragments. This procedure provides access to 
antibodies that have not yet encountered antigen, although the frequency of those genuine 
‘germline antibodies’ is depended on the source of B-cells. A large and diverse naïve 
library can be used to generate antibodies to a large panel of antigens, including self, non-
immunogenic and relatively toxic antigens (Griffiths et al., 1993; Marks et al., 1991; 
Vaughan et al., 1996). The naïve library has to be extremely large to represent almost the 
entire immune repertoire and allows selection of antigen binders with sufficient affinity. 
They must be in the order of 1010 or more, a size that is technically difficult to attain 
(Marks et al., 1991; Voughan et al., 1996). The affinity of antibodies selected from a naïve 
library is proportional to the size of the library, ranging from 106-7 M-1 for a small library, 
to 108-10 M-1 for a very large repertoire made by brute force cloning (Vaughan et al., 1996). 
Alternatively, ‘synthetic’ libraries have been made artificially by in vitro assembly of V-
gene segments and D/J fragments. PCR techniques and degenerate primers are used to 
introduce diversity at precise locations, typically CDR3s (Ellman and Gallop, 1998; 
Hoogenboom and Chames, 2000). The regions and degree of diversity may be chosen to 
correspond to areas of highest natural diversity of the antibody repertoire. 
Ultimately, the value of any library is best determined by its success in yielding specific, 
high-affinity ligands for a variety of target molecules. However, antibodies with modest 
affinity can be engineered to bind with higher affinity to a target molecule by constructing 
multivalent molecules (Plückthun and Pack, 1997; Hoogenboom, 1997) or in vitro affinity 
maturation. Diversity in the antibody genes may be introduced using a variety of methods 
such as: mutator strains (Low et al., 1996; Irving et al., 1996), error prone PCR (Hawkins 
et al., 1992), chain shuffling (Clackson et al., 1991; Marks et al., 1992), DNA shuffling 
(Stemmer, 1994a,b), codon based mutagenesis (Virnekäs et al., 1994). The ability to alter 
affinity and selectivity by evolution of a parent antibody is a powerful advance in antibody 
display technology. 
Phage display has been mostly used for affinity screening of combinatorial peptide and 
protein libraries, to define epitopes for monoclonal antibodies, to increase antibody 
affinity, to select enzyme substrates and to screen cloned antibody repertoires (Clackson et 
al., 1991; Griffith and Duncan, 1998; Hoogenboom et al., 1998; Benhar et al., 2000). 
Phage display systems have also been used to provide an understanding of the structural 
bases of an interaction in systems in which insights is limited (Wright et al., 1995; 
McConnell et al., 1996). Antibody phage display is versatile in allowing the effective 
display of scFv (Orlandi et al., 1989; McCafferty et al., 1990), Fab fragments (Barbas et 
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al., 1991, Hoogenboom et al., 1991; Yang et al., 1995), and diabody fragments (Holliger et 
al., 1993; McGuinness et al., 1996). 
 
I.2.5 Expression of antibody genes in plants: immunomodulation 
The first plant expressed antibody, a full length IgG, was described in 1989 (Hiatt et al., 
1989). Since then, plants have been engineered to synthesize a wide range of recombinant 
antibodies, from dAbs (Benvenuto et al., 1991), scFv (Fiedler and Conrad, 1995; 
Artsaenko et al., 1998; Zimmermann et al., 1998; Vaquero et al., 1999; De Wilde et al., 
1999; Smith and Glick, 2000; Stöger et al., 2000) and bispecific scFv (Fischer et al., 
1999d) to Fab fragments (De Neve et al., 1993) and secretory IgA antibodies (Ma et al., 
1995; Ma and Hein, 1996; Ma and Hiatt, 1996), that can be subsequently used for therapy, 
diagnosis or laboratory and industrial applications (De Wilde et al., 1999, Peeters et al., 
2001). Although the maximum level of antibody accumulation depends on plant species, 
tissues and on the intrinsic properties of the antibody itself, recombinant protein 
accumulation and stability can be optimized by exploiting the protein sorting and targeting 
mechanisms of plant cells. Directing the target rAbs to the secretory pathway using either 
plant (De Neve et al., 1993) or murine (Hiatt et al., 1989) leader peptides, results in their 
accumulation in the intracellular space beneath the cell wall (apoplast), from where 
correctly processed, active rAbs can be recovered (De Wilde et al., 1998). Many studies 
have indicated that the full size antibodies and Fab fragments are accumulated at high 
levels (more than 0.1% of TSP) upon secretion by adding an N-terminal signal leader 
peptide sequence. Currently scFvs have been targeted to the apoplast, the ER and the 
cytosol. Targeting of scFvs torwards the apoplast or cytosol can result in large variation of 
accumulation levels ranging from 0.5 to 0.1% of TSP or even undetectable levels (De 
Wilde et al., 1999). The highest levels of scFv fragments (1-6.8% of total soluble protein) 
are obtained when they are retained in the ER by adding an N-terminal signal sequence and 
a C-terminal KDEL retention signal (De Jaeger et al., 2000). The scFv antibody fragments 
have a higher chance of being correctly folded in the cytosol because the two variable 
domains are interconnected by a flexible peptide linker, avoiding the need for assembly of 
different chains and the formation of inter-chain disulfide bridges. 
The capability of plant cells to synthesize, process and target large, complex mammalian 
proteins in a manner very similar to their natural hosts makes them an attractive alternative 
for rAb production. Antibodies or antibody fragments produced in plants are often referred 
to as ‘plantibodies’ and they can be exploited for applications in the field of molecular 
farming (Fischer et al., 1999c; Peeters et al., 2001). After isolation and purification from 
the plant tissue, the rAbs can be used in industrial processes, as diagnostic tools, for 
immunochromatography, or in medical therapy. In addition, there is a growing interest for 
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immunomodulation strategy of in planta applications, in which antibodies or antibody 
fragments are produced to modulate the function of a corresponding antigen (De Jaeger et 
al., 2000). Immunomodulation is defined as a molecular protein based technique that 
allows interference with cellular metabolism, signal transduction or pathogen infectivity by 
the ectopic expression of genes encoding recombinant antibodies (Conrad and Manteuffel, 
2001). Recombinant antibodies that specifically recognize soluble or membrane associated 
receptors, enzymes or DNA-binding proteins can interfere with the functions of these 
proteins by generating antigen-antibody complexes, or cause steric changes of the 
molecular structure combined with a loss of function. Finally, the antigen can be 
mistargeted as a result of antibody binding. 
The expression of specific scFv’s in different plant species, plant organs and cellular 
compartments offers the possibility of manipulating plant metabolism, changing the 
agronomic traits, or blocking regulatory factors, such as the immunomodulation of enzyme 
or signal molecule activity (Conrad and Fiedler, 1998; Franken et al., 1997; De Jaeger et 
al., 2000; Giddings et al., 2000; Schillberg et al., 2001; Fischer et al., 2001). The 
immunomodulation approach has been shown to be also applicable for modulating the 
infection process of plant viruses (Tavladoraki et al., 1993; Voss et al., 1995; Zimmerman 
et al., 1998; Fecker et al., 1997; Schillberg et al., 2000). 
Owen et al. (1996) demonstrated the immunomodulation of the activity of the endogenous 
photoregulatory protein phytochrome by the use of a cytosolic scFv. A similar approach 
was used to block the biological activity of the phytohormone abscisic acid by 
accumulating high concentrations of an anti-ABA-scFv in the ER of tobacco leaf cells. 
Those plants wilted under ambient conditions (Artsaenko et al., 1995) because of an 
increased transpiration rate, which indicated that they were unable to close their stomata. 
Philips et al. (1997) enabled for the first time the seed specific immunomodulation of ABA 
activity. In this study the tobacco plants had normal vegetative growth and development 
patterns while the seeds displayed an altered phenotype due to the reduction of ABA 
activity. Transgenic tobacco lines that accumulate high levels of an anti-gibberellin scFv in 
the ER showed a dwarf phenotype and lower gibberellin (Shimada et al., 1999). 
The feasibility and flexibility of recombinant antibody technology makes the plantibody 
approach one of the most recent innovations in the field of molecular techniques for the 
analysis and manipulation of plant metabolic pathways, pathogen infections and 
development. 
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I.3 Aim of this thesis 
The fast moving field of recombinant antibody technology and expression has opened new 
opportunities, not only for the medical sciences, but also for applied and fundamental 
agronomic research. The immunomodulation of regulatory processes in physiology and 
development is an interesting and powerful tool for plant cell biology. Furthermore, the 
advantage of immunomodulation versus the use of existing mutants or conventional 
inhibitor and antisense techniques is, that antibody binding can activate or inactivate the 
end product of a biosynthetic pathway without affecting the function of any precursors 
(Artsaenko et al., 1999; Conrad and Manteuffel, 2001). 
The objective of the present study was to modify levels of polyamine biosynthesis by using 
genetic engineering and antibody technology for altering polyamine production thereby 
developing transgenic plants to increase their nutritional and health value. Tobacco plants 
were initially used as a model plant prior to moving into crops. The aim of the study will 
be achieved by the following approaches: 
• Overexpression of ODC and SDE genes: The ODC gene will be amplified from a 
human prostate cDNA library and integrated into plant expression vectors for 
generation of transgenic tobacco. The enzymes will be targeted in different plant cell 
compartments to verify expression rate and integrity of the protein in these 
compartments. Stable transformed tobacco lines expressing apoplastic and cytosolic 
ODC and co-expressing ODC and SDE enzymes in apoplast will be generated. 
Immunoblot analyses will be performed to investigate the accumulation levels and the 
stability of the heterologous enzymes. The effect of recombinant proteins on the 
polyamine metabolism will be investigated by analysis of putrescine, spermidine and 
spermine levels. The enzymatic activity of ODC will be determined to investigate 
whether the overexpressed human ODC is a functional and active enzyme. 
• Inhibition of PAO activity and stabilisation of ADC and ODC using specific scFv 
fragments with high affinity generated by phage display technology: The antibody 
mediated regulation of ADC and ODC enzymes will enable enhanced production of 
putrescine while maintaining and/or improving their catalytic activity. Antibodies that 
inhibit PAO function could increase the spermidine pool by blocking the degradation 
of polyamines (Figure I-2). Recombinant scFv antibodies will be constructed by 
generation of phage displayed libraries from animals immunized with bacterial 
produced GST polyamine fusion proteins. Selected scFv-fragments will be tested for 
their reactivity and functionality to the specific target molecule in ELISA. The 
candidate scFvs will be characterised in surface plasmon resonance experiments to 
determine the affinity binding constant and epitope mapping. Electrophoretic mobility 
shift assays (EMSA) will be performed to test the functionality of engineered scFv. The 
effect of selected scFv-fragments on the enzymatic activity of target molecule will be 
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analysed by in vitro assays. Promising scFv-fragments will be subcloned into plant 
expression vectors and targeted to the apoplasm and the ER as control. Stable 
transformed tobacco lines accumulating ODC-specific scFv will be generated to 
investigate the biological effect of plant produced scFvs upon down or up regulation of 
ODC enzymatic activity. 
A schematic overview of this Ph.D thesis is presented in Figure I-5. 
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Figure I-5 Schematic overview of the project 
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II Material and Methods 
II.1 Material 
II.1.1 Chemicals and consumables 
The chemicals used throughout the work were purchased from the following companies: 
Bio-Rad (München), Roche (Mannheim), Fluka (Neu-Ulm), Gibco BRL (Eggenstein), 
Merck (Darmstadt), Amersham Pharmacia Biotech (Freiburg), Roth (Karlsruhe), Serva 
(Heidelberg), Sigma (Deisenhofen). The consumables were from: Amicon (Witten), 
Biozym (Hess. Oldendorf), Eppendorf (Hamburg), Greiner (Solingen), Kodak (Stuttgart), 
Millipore (Eschborn), Nunc (Bieberach), Schott Glaswerke (Mainz), Serva (Heidelberg), 
USB/Amersham (Braunschweig), Whatman (Bender & Hobein, Bruchsal) and Zeiss 
(Oberkochem). 
 
II.1.2 Enzymes and reaction kits 
Restriction enzymes either from New England Biolabs (Schwalbach) or GibcoBRL were 
used for DNA digestion. ExpandTM high fidelity DNA Taq polymerase from Roche was 
used for PCR amplification from cDNA libraries. Taq polymerase from Gibco BRL was 
used for amplification of mouse heavy and light chain fragments and for amplification of 
cloned DNA (‘‘check-PCR’’). 
The following kits were used: 
Plasmid isolation kits (Mini, Midi, Maxi) Qiagen (Hilden) 
QIAquick gel extraction kit Qiagen 
QIAquick PCR purification kit Qiagen 
RNeasy mini kit Qiagen 
SuperscriptTM preamplification system kit GibcoBRL 
BCA protein assay kit Pierce (Rockford) 
Bradford protein assay kit Bio-Rad 
PCR DIG probe synthesis kit Roche 
DIG luminescent detection kit Roche (Mannheim) 
 
II.1.3 Primary antibodies, secondary antibodies and substrates 
Mouse anti-GST monoclonal antibody and rabbit anti-GST polyclonal antibodies, provided 
by Dr. Michael Monecke (RWTH Aachen, Institut für Biologie VII, Germany) were used 
for analyses of GST and GST fusion protein expression. Rabbit anti-GST antibody was 
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also used as capture antibody for epitope mapping in BIAcore analyses (II.2.8.7). Mouse 
anti-c-myc tag monoclonal antibody (9E10) (ATCC clone number CRL-1729) was used 
for detection of scFv-fragments by dot blot (II.2.4.4), immunoblot (II.2.4.3) and ELISA 
(II.2.8.1). Mouse anti-his6 (Qiagen) and mouse anti-Grp78 (KDEL) (StressGen 
Biotechnologies Corp. Victoria, Canada) antibodies were also used for detection of scFv-
fragments in transient protein expression experiments. IgY’s from chicken raised against 
ODC-GST and ADC-GST fusion proteins, provided by Dr. Bernd Schneider, Institut für 
Biologie VII, Germany) were used in capture ELISA analyses (II.2.8.2) of scFv-fragments. 
Streptavidin alkaline phosphatase conjugated (StrepAP) polyclonal antibody (Dianova) was 
used for detection of biotinylated scFv fragments in competition ELISA (II.2.8.4). Alkaline 
phosphatase (AP) or horseradish peroxidase (HRP)-conjugated to goat anti-mouse IgG 
(H+L, Fc) (Dianova) antibodies were used as secondary antibody in immunoblot analysis 
(II.2.4.3) and ELISA (II.2.8.1) NBT/BCIP (Bio-Rad) and pNPP (Bio-Rad) were used as 
substrate for detection of immobilized proteins in Immunoblot (II.2.4.3) and ELISA 
(II.2.8.1), respectively. 
 
II.1.4 Bacterial strains 
E. coli strains DH5α and XL1-Blue were used as a host cells for all intermediate cloning 
constructs; BL21 was used for expression of GST fusion proteins (II.2.3.1); TG1 was used 
for generation of phage-displayed antibody libraries used in solid-phase panning (II.2.7). 
HB2151 was used for expression of soluble scFv-fragments (II.2.3.3) (Table II-1). 
 
Table II-1 Names, suppliers and genotypes of Escherichia coli strains used throughout the 
work. 
Strain Source Genotype 
DH5α Ausubel et al., 1994 
F- (f80d Lac 2∆M15) ∆(LacZYA-argF) U169end A1 rec1 
hsdR17(rk- mk+) deoR thi-1 supE44 gyrA96 relA1 λ- 
HB2151 Ausubel et al., 1994 K12, ara, ∆(lac-pro), thi/ F´ pro A+B+, lacIqz∆M15 
BL21(λDE3) Novagen F
- ompT hsdSB (rB- mB-) gal dcm (DE3) 
XL1-Blue Stratagene 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ 
proAB laclIq Z∆M15 Tn10 (Tetr)] 
TG1 Stratagene  
supE thi-1 ∆(lac-proAB) ∆(mcrB-hsdSM) 5(rK- mK-) 
[F´traD36 proAB lacIq Z∆M15] 
SCS 110 Stratagene  
rpsL (Strr) thr leu endA thi-1 lacY galK galT ara tonA tsx dam 
dcm supE44 ∆(lac-proAB) [F´ traD36 proAB lacIq Z∆M15] 
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Agrobacteria strains: 
Agrobacterium tumefaciens GV 3101 (pMP90RK GmR, KmR, RifR (Koncz and Schell, 
1986) was used for agrobacterium-mediated gene transfer (II.2.1.6). 
 
II.1.5 Plants and animals 
Nicotiana tabacum L. cv. Petite Havana SR1 was used for transient protein expression 
after vacuum infiltration of agrobacteria (II.2.2.1), and generation of stable transformed 
plants (II2.2.4). Stable transformed tobacco plants targeting recombinant spermidine 
synthase (SDE) to the apoplast were provided by Dr. Bernd Schneider (RWTH Aachen, 
Institut für Biologie VII, Germany). 
6-8 weeks old female BALB/c mice were used for immunization with ADC, GST-ODC 
and GST-PAO fusion proteins (II.2.5). Brown Leghorn chicken about 12 weeks old were 
immunized with GST-ADC, GST-ODC and GST-PAO. 
 
II.1.6 Phage 
M13KO7 helper phage (Amersham Pharmacia Biotech) is an M13mp1 derivative 
containing a modified gene 11 [G changed to T at position 6125, giving a methionine to 
isoleucine change at codon 40 of the gene 11 protein]. The p15A origin of replication and 
the kanamycin resistance gene from Tn903 are present in M13KO7. 
 
II.1.7 Vectors 
Schematic presentation of the vector maps are presented in the Appendix. 
pGEM-3zf (Promega) was used for cloning the human ODC gene amplified from prostate 
cDNA library. 
pGEX-5X-3 from Amersham Pharmacia Biotech, modified at the multiple cloning site by 
insertion of a NcoI site was used for subcloning the ODC gene and expression of the GST 
fusion protein. 
pET22b(+) from Novagen, was used for cloning and purification of recombinant proteins 
via IMAC (immobilized metal ion affinity chromatography). 
pHEN4II phagemid vector containing SfiI-BstEII, AscI-NotI cloning sites, the 218* linker 
was used to establish the mouse phage display libraries. The pHEN4II vector (Zhang et al., 
2001) based on the pHEN4C vector (Hoogenboom, et al., 1991). 
Chapter II Material and Methods 
 25
pSynI used for cloning and expression of soluble scFv-fragments was generated from 
pHEN1 phagemid vector (Hoogenboom et al., 1991) by removing the fd-gene III and 
addition of a C-terminal His6 tag (Dr. Ricarda Finnern, Fraunhofer IME, Aachen, 
Germany) 
pUC18 (Yanisch-Perron and Messing, 1985) containing the SCA24OmW cassette (Dr. 
Sabine Zimmermann, Institut für Biologie VII, RWTH, Aachen, Germany) (see III.4.1.1) 
was used for subcloning of the ODC gene. 
PSSH1 plant expression [10,3 kBp, AmpR CbR, KmR] (Voss et al., 1995) was used for 
transformation of A. tumefaciens and expression of ODC in different plant cell 
compartment. pSSH1 plasmid is a derivative from the binary vector pPCV002 (Koncz and 
Schell, 1986). It contains the CaMV-35S expression cassette from pRT101 (Töpfer et al., 
1988) with a duplicated 35S enhancer region (Kay et al., 1987; Becker, 1990) and the 3' 
UTR. 
pTRA (Thomas Rademacher, Institut für Biology VII, RWTH Aachen, Germany) is a 
optimized plant expression vector containing the 35SS promoter and the pA35S 
untranslated region from CaMV. A matrix attachment region was introduced to improve 
transcription. 
 
II.1.8 Oligonucleotides 
Oligonucleotides used for sequence analysis and amplification of DNA are listed below. 
All oligonucleotides were synthesized by MWG (Ebersberg, Germany). 
1. Primers used for amplification of human ODC from prostate cDNA library 
forward ODC: 5′ – CCG GAA TTC CCC ATG GGT AAC TTT GGT AAT GAA 
                               GAG T - 3′ (37-mer) 
reverse ODC: 5′ –  GGG AAG CTT GTC GAC CAC ATT AAT ACT AGC CGA 
                               AGC AGC A - 3′ (40 -mer) 
 
2. Primers used for PCR amplification of recombinant DNA (E. coli and A. 
tumefaciens) from: 
• pSS and pTRA: 
forward pSS 5′: 5′ - GAC CCT TCC TCT ATA TAA GG (20-mer) 
reverse pSS 3′: 5′ - C AC ACA TTA TTC TGG AGA AA (20-mer) 
 
• pHEN4II: 
LMB3: 5′- CAG GAA ACA GCT ATG AC - 3′ (17-mer) 
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fdseq: 5′- GAA TTT TCT GTA GG - 3′ (14-mer) 
 
3. Primers used for cDNA synthesis and PCR amplification of mouse VH- and VL-
domains 
Table II-2 Murine phage display primer sequences for first strand cDNA generation from 
total RNA in 5′-3′ orientation. 
COH 30 (CH1 IgG1) GGC CAG TGG ATA GAC AGA 
COH 32 (CH1 IgG2a/2b) TAA CCC TWG ACC AGG CAT CC 
Mu PD 31 (CL1 κ) 
GCT GAT GCT GCA CCA ACT GTA TCC GTC GAC GCG 
GCC GCG ACT AGT 
Mu PD 32 (CL1 λ) 
TTT CCA CCT TCC TCT GAR GAG CTT GTC GAC GCG 
GCC GCG ACT AGT 
 
Table II-3 Sequences of murine VH domain specific front primers MPDVHF1-MPDVHF16 
in 5′-3′ orientation. 
Name Overhang region Restriction enzymes (SfiI/NcoI) Binding region 
MPDVHF1 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAK GTR CAG CTT CAG 
GAG TCR GGA 
MPDVHF2 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
CAG GTG MAG CTG AWG 
GAR TCT GG 
MPDVHF3 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAG GTC CAG CTR CAR 
CAR TCT GGA CC 
MPDVHF4 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
CAG GTW CAG CTS CAG 
CAG TCT G 
MPDVHF5 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
SAG GTC CAR CTG CAG 
SAR YCT G 
MPDVHF6 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAG GTT CAG CTG CAG 
SAR YCT GGR 
MPDVHF7 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAR GTG AAG CTG GTG 
GAR TCT GGR 
MPDVHF8 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAG GTG AAG STY MTC 
GAG TCT GGA 
MPDVHF9 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAR GTG AAG CTK GAK 
GAG WCT GR 
MPDVHF10 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAV GTG MWG CTK GTG 
GAG TCT GGK 
MPDVHF11 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAG GTG CAR CTK GTT 
GAG TCT GGK 
MPDVHF12 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
SAG GTY CAG CTK CAG 
CAG TCT GGA 
MPDVHF13 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
CAG ATC CAG TTG GTG 
CAG TCT GGA 
MPDVHF14 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
CAG GTS CAC STG RWG 
SAG TCT GGG 
MPDVHF15 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
CAG GTT ACT CTR AAA 
GWG TST GGC C 
MPDVHF16 C ATG CCA TGA CTC GC 
G GCC CAG CCG 
GCC ATG GCC 
GAT GTG AAC TTG GAA 
GTG TCT GG 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
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Table II-4 Sequences of murine VL-domain specific front primers MPDVLF1-MPDVLF15 in 
5′-3′ orientation. 
Name Overhang region Restriction enzymes (AscI) Binding region 
MPDVLF1 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT GTG MTG WCH 
CAG TCC CCA 
MPDVLF2 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT CAG ATG ATT 
CAG TCT CC 
MPDVLF3 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT GTT CTC WHC 
CAG TCT CC 
MPDVLF4 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT GTG MTG WCH 
CAG TCT CAA 
MPDVLF5 CAT GCC ATG ACT CGC GGC GCG CCT 
GAT RTT KTG ATG ACC 
CAR RCK GCA 
MPDVLF6 CAT GCC ATG ACT CGC GGC GCG CCT 
GAT RTT KTG ATG ACC 
CAR RCK CCA 
MPDVLF7 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT GTG ATG ACC 
CAR BHT G 
MPDVLF8 CAT GCC ATG ACT CGC GGC GCG CCT 
GAT ATT KTG ATG ACC 
CAR AYT CC 
MPDVLF9 CAT GCC ATG ACT CGC GGC GCG CCT 
RAM ATT GTG MTG ACC 
CAA TYT CCW 
MPDVLF10 CAT GCC ATG ACT CGC GGC GCG CCT 
SAA AWT GTK CTS ACC 
CAG TCT CCA 
MPDVLF11 CAT GCC ATG ACT CGC GGC GCG CCT 
GAY ATY CAG ATG ACM 
CAG WCT AC 
MPDVLF12 CAT GCC ATG ACT CGC GGC GCG CCT 
GAY ATY CAG ATG ACH 
CAG WCT CC 
MPDVLF13 CAT GCC ATG ACT CGC GGC GCG CCT 
GAC ATT GTG ATG ACT 
CAG GCT AC 
MPDVLF14 CAT GCC ATG ACT CGC GGC GCG CCT 
CAR SYT GTK STS ACT 
CAG KAA T 
MPDVLF15 CAT GCC ATG ACT CGC GGC GCG CCT 
CAR SYT GTK STS ACT 
CAG KCA T 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
 
Table II-5 Sequences of murine VH-domain specific back primers MPDVHB1-MPDVHB5 
in 5′-3′ orientation 
Name Overhang region Restriction enzymes (BstEII) Binding region 
MPDVHB1 CTA GTG GTA CTC CAC GGC GCG CCT 
MRG AGA CDG TGA SMG 
TRG TC 
MPDVHB2 CTA GTG GTA CTC CAC GGC GCG CCT 
MRG AGA CDG TGA SRG 
TRG TG 
MPDVHB3 CTA GTG GTA CTC CAC GGC GCG CCT 
MRG AGA CDG TGA SCA 
GRG TC 
MPDVHB4 CTA GTG GTA CTC CAC GGC GCG CCT 
MRG AGA CDG TGA STG 
AGG TT 
MPDVHB5 CTA GTG GTA CTC CAC GGC GCG CCT 
MRG AGA CDG TGA STG 
ARA TT 
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Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
 
Table II-6 Sequences of murine κ VL-domain specific back primers MPDVLB1-MPDVLB5 
in 5′-3′ orientation 
Name Overhang region Restriction enzymes (SalI/NotI) Binding region 
MPDVLB1 CT AGT GGT ACT CCA C 
GC GGC CGC GTC 
GAC 
AGC MCG TTT CAG YTC 
CAR YTT 
MPDVLB2 CT AGT GGT ACT CCA C 
GC GGC CGC GTC 
GAC 
AGC MCG TTT KAT YTC 
CAR YTT 
MPDVLB3 CT AGT GGT ACT CCA C 
GC GGC CGC GTC 
GAC 
AGC MCG TTT BAK YTC 
TAT CTT TGT 
MPDVLB4 CT AGT GGT ACT CCA C 
GC GGC CGC GTC 
GAC 
AGC MCG AGC MCG TTT 
TAT TTC CAA MKT 
MPDVLB5 
(λ) 
CT AGT GGT 
ACT CCA C 
GC GGC CGC GTC 
GAC 
CTG RCC TAG GAC AGT 
SAS YTT GGT 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
 
Table II-7 Primers used for DNA sequencing [LI-COR IR2-DNA sequencer, labelled with 
IRD 700 or IRD 800 (USB/Amersham)]. Sequences given in 5′-3′ direction. 
Universe GTT GTA AAA CGA CGG CCA GT 
Reverse (P4) ACA CAG GAA ACA GCT ATG AC 
pHEN forward GCC GCT GGA TTG TTA TTA CTC GC 
pHEN backward TTT CAA CAG TCT ATG CGG CCC C 
pSS 5′ ATC CTT CGC AAG ACC CTT CCT CT 
pSS 3′ AGA GAG AGA TAG ATT TGT AGA GA 
pGEX forward GGG CTG GCA AGC CAC GTT TGG TG 
pGEX backward TTT CAA CAG TCT ATG CGG CCC C 
P62 Myc.SeqRic. GCC CCA TTC AGA TCC TCT TCT G 
 
 
II.1.9 Buffers, media and solutions 
All standard solutions, buffers, and media were prepared according to Sambrook et al. 
(1989), Ausubel et al. (1995) and Coligan et al, (1995). Compositions of non-standard 
solutions or buffers are listed at the end of the respective method section. Media for 
cultivating bacteria were sterilized by autoclaving (121oC/1-2 bar), all other solutions were 
sterile filtered (0.2 µm). Thermo labile components such as antibiotics were sterile filtered 
and added to the media after autoclaving and cooling to 50°C. 
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II.1.10 Matrices and membranes 
Glutathione sepharose 4B from Amersham Pharmacia Biotech was used for purification of 
GST fusion proteins (II.2.3.1).  
Ni-NTA agarose matrix from Bio-RAD was used for purification of scFv fragments from 
large scale cultures by immobilized metal ion affinity chromatography (IMAC) (II.2.3.3).  
ImmobilonTM-P transfer membrane (PVDF) (0.45µm) from Millipore, HybondTM-C 
nitrocellulose membrane (0.45µm) from Amersham Life Science and Whatman no.1 paper 
from Whatman (Maidstone, England) were used in immunoblot analysis (II.2.4.3). Hybond 
N+ nylon transfer membrane (0.45µm) from Amersham Life Science was used in Northern 
blot analysis (II.2.2.8) 
 
II.1.11 Equipment and applications 
Biochrom 20 amino acid analyser (Amersham Pharmacia Biotech) and EZchrom V 6.7 
data system software (Amersham Pharmacia Biotech). 
Cameras: MP4 (Polaroid, Cambridge, MA, USA). E.A.S.Y 429K camera (Herolab, 
Wiesloch). 
Centrifuges: AvantiTM 30 and AvantiTMJ-25 (Beckman, California, USA), Biofuge A 
(Heraeus, Hanau), Sigma 3-10 and Sigma 4-10 (Sigma, St. Louis, Missouri, USA), RC5C 
and RC5B plus (Sorval instruments, Du Pont, Bad Homburg). Rotors: F0650, F2402H, 
JLA 10.500 and JA 25.50 (Beckman), #1140 and #11222 (Sigma), RLA-300, SS-34 and 
GS-3 (Du Pont). 
Chromatography equipment: ÄKTA explorer 10xT (Amersham Pharmacia Biotech), Gel 
filtration XK26 column 26 mm inside diameter, 20 cm length (Amersham Pharmacia 
Biotech), 150 ml super-loop (Amersham Pharmacia Biotech) and UNICORN control, 
evaluation and documentation software (Amersham Pharmacia Biotech). 
DNA gel electrophoresis apparatus: wide mini and mini cells for DNA agarose 
electrophoresis and power supplies (Bio-Rad). 
DNA-sequencing machine: LI-COR IR2-4200 Sequencer (LI-COR, MWG-Biotech) and 
Base ImageIRTM 4.0 software (LI-COR). 
Electroporation apparatus: “Gene pulserTM”, “Pulse controller” unit, Extender unit 
(BioRad) and 0.2 cm cuvettes (Bio-Rad). 
InnovaTM 4340 incubator shaker (New Brunswick Scientific, Nürtingen). 
PCR Thermocyclers: Primus and Primus 96 plus (MWG-Biotech). 
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Photometers: Spectrophotometer Uvikon 930 (Kontron, Neufahrn) and multi-channel 
spectrophotometer Spectromax 340 (Molecular Devices, Sunnyvale, Kalifornien).  
Probe sonicator: (Braun Biotech, Melsungen). 
Protein gel electrophoresis equipment: Mini PROTEAN IITM from BioRad. Gel Air 
Dryer (Bio-Rad). 
Surface plasmon resonance: BIACORE® 2000 (BIACORE, Uppsala, Schweden) + PC, 
Windows NT 4.0 operating system (Microsoft) and Software (BIAControl 1.3 and 
BIAEvaluation 3.0). 
UV-Transilluminators: wavelength 302 nm and UVT-20M (Herolab). UV-chamber (Bio-
Rad). 
Software: Windows NT 4.0 operating system (Microsoft); Microsoft Office 2000 
(Microsoft); Adobe Photoshop 6.0 (Adobe); Chromas; Origin 6.0 (Data analysis and 
technical graphics, Microcal Software, Inc.); GCG (Wisconsin Package TM of Genetic 
Computer Group). 
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II.2 Methods 
All experiments related to the genetic engineering were performed according to the 
regulations of “S1-Richtlinien” and were officially approved by the “Regierungspräsidium 
des Landes NRW” (RP-Nr.: 23.203.2 AC 12, 21/95) and “BGA” [AZ 521-K-1-8/98:AI3-
04/1/0866/88 (S1) and 55.8867/-4/93 (greenhouse)]. 
General recombinant DNA techniques, i.e. PCI (phenol/chloroform/isoamyl alcohol) and 
CI (chloroform/isoamyl/alcohol) extraction, DNA precipitation, restriction enzyme 
digestion, DNA ligation, DNA agarose gel electrophoresis, were according to the standard 
protocols described in Sambrook et al. (1989) and Ausubel et al. (1995). 
 
II.2.1 Recombinant DNA technologies 
II.2.1.1 Competent cells for RbCl-mediated transformation 
E. coli strain DH5α competent cells were prepared for RbCl-mediated transformation by 
heat-shock as described by Hanahan (1985). A single bacterial colony was inoculated in 
5 ml of LB broth and cultured at 37°C overnight (o/n). 0.5 ml of the o/n culture was 
transferred into 50 ml of LB broth containing 20 mM MgSO4 and 10 mM KCl. The cells 
were cultured at 37°C for 3-4 hours until the OD600nm reached 0.4-0.5 and then transferred 
to an ice-cold tube. After incubation on ice for 10 min, the cells were recovered by 
centrifugation (2000g/4°C/10 min). The pellets were resuspended in 15 ml ice-cold TfB-I 
solution by gentle vortexing and stored on ice for 10 min. The cells were recovered by 
centrifugation as described above and resuspended in 2 ml ice-cold TfB-II. 200 µl-aliquots 
of the suspension were dispensed into prechilled microcentrifugation tubes, frozen 
immediately in liquid nitrogen and stored at -80°C. 
 
TfB-I pH 5.8: 
                       Potassium acetate 30 mM 
                       MnCl2 50 mM 
                       CaCl2 10 mM 
                       Glycerol 15% (v/v) 
 
TfB-II pH 6.8: 
                         MOPS 30 mM 
                         CaCl2 75 mM 
                         RbCl 10 mM 
                         Glycerol 15% (v/v) 
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II.2.1.2 Transformation of E. coli by heat-shock 
As soon as the competent cells (II.2.1.1) were thawed, plasmid DNA (up to 100 ng) 
(II.2.1.10) or ligation products (Sambrook et al., 1989) were mixed gently with the 
competent cells and incubated on ice for 30 min. The cells were then exposed to 42°C for 
90 seconds and placed on ice for 2 min. 800 µl of LB medium were added to the tubes and 
incubated at 37°C for 45 min. 200 µl of cells were plated onto a LB-agar plate 
supplemented with appropriate antibiotics and incubated at 37°C overnight. 
II.2.1.3 Preparation of electrocompetent E. coli 
Electrocompetent E. coli were prepared from the following strains, DH5α, BL21(DE3), 
SCS110, HB101, XL1-blue, and TG1 as described by Dower et al. (1988). A single 
bacterial colony from an LB plate was inoculated in 5 ml LB-broth and cultured at 37°C 
o/n. Three ml of fresh o/n culture was transferred into 500 ml of LB broth. The cells were 
cultured at 37°C for 3-4 hours until the mid-log phase (OD600nm = 0.5-0.8). Then the cells 
were placed on ice for 15-20 min and harvested by centrifugation (3000g/4°C/10 min). 
Cells were washed three times with sterile water and resuspended in ice-cold 10% (v/v) 
glycerol to a 300-fold concentration from the original culture volume (at >1010 cells/ml). 
40 µl aliquots were stored at -80°C. 
II.2.1.4 Transformation of E. coli by electroporation 
Electrocompetent cells (II.2.1.3) were thawed on ice and mixed with 1 pg to 300 ng of 
DNA in sterile dH2O. The cell/DNA mixture was transferred into a prechilled 
electroporation cuvette (0.2 cm) and assembled into a safety chamber. After application of 
the pulse (25 µF, 2.5 kV, 200 Ω), the cells were diluted in 1 ml of SOC medium and 
incubated at 37°C with shaking for 1 h. Finally, 100 µl of the cells were plated onto LB-
agar containing appropriate antibiotics and incubated at 37°C o/n. 
II.2.1.5 Preparation of electrocompetent Agrobacterium cells 
A single colony of Agrobacterium tumefaciens strain GV3101 grown on YEB-agar plate 
containing 100 µg/ml rifampicin (Rif) and 25 µg/ml kanamycin (Km) (YEB-Rif-Km) was 
inoculated in 5 ml of YEB-Rif-Km medium in a 100 ml Erlenmeyer flask and incubated at 
28°C for two days with shaking (250 rpm). 1 ml of the culture was transferred into 100 ml 
of YEB-Rif-Km medium and cultivated at 28°C for 15-20 h with shaking (250 rpm) until 
the OD600nm reached 1-1.5. The cells were chilled on ice for 15 min and spun down by 
centrifugation (4,000g/4°C/5 min). The culture medium was decanted and the cells were 
washed three times with 10 ml of dH2O by centrifugation and resuspended in 500 µl of 
sterile 10% (v/v) glycerol. 45 µl-aliquots of the suspension were dispensed into prechilled 
microcentrifugation tubes, frozen immediately in liquid nitrogen and stored at -80°C. 
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YEB-Rif-Km medium: 
                                        Nutrient Broth 0.5% (w/v) 
                                        Yeast Extract 0.1% (w/v) 
                                        Peptone 0.5% (w/v) 
                                        Sucrose 0.5% (w/v) 
2 mM MgSO4, 100 µg/ml rifampicin, 25 µg/ml kanamycin were added after autoclaving 
and cooling. 
II.2.1.6 Transformation of Agrobacterium by electroporation 
0.2-1.0 µg of plasmid DNA (II.2.1.10) in sterile dH2O was added to a thawed aliquot of 
electrocompetent Agrobacterium cells (II.2.1.5) and incubated on ice for 3 min. The 
cell/DNA mixture was transferred into a prechilled electroporation cuvette (0.2 cm) and 
assembled into a safety chamber. After application of the pulse (25 µF, 2.5 kV, 200 Ω), the 
cells were diluted in 1 ml of SOC medium in a 4.0-ml tube and incubated at 28°C with 
shaking (250 rpm) for 1 h. Finally, 1-10 µl of the cells were plated on YEB-agar 
containing 100 µg/ml rifampicin (Rif), 25 µg/ml kanamycin (Km) and 100 µg/ml 
carbenicillin (Carb) (YEB-Rif-Km-Carb) and incubated at 28°C for 2-3 days. As a control 
transformation of Agrobacterium cells with H2O was performed. 
II.2.1.7 Determination of the efficiency of recombinant bacteria transformation 
Efficiency of transformation of each new batch of competent cells was measured by test 
transformations with known concentrations of supercoiled plasmid pUC18 for E. coli and 
pSSH1 for A. tumefaciens cells. The following transformation rates were obtained; RbCl 
>107/µg pUC18, electrocompetent E. coli >108/µg pUC18 and A. tumefaciens >103/µg 
pSSH1. 
II.2.1.8 Culturing of E. coli and glycerol stock preparation 
Individual colonies of all strains were obtained by plating the pertaining strain on LB agar 
plates. Strains carrying an F′ factor were spread on M9 plates. Incubation was performed at 
37oC. The plates were stored at 4oC for short periods (less than 2 weeks). LB medium 
containing the suitable antibiotics and 2% glucose was inoculated with a single 
recombinant colony of E. coli and grown o/n at 37°C with vigorous shaking (225 rpm). 
Glycerol stocks were prepared by mixing 600 µl of a fresh overnight culture with 600 µl of 
40% sterile glycerol. Bacteria glycerol stocks were stored at -80°C. 
II.2.1.9 Growth of recombinant A. tumefaciens and preparation of glycerol stocks 
Single colonies of A. tumefaciens were examined for the presence of plasmids by control 
PCR (II.2.1.13). Positive colonies were inoculated in 10 ml of YEB-Rif-Km-Carb medium 
and cultivated at 28°C for 2-3 days with vigorous shaking at 250 rpm. The culture was 
transferred to Falcon tubes and Agrobacteria cells were pellet by centrifugation at 4000g 
for 10 min at 15°C. The cells were resuspended in a 1:1 volume of YEB Rif-Km-Carb 
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medium and glycerol stock media (GSM). The suspension was aliquoted (100µl) and 
stored at –80°C for further experiments. 
 
Glycerol stock media (GSM): 
                                                  Glycerol 50% (v/v) 
                                                  MgSO4 100 mM 
                                                  Tris, pH 7.4 25 mM 
 
II.2.1.10 Isolation of plasmid-DNA from E.coli 
Recombinant plasmid DNA was purified with the Qiagen plasmid DNA Mini-and Midi- 
prep kits according to the manufacturers instructions based on the alkaline lysis method 
(Sambrook et al., 1989). Quality and yield of plasmid DNA was examined by reading the 
absorbance at 260 nm and 280 nm in a spectrophotometer according to Müller et al., 
(1993) and Sambrook et al. (1996). The integrity of DNA was verified by a control 
restriction digest followed by agarose gel electrophoresis (II.2.1.11). Isolated plasmid 
DNA was stored at -20°C. 
II.2.1.11 Agarose gel electrophoresis of DNA 
Plasmid DNA and PCR-fragments were separated in 0.8-1.2% (w/v) agarose gels. 
Preparation of agarose gels and electrophoresis of the samples were carried out as 
described by Sambrook et al., (1989). Ethidium bromide was added to the gel solution and 
TBE electrophoreses running buffer prior to the experiment. Known amounts of DNA 
molecular markers such as 1 Kb ladder, 100 bp ladder and λ-digested with PstI were used 
for evaluation and determination of DNA concentration and size. The DNA bands were 
visualised directly upon illumination with a UV transilluminator at 302 nm. 
Documentation of the DNA gels was performed by using a black and white E.A.S.Y 429K 
camera (Herolab) and a photo printer (Mitsubishi). 
II.2.1.12 Preparative agarose gel electrophoresis 
Preparative gel electrophoresis was used for large scale purification of a particular DNA 
fragment from a mixture of DNA fragments after restriction enzyme digestion. The 
agarose containing the DNA fragment of interest was excised from the gel on an UV 
transilluminator with a sterile scalpel. The DNA extraction was performed with QIAquick 
Gel extraction kit according to the manufacturers guidelines. The concentration of 
recovered DNA was measured by spectrophotometer or determined by agarose gel 
electrophoresis and was used in further experiments. 
II.2.1.13 PCR amplification 
Polymerase chain reaction (PCR) was used for amplification of ODC gene from a human 
prostate cDNA library using synthetic oligonucleotides based on the ODC database 
Chapter II Material and Methods 
 35
sequence (Gen-bank accession number M16650). DNA was amplified, based on the 
protocol of Sambrook et al. (1989), with Taq- or high fidelity DNA-polymerase and DNA 
polymerase buffer from Roche. The reactions were performed in 0.2 ml PCR reaction 
tubes (Biozym Diagnostik GmbH, Hessisch Oldendorf), using a DNA thermal Cycler 
(MWG). The cycler contained a heated lid to avoid the use of mineral oil. 
For generation of highly sensitive hybridization probes suitable for detection of low copy 
target sequences in Northen-blot hybridization (II.2.2.8), DIG-dUTP (alkali-labile) was 
incorporated into ODC-PCR product according to the manufacturers instructions (Roche). 
For rapid identification of recombinant E. coli and Agrobacteria control-PCR was carried 
out to detect plasmids as described by Jesnowski et al. (1995). 
The optimal annealing temperature (Tp) of the primers was experimentally optimised or 
calculated based on the empiric formula (Wu et al., 1991): 
Tp = {22 + 1,46 [2* (G + C) + (A + T)]} 
PCR reactions were carried out in a total volume of 50 µl as described below: 
 
Components Volume Final concentration 
10X PCR buffer 5 µl 1X 
50 mM MgCl2 1.5 µl 1.5 mM 
10 mM dNTPs 1 µl 0.2 mM each 
10 pmol forward Primer  0.5-1 µl 10 pmol  
10 pmol backward primer  0.5-1 µl 10 pmol  
Template DNA 0.5-5 µl 10-100 ng 
Taq DNA polymerase (5U/µl) 0.25 µl 1.25 units 
dd H2O  to 50 µl  
 
Amplification was carried out under the following conditions: 
    5 min 95°C 
    1 min 94°C 
    1 min 55°C          x 20-35 
    1 min 72°C 
    5 min 72°C  
 
The annealing temperature and the time for denaturation, were changed according to Tp 
value of primers and the length of the target gene. 
The performance of each PCR reaction was checked by running 5µl of each reaction on 
agarose gels (II.2.1.11), with appropriate DNA markers. 
Chapter II Material and Methods 
 36
II.2.1.14 DNA sequencing 
Fluorescently labeled primers were used for sequence analysis by chain terminating 
inhibitors (Sanger et al., 1977) using the “Thermosequenase sequencing kit’’ and the LI-
COR 4200 IR2 automated DNA sequencer. For evaluation of sequencing data the Base 
ImageIR 4.0 software package was used. 
pGEX forward and pGEX backward primers were used for sequencing the ODC gene 
cloned in the pGEX-5X-3 vector. Forward and backward pHEN primers were used for 
sequencing of scFv-fragments in the pHEN4II phagemid vector. Universal and reverse 
primers were employed for sequencing genes in pUC- or pGEM vectors. pSS 5’ and pSS 
3’ were used for sequence analysis of genes in pSSH1 vector and pTRA vector. 
P4 (reverse) and P62 (Myc.SeqRic) were used for sequence analysis of scFv-fragments 
cloned into pSyn vector. 
II.2.1.15 Sequence analysis 
Chromas software package was used for displaying the chromatogram files from LI-COR 
automated DNA sequencer. The sequences were edited and exported for further analysis 
with the Wisconsin Package TM of Genetic Computer Group (GCG). 
 
II.2.2 Generation and characterisation of transgenic plants 
II.2.2.1 Transient assay in tobacco leaves by vacuum infiltration 
Growth of recombinant Agrobacterium (II.2.1.9) and vacuum infiltration of tobacco leaves 
was performed as described by Kapila et al. (1996) and Vaquero et al. (1999). 
II.2.2.2 Preparation of recombinant Agrobacteria 
100 ml of YEB-Km-Rif-Carb medium was inoculated with 100 µl of glycerol stock of the 
selected recombinant Agrobacteria carrying with a plant expression vector. The culture 
was grown at 28°C o/n with shaking at 250 rpm. Next day the cells were pelleted by 
centrifugation at 5000 g for 10 min at 15°C and transferred into 250 ml of induction 
medium and cultivated at 28°C o/n with shaking at 250 rpm. Agrobacteria cells were 
centrifuged (4000g/15-25°C/15 min) and resuspended in 50 ml of MMA solution and kept 
at RT for 2 h. The OD600nm was measured after 1:10 dilution and the cell suspension was 
adjusted to an OD600nm of 1. 100 ml of the diluted cell suspension was used for vacuum 
infiltration of plant leaves (II.2.2.1). 
 
Induction medium: 
                                 YEB medium pH 5.6 
                                 MES 10mM 
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2 mM MgSO4, 25 µg/ml kanamycin, 100 µg/ml rifampicin, 100 µg/ml carbenicillin, 
20 µM acetosyringone were added after autoclaving and cooling. 
 
MMA buffer: 
                       MS-salts (Murashige & Skoog, basic salt mixture) 0.43% (w/v) 
                       MES; pH 5.6 10 mM 
                       Sucrose 2% (w/v) 
                       Acetosyringone was added directly before use 200 µM 
 
II.2.2.3 Vacuum infiltration of intact leaves 
Young N. tabacum cv. Petite Havana SR1 leaves (4 leaves for each construct) were placed 
in 100 ml of agrobacteria suspension in a “Weck” glass and a continuous vacuum (60-
80 mbar) was applied for 15-20 min. The applied vacuum was released rapidly, the leaves 
were briefly rinsed in tap water and kept on wet Whatman paper no. 1 with adaxial side 
upwards. The plastic tray was sealed with saran wrap and placed at 22°C with a 16 h 
photoperiod for 60 h. Leaves were weighed, frozen in liquid nitrogen and stored at -80°C 
until analysis. As control, leaves were infiltrated with agrobacteria suspension, which did 
not contain the pSSH1 or pTRA plasmid. 
II.2.2.4 Recombinant agrobacterium-mediated stable transformation of tobacco 
plants 
Stable transformation of N. tabacum was performed with the help of Dr. Flora Schuster 
(RWTH Aachen, Institute für Biology VII). Transgenic N. tabacum cv. Petite Havana SR1 
were generated by leaf disc transformation using recombinant Agrobacteria transformed 
with pSSH1 plasmid carrying apoplasmic ODC gene (II.2.1.5). Transgenic T0 plants were 
regenerated from transformed callus (Fraley et al., 1983; Horsch et al., 1985). Briefly, wild 
type plants were grown on MS medium in “Weck” glasses and the youngest leaves (length 
up to 4 cm) were used for transformation. The agrobacteria suspension was prepared as 
described above and the OD600nm was adjusted to at least 1.0 after dilution in MMA buffer. 
The leaves were cut into 8-10 pieces and transferred into “Weck” glasses containing 50-
100 ml of agrobacteria suspension and incubated at RT for 30 min. The leaf pieces were 
then transferred onto sterile pre-wetted Whatman filters in petri dishes closed with saran 
wrap and incubated at 26-28°C in the dark for two days. Following washing with distilled 
water containing 100 µg/ml kanamycin, 200 µg/ml claforan and 200 µg/ml Betabactyl 
(Ticarcillin/Clavulanic acid, 25:1), leaf pieces were transferred onto MS II-plates and 
incubated at 25°C in the dark for one week and with a 16 h photoperiod for 2-3 weeks. 
After shooting, the shoots were removed and transferred onto MS-III-plates and incubated 
at 25°C with a 16 h photoperiod for 10-14 days until roots developed. The small plants 
were transferred into “Weck’’ glasses containing MS-III medium and incubated at 25°C in 
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16 h light rhythm for 2 weeks until transferred into soil. The young leaves from 
regenerated transgenic plants were used for immunoblot analysis of expressed scFvs. 
 
MS medium:  
                            MS-salts 0.43% (w/v) 
                            Myo-Inosite (SERVA) 0.1% (w/v) 
                            Sucrose 2% (w/v) 
                            Thiamin-HCl 0.4 mg/l 
                            A. bidest add to 1000 ml 
 
The pH was adjusted to 5.8 with 1 N NaOH (for preparation of solid medium, 0.8% (w/v) 
agar were added), autoclaved and 500 µl of vitamin solution I were added upon cooling to 
55°C. 
 
MS-II medium: 
                           MS medium supplemented with: 
                            BAP (in DMSO, from Sigma) 1 mg/l 
                            NAA (from Sigma) 0.1 mg/l 
                            Kanamycin 100 mg/l 
                            Claforan 200 mg/l 
                            Betabactyl 200 mg/l 
 
MS-III medium: 
                            MS medium supplemented with: 
                            Kanamycin 100 mg/l 
                            Claforan 200-250 mg/l 
                            Betabactyl 200-250 mg/l 
 
Vitamin solution I: 
                            Glycin 0.4% (w/v) 
                            Nicotinic acid 0.1% (w/v) 
                            Pyridoxin 0.1% (w/v) 
Filter sterilized and stored at 4°C. 
II.2.2.5 Growth of N. tabacum cv. Petite Havana SR1 
Tobacco plants were grown in ED73 standard soil (Patzer, Sinntal-Jossa) with 0-30% (v/v) 
sand under the following conditions: 16 h artificial light, 25°C (or higher depending on the 
outside temperature), 10 000 Lux (plus the sun light) and 70-90% humidity. To prevent 
pollination from other plants flowers were covered with plastic bags with micro pores. 
Mature, dried seeds were stored in paper bags at RT. 
II.2.2.6 Preparation of total soluble proteins from plant leaves 
For the extraction of transiently expressed ODC and scFv in vacuum infiltrated tobacco 
leaves (II.2.2.3) or in stable transformed tobacco plant (II.2.3.4), frozen leaves were 
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ground in liquid nitrogen to a fine powder with a mortar and pestle. Total soluble proteins 
were extracted using 2 ml of extraction buffer per gram leaf material. Cell debris was 
removed by two rounds of centrifugation (16000g/4°C/30 min) and the supernatant was 
used for expression analyses by immunoblot (II.2.4.3). 
 
Extraction buffer: 
                            Tris-HCl, pH 7.5 200 mM 
                            EDTA 5 mM 
                            DTT 0.1 mM 
                            Tween 20 0.1% (v/v) 
II.2.2.7 Extraction of RNA from transgenic plants 
Total RNA was isolated from vacuum infiltrated tobacco leaves expressing apoplasmic and 
ER retained ODC. Young infiltrated leaves were ground in liquid nitrogen to a fine powder 
using mortar and pestle (baked at 180°C). The powder was transferred to a 2 ml RNase 
free tube and extraction of total RNA was performed using RNeasy mini kit (Qiagen) 
according to the manufacturers instructions. 3 µl of extracted total RNA were run on an 
agarose gel to check quantity and purity of RNA. 
II.2.2.8 Northern-blot analysis 
RNA samples, in different concentrations were mixed 1:3 (v/v) with RNA loading buffer, 
denaturated for 10 min at 65°C and separated in 1% (w/v) agarose gel with 2.4 M 
formaldehyde in MOPS buffer. The gel was run at 65 volts for 2 h, then equilibrated two 
times in 20x SSC buffer for 15 min. The transfer of RNA-samples from the agarose gel 
onto Hybond N+ nylon membrane was performed by a ‘downward’ alkaline capillary 
transfer for 3 h at RT (Chomczynski, 1992). UV transilluminator was used for cross-
linking the RNA samples to the membrane and then the membrane was air dried. The 
membrane was prehybridized at 54°C for 2 h and hybridized o/n in standard hybridization 
solution containing 1 µl of ODC-DIG-dUTP labelled probe. 
After hybridization the membrane was washed with the following washing buffers. 
Detection of dioxigenin labeled ODC was performed by DIG luminescent detection kit 
according to the manufacturers instructions. 
 
10x MOPS buffer (pH 7.0): 
                            MOPS 200 mM 
                            NaAc 50 mM 
                            EDTA 10 mM 
 
RNA-loading buffer (750 µl): 
                            10x MOPS 100 µl 
                            Formamide 465 µl 
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                             37% Formaldehyde 135 µl 
                             88% Glycerol 50 µl 
                              Bromophenol-Blue 1 µg 
 
20x SSC pH 7.4: 
                            NaCl 3 M 
                            Tri-Sodiumcitrate 0.3 M 
 
Washing buffer: 
                            2x SSC/0.1% (v/v) SDS 
                            0.2x SSC/0.1% (v/v) SDS 
 
II.2.3 Expression and purification of recombinant proteins 
II.2.3.1 Expression and purification of polyamine-GST fusion proteins from E. coli 
GST and GST-fusion proteins were expressed and purified according to a modified 
protocol based on Smith (1993). 
A freshly transformed single colony of E. coli strain BL21(λDE3) (Novagen) harbouring 
recombinant plasmid DNA was inoculated in 10 ml of 2YT medium containing 1% (w/v) 
glucose and 100 µg/ml ampicillin and cultivated o/n at 37°C with vigorous shaking. The 
following day 400 ml of fresh 2YT/0.1% (w/v) glucose media were inoculated with 3 ml 
overnight culture and grown at 30°C and 225 rpm to an OD 600 nm of 0.8-1. Expression of 
recombinant proteins was then induced by addition of IPTG to a final concentration of 
0.1 mM. Cells were cultured o/n at 18°C. The cells were harvested by centrifugation 
(10 min/7700 g/4°C) and the supernatant discarded. The pellet was dried, resuspended in 
cold PBS buffer (20 ml/400 ml bacterial culture) and sonicated on ice 4 times for 40 sec 
(150W with 30 sec intervals). Triton X-100 (20% (v/v) stock solution) was added to 1% 
final concentration. The cell lysate was incubated for 30 min at 4°C on a rotary shaker. 
Cell debris and insoluble components were removed by centrifugation 
(20 min/15000 g/4°C) and the supernatant subjected to glutathione affinity 
chromatography according to the manufacturers instructions (Amersham Pharmacia 
Biotech). 
II.2.3.2 Expression and purification of ODC and PAO proteins 
The pET22b in BL21(λDE3) carrying the ODC and PAO genes (kind provided by Dr. B. 
Schneider, RWTH Aachen, Institut für Biologie VII, Germany) were grown in 10 ml of LB 
medium at 37°C containing 100 µg/ml ampicillin (LBA). The following day, the non-
induced o/n culture was diluted 1:60 with fresh LBA medium and grown at 37°C with 
vigorous shaking until OD600 reached 0.6. IPTG at a final concentration of 1 mM was 
added and the culture was grown at 37°C for 4 hours. The cells were harvested by 
centrifugation at 4000 g for 15 min. Polyamine proteins were purified from inclusion 
Chapter II Material and Methods 
 41
bodies via C-terminal his6 tag using Ni-NTA affinity chromatography under denaturating 
conditions as described below. The bacterial pellet was resuspended in lysis buffer B 
containing 8 M urea and incubated for 1 h at room temperature. After centrifugation at 
10000 g for 30 min, the supernatant was loaded onto pre-equilibrated Ni-NTA column and 
passed through the columns twice. After several washing steps with washing buffer, the 
bound protein was eluted twice with 300 µl of elution buffer and stored in 8 M urea. 
Fractions were collected and analysed by SDS-PAGE (II.2.4.2) and stored at -20°C for 
further experiments. 
 
Lysis buffer B:  8 M urea; 0.1 M NaH2PO4; 0.01 M Tris HCl pH 8.0 
Washing buffer C:  8 M urea; 0.1 M NaH2PO4; 0.01 M Tris HCl pH 6.3 
Elution buffer E:  8 M urea; 0.1 M NaH2PO4; 0.01 M Tris HCl pH 4.5 
 
II.2.3.3 Large scale expression of scFv in pSyn and purification of soluble scFv by 
IMAC 
For large scale expression scFv cDNAs were subcloned into the procaryotic expression 
vector pSyn using either NcoI/NotI restriction sites or SfiI/NotI restriction sites if an 
internal NcoI restriction site was present. Recombinant pSyn plasmids were transformed 
into E. coli strain HB101. A single recombinant colony was inoculated in 10 ml of 2YT 
medium containing 1 % (w/v) glucose and 100 µg/ml ampicillin and cultivated at 37°C 
with shaking (200 rpm). 
Three ml of the o/n culture were transferred into 500 ml of 2YT media containing 0.1% 
(w/v) glucose and 100 µg/ml ampicillin and grown at 37°C until the OD600 nm reached 0.7-
0.8. Expression of scFv fragments were induced by addition of IPTG to a final 
concentration of 1 mM for 3 hours at 30°C. The culture was centrifuged 
(4000 g/4°C/20 min) and the pelleted bacteria were resuspended in 10 ml of resuspension 
buffer (30 mM Tris, 20 % (w/v) sucrose, pH 8.0). EDTA was added to a final 
concentration of 1 mM. The suspension was incubated at 4°C for 10 min with gentle 
agitation followed by centrifugation at (8000 g/4°C/20 min). The supernatant S1 was 
removed and kept on ice. The pellet was resuspended in 9 ml of cold 5 mM MgSO4  and 
incubated at 4°C for 8-9 min on a rotatory shaker. EDTA was added to a final 
concentration of 1 mM and the suspension was agitated for 3 more minutes followed by 
centrifugation at (8000 g/4°C/20 min). The supernatant (S2) was mixed with the first 
supernatant (S1) and dialysed against PBS prior to IMAC affinity purification. 
Ni-NTA-agarose was added in a disposable column and equilibrated with 10-20 volumes 
of wash buffer. Imidazol and sodium chloride were added into the dialyzed periplasmic 
fraction to a final concentration of 10 mM and 500 mM, respectively. The sample was 
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passed twice through the pre-equilibrated Ni-NTA matrix. The column was washed with 
20 volumes of wash buffer and the proteins were eluted in three fractions with 700 µl of 
elution buffer. Collected fractions were immediately dialysed against PBS (pH 7.4) to 
remove imidazol and salt. To control the yield and purity of dialyzed scFv fragments 5 µl 
were run in a SDS-PAGE (II.2.4.2). The concentration was determined using the Pierce 
BCA protein assay (II.2.4.1). 
 
Wash buffer: 1x PBS, 10 mM imidazol; 500 mM NaCl 
Elution buffer: 1x PBS, 250 mM imidazol pH 4.5 
 
II.2.4 Protein analysis 
II.2.4.1 Quantification of proteins 
The concentration of purified protein was determined by Bradford (Bradford, 1976) or 
BCA (Pierce) assays. For Bradford assay the protein solution of interest was serially 
diluted. BSA was also serially diluted and used as standard. 10 µl of each dilution was 
transferred into the wells of a low binding microtiter plate (Greiner, Solingen, Germany). 
10 µl of the buffer was used as a blank. 200 µl of Bradford reagent were added to each 
well, mixed with the proteins and incubated at RT for 10 min followed by the measurement 
of OD595nm. For each dilution, measurements were performed in duplicate and the average 
was taken for the calculation of the protein concentration. 
The Pierce BCA protein assay is a detergent-compatible formulation based on 
bicinchoninic acid (BCA) for the colorimetric detection and quantification of proteins 
(Smith et al., 1985; Sorensen and Brodbeck, 1986). This method combines reduction of 
Cu+2 to Cu+1 by proteins in an alkaline medium with the sensitive and selective 
colorimetric detection of the cuprous cation (Cu+1) using bicinchoninic acid (Wiechelman 
et al., 1988). Concentration measurements were done according to the manufacturers 
instructions, using BSA as standard. 
II.2.4.2 SDS-PAA gel electrophoresis and Coomassie brillant blue staining 
Discontinuous SDS-polyacrylamide gels (for the stacking gel: T = 4%, C = 2.6%, pH 6.8; 
for the separating gel: T = 12%, C = 2.6%, pH 8.8) (Ausubel et al., 1995) were used for 
separation of protein samples. Before loading onto the gel, protein samples were 
denaturated in the presence of SDS and β-mercaptoethanol. The proteins were separated 
electrophoretically with 20V/cm for 1 hour. Protein bands were revealed by staining with 
Coomassie brilliant blue or transfer to nitrocellulose membrane for immunoblot analysis 
(Ausubel et al., 1995). Proteins were detected after incubating the gel for 30 min in 
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Coomassie staining solution at RT under constant rocking. Coomassie staining was 
removed by destaining solution until the protein bands was clearly visible. 
 
SDS-PAGE running buffer (pH 8.3): 
                                  Tris 125 mM (w/v) 
                                  Glycine 960 mM (v/v) 
                                  SDS 0.5% (w/v) 
 
Coomassie staining solution: 
                                  Coomassie brillant blue G-250 0.25% (w/v) 
                                  Methanol 50% (v/v) 
                                  Glacial acetic acid 9% (v/v) 
 
Coomassie destaining solution:  
                                  Methanol 10% (v/v) 
                                  Glacial acetic acid 10% (v/v) 
II.2.4.3 Immunoblot analysis 
Separated proteins (II.2.4.2) were transferred from an SDS-PAA gel to PVDF or 
HybondTM-C nitrocellulose membrane (0.45 µm). After blotting the membrane was 
blocked with PBS buffer containing 3% (w/v) skim milk powder (MPBS). As primary 
antibody either anti c-myc, anti his6 or anti KDEL were used in a dilution of 1:5000 in 
1xPBS. Attachment of the primary antibody was detected by addition of the secondary 
polyclonal antibody coupled to alkaline phosphatase (AP). Both, primary and secondary 
antibodies were diluted in blocking buffer. The target protein was finally revealed by 
addition of substrate BCIP/NBT. 
 
PBS buffer (pH 7.3):  
                                  NaCl 137 mM 
                                  KCl 2.7 mM 
                                  Na2HPO4x2H2O 8.1 mM 
                                  KH2PO4 1.5 mM 
 
Transfer buffer (pH 8.3): 
                                  Tris-HCl, pH 8.3 25 mM 
                                  Glycine 92 mM 
                                  Methanol 20% (v/v) 
 
AP buffer (pH 9.6): 
                                 Tris-HCl, pH 9.6 100 mM 
                                 NaCl 100 mM 
                                 MgCl2 5 mM 
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II.2.4.4 Dot blot analysis  
50 µl of supernatant (II.2.8.1) containing soluble scFv fragments expressed on a small-
scale were immobilized on Immobilon-P PVDF membrane using a dot blot apparatus. 
Immobilized scFv fragments were detected using 1:2500 diluted anti-c-myc monoclonal 
antibody 9E10 followed by 1:5000 diluted AP-labelled goat anti-mouse polyclonal 
antiserum. Binding of AP-conjugated secondary antibodies was revealed by adding 
BCIP/NBT substrate. 
 
II.2.5 Immunization of mice 
The treatment and maintenance of laboratory animals was approved by the 
‘Regierungspräsidium des Landes NRW’ (RP-Nr.: 23.203.2 AC 12, 21/95) and supervised 
by Dr. Hirsch as responsible biosafety officer at the Institut für Biologie I, RWTH Aachen. 
Two female mice (Balb/c) each were immunized with 50 µg of ADC, ODC-GST and 
PAO-GST fusion proteins mixed with 40µl GEBRU’s adjuvant. Two further injections 
into the tail vein were given at biweekly intervals with the same amount of antigen and 
20µl GEBRU’s adjuvant per mouse. The final boost was performed 4 days prior to 
sacrifice. After the last boost, blood was taken from the tail vein using a 26 gauge needle 
(1-2 µl) and a capillary for picking up blood. The blood was diluted 1000-fold with PBS 
for estimation of antibody titers. 
II.2.5.1 Determination of antisera titers by ELISA 
The determination of polyclonal antibody titers from sera of mice was performed by direct 
ELISAs (II.2.8.1) using ADC, ODC and PAO proteins as antigens (Fischer, 1990). To 
determine the titer of ADC-specific antibodies, 10 µg/ml of ADC cleaved from GST with 
Factor Xa were coated to ELISA plates. For determination of ODC-GST- and PAO-GST-
specific antibodies, ODC and PAO proteins (II.2.3.2) were coated in 8 M urea to ELISA 
plates. GST (10 µg/ml) was included as control. Antigens were coated at 37oC for 1.5 
hours and blocked with 1% BSA (w/v) in 1xPBS. Serial dilutions of sera (1:500- 
1:256000) in blocking buffer were added to the coated plates and incubated at 37°C for 1.5 
hours. After three washes with PBST bound antibodies were detected by addition of 
1:5000 diluted AP-labelled goat anti-mouse polyclonal antibodies in blocking buffer and p-
nitrophenyl phosphate (pNPP) as substrate (Sigma). ELISA plates were incubated at 37°C 
for 1 h followed by measurement of the OD at 405 nm. 
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II.2.6 Construction of phage displayed scFv libraries 
II.2.6.1 Isolation of total RNA from spleen cells 
Spleens from immunised mice (II.2.5) were removed and dissected. Spleenocytes were 
prepared by disrupting the spleens through a meshing net and washed twice with RPMI 
1640 solution. The cells were homogenised in 1xPBS, aliquoted to not more then 1x108 
cells and subjected to total RNA isolation using the ‘RNeasy Midi kit’ followed by a 
TRIZOL extraction (GibcoBRL) to obtain high yield and pure RNA. 
II.2.6.2 First strand cDNA synthesis  
First-strand cDNA was synthesised from 5 µg of total RNA using ‘SuperscriptTM 
preamplification system kit’ (GibcoBRL) and gene specific primers COH 30, COH 32, 
MuPD 31; MuPD 32 that bind to the constant region of mouse IgG1, IgG2a/2b, κ and λ, 
respectively. cDNA synthesis was performed according to the manufacturers instructions. 
II.2.6.3 Construction of scFv libraries  
Mouse heavy and light chain variable regions were amplified by PCR using primers 
specific to murine IgG1, IgG2a/2b heavy chain λ and κ light chain (II.1.9). For each 
forward primer separate PCR reactions were performed whereas backward primers were 
used as a cocktail. PCR reactions were carried out in a total volume of 50 µl by adding 
10 pmol of each primer(s) and 1/10 to 1/16 of the first strand cDNA reaction under the 
following conditions: intial denaturation at 95°C for 5 minutes followed by 35 cycles at 
94°C for 1 min, 55°C for 1 min, 72°C for 1 min and a final elongation for 10 min at 72°C. 
Heavy (VH) and light (VL) chain fragments were gel purified using “QIAquick gel 
extraction kit” (Qiagen) (II.2.1.12) and digested with SfiI and BstEII, or AscI and NotI 
enzymes, respectively. pHEN4II phagemid DNA was digested with SfiI and BstEII or AscI 
and NotI and gel purified. 200 ng of purified vector were ligated with a five fold molar 
excess of purified fragments. Ligation products were electroporated into electrocompetent 
E. coli TG1 cells to create the sublibraries. The scFv fragment libraries were constructed 
by excising VH or VL fragments with the respective enzymes and ligating them into the 
linearised pHEN4II containing VL or VH fragments. 
II.2.6.4 BstNI fingerprinting 
The variability of the generated scFv fragment libraries was tested by restriction with 
BstNI. PCR-amplified scFv fragments from 20 randomly selected E. coli colonies were 
digested with 5 U BstNI at 60oC for 2 h. This method was first described in phage display 
protocols by Marks et al. (1991) and Hoogenboom et al. (1996). Digested fragments were 
separated in a 2% (w/v) agarose gel (II.2.1.12) and the variability of the library was 
estimated. 
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II.2.7 Phage displayed antibody selection 
Phage particles were rescued from the scFv-libraries by superinfection with helper phage 
M13KO7 (Clackson et al., 1991). Phage titers were determined by addition of phage 
dilutions to exponentially growing E. coli TG1. For isolation of phages exposing antigen-
specific antibodies panning procedures were performed. Polyamine-GST fusion proteins 
(10 µg/ml ) were immobilized o/n to immunotubes. To exclude the binding of phage 
presenting GST-specific scFv fragments, 1012  phages from each library were preincubated 
with GST (10 µg/ml) in 2% MPBS (w/v) at RT for 30 min. Then the phage solution was 
added to the antigen-coated immunotubes and incubated for 30 min under rotation and then 
1.5 h w/o movement. Phages that showed no or low affinity for the immobilized antigen 
were washed away by PBS, 0.05% (w/v) Tween20 followed by PBS. Each washing step 
was performed 20 times by filling the tube and decanting immediately. Phages with 
affinity to the antigen were eluted from the tube by addition of 1 ml of 100 mM 
triethylamine (freshly made) while rotating on an under and over turntable for 8-10 min 
followed by neutralisation with 1 M Tris-HCl pH 7.4. Nine ml of log phase E. coli TG1 
cells were infected with eluted phages and plated on 2x YT agar plates containing 2% 
(w/v) glucose and 100 µg/ml ampicillin (2x YTGA-agar). The plates were incubated o/n at 
37oC. Cells were scraped off the agar by adding 5 ml of 2x TY medium containing 15% 
(v/v) glycerol and stored at -70oC for a new round of selection. 
The total eluted phage titer indicating the successful binding and elution of phages, was 
determined after each round of panning by addition of dilutions to exponentially growing 
E. coli TG1. An increasing titer of eluted phages in subsequent round of pannings indicated 
the enrichment for clones, which bind most strongly to the target antigen. 
 
II.2.8 Characterisation of phage displayed scFv fragments 
II.2.8.1 Soluble expression of scFv fragments and direct ELISA 
Screening of scFv-fragment libraries was performed after the third round of panning by 
small scale induction of scFv expression from pHEN4II phagemid vector in ELISA plates. 
120 recombinant clones of E. coli strain TG1 were randomly selected and inoculated in 
100 µl of 2x TY, 100 µg/ml ampicillin, 1% (w/v) glucose in microtiter plates. The plates 
(master plates) were grown at 37oC overnight. The next day, cells were transferred from 
the master plate to a second plate containing 125 µl 2x TY, 100 µg/ml ampicillin, 0.1% 
(w/v) glucose. Bacteria were grown at 37oC until the OD600 nm reached 0.1-1. Soluble scFv 
fragment expression was induced at 30oC for 16-24 h by addition of IPTG to a final 
concentration of 1 mM. The cells were removed by centrifugation and the supernatant was 
used for soluble ELISA.  
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A high binding ELISA plate was coated with antigen (10 µg/ml) o/n at 4oC. After blocking 
with 2% (w/v) MPBS the supernatant was applied to the plate and incubated for 2 h at RT. 
Bound scFv fragments were detected using 1:5000 diluted anti c-myc monoclonal antibody 
9E10 and 1:5000 diluted AP-conjugated goat anti mouse polyclonal antibody. ELISA 
readings were performed at OD405 nm  after incubation at 37oC with pNPP for 1 h. 
II.2.8.2 Capture ELISA of selected scFv fragments 
Capture ELISA was performed by o/n coating of chicken IgY’s specific to ODC-GST and 
ADC proteins in two different dilutions 1:1000 and 1:5000. The plate was blocked for 2 h 
at RT with 2% (w/v) MPBS, then incubated with 10 µg/ml of bacterial purified antigen 
(ADC-GST, ODC-GST or GST) (II.2.3.1). Finally, supernatant from the periplasmic 
expression of the 15 selected scFv-fragments (II.2.8.1) was applied and incubated at RT for 
2 h. Bound scFv fragments were detected with 9E10 monoclonal antibody and the 1:5000 
diluted AP-conjugated goat anti mouse polyclonal antibody. The remaining steps were 
carried out as described above. 
II.2.8.3 Biotinylation of scFv 
Affinity purified scFvADC3 (II.2.3.3) was reversibly biotinylated using biotin disulfide N-
hydroxysuccinimide ester (Sigma, St Louis, Missouri, USA). 0.5 mg of scFvADC3 in PBS 
was mixed with 0.25 ml of 1 M NaHCO3 (pH 8.6) and a 15-20 molar excess of biotin 
solution added at room temperature for 30 min. Free biotinylation reagent was removed by 
dialysis against PBS at 4oC o/n.  
Biotinylation efficiency of the scFvADC3 was determined by immunoblot (II.2.4.3) using 
the non-biotinylated scFvADC3 and another biotinylated scFv fragment of known 
concentration as a standard. 
II.2.8.4 Competition ELISA of biotinylated scFv fragments 
Competition ELISA was used to determine whether the two scFv fragments generated 
against ADC recognise overlapping or non-overlapping epitopes. ADC-GST fusion protein 
was coated o/n at 4oC to a microtiter plate at a concentration of 1 µg/ml. scFvADC3 and 
scFvADC7 were serially diluted in a suitable constant concentration of biotinylated 
scFvADC3 (1:80), determined from a direct ELISA, in siliconized microtiter plates. All 
dilutions were transferred to the ADC-GST coated plate. Bound scFvADC was detected 
with StrepAP antibody. The remaining steps were carried out as described above (II.2.8.1). 
II.2.8.5 Electrophoretic mobility shift assay (EMSA) 
Varying amounts of ODC-GST antigen were incubated for 1 hr at RT with 2 µg of affinity 
purified scFv specific to ODC. Then, the electrophoretic mobility was compared to the 
electrophoretic mobility of purified antigen and scFv alone. Samples were loaded on a 
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native 9% non-reducing PAGE pH 9 and run at 100 V for 5 hours. Proteins were visualized 
by Coomassie blue staining (II.2.4.2). 
II.2.8.6 Gel Filtration 
A Sephadex 200 column (Amersham Pharmacia Biotech) was equilibrated with 1xPBS. 
Affinity purified scFvs (II.2.8.1) were loaded and run at 1 ml/min. Cytochrome C 
(12400 Da), carbonic anhydrase (29000 Da), BSA (66000 Da), β-amylase (200000 Da) and 
Dextran Blue (2000000 Da) were run as molecular weight standards. The eluates were 
monitored by UV 260 nm and 280 nm and Blue dextran by 610 nm. 
II.2.8.7 Characterisation of scFv fragments by BIACORE 
Biomolecular interaction analyses of binding of purified scFvODC to ODC-GST antigen 
were done by surface plasmon resonance (SPR) on a BIACORE 2000 (BIAcore). All 
injected samples were diluted in HBS buffer (10 mM HEPES, 150mM NaCl, 3.4 mM 
EDTA, 0.005% Surfactant P20) and subjected to centrifugation prior to injection 
(14000 rpm/10 min/4oC) to remove insoluble components. 
The ligands were immobilized on a CM5-rg sensor chip using the amine coupling kit 
(BIAcore). The immobilization of proteins on the chip was performed at a flow rate of 
5 µl/min. The carboxyl groups on the sensor surface were activated with an injection of a 
solution containing 100 mM EDC/NHS (N-Ethyl-N’-(Dimethylaminopropyl)-
Carbodimide-Hydrochloride, 400 mM N-Hydroxyl-Succinimide). After each binding 
experiment the surface was regenerated with 15-20 µl of 1.2 M Guanidine HCl followed 
by 30 sec injections of HBS. The data were analysed using the BIAevaluation (3.0) 
software. 
 
II.2.9 Determination of ODC activity 
Tobacco leaf tissue was extracted in extraction buffer at ratio 500 mg/ml. 
Polyvinylpyrrolidone (100 mg) was added during grinding. Following centrifugation at 
15000xg for 10 min at 4 oC, the supernatant was used directly for enzyme activity assays. 
Tissue was always processed immediately after harvest and all assays were performed 
using fresh extracts. Enzyme assays were carried out in 2 ml Eppendorff tubes. A 3mm 
diameter filter paper disc impregnated with 100 µl of 2 M KOH and transfixed with a 3 cm 
needle was used to trap the 14CO2 liberated during the reaction.  
The reaction mixture used to determine ODC activity contained 20 µl of extraction buffer 
(pH 7.0), 160 µl of crude enzyme and 20 µl of the substrate mix [20 µl of DL-(1-14C) 
ornithine (Moravek Biochemicals, Brea, California) (specific activity 53 mCi/mmol, 
diluted in distilled water]. Assays were carried out at 37oC for 45 min. Then 200 µl of 10% 
(v/v) perchloric acid was added to stop the reaction. After further 45 min incubation, the 
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filter paper was placed in scintillation vials with 1.5 ml scintillation liquid and radioactivity 
was measured in liquid scintillation counter. Each reaction was performed in four 
replicates. 
Extraction buffer: 
                               HEPES pH 7.5 100mM 
                               DTT 2mM 
                               EDTA 1 mM 
 
II.2.10 Extraction of polyamines from tobacco plants 
Young leaves from 1-2 months old tobacco plants were used for extraction of free 
polyamines. Frozen leaf samples were ground in liquid nitrogen and polyamines extracted 
in the presence of 10% TCA (1:3 w/v) (Tabor et al., 1973). The homogenate was incubated 
for 4 h on ice and then centrifuged at 15000 rpm at 4°C. The supernatant was filtered 
sterilised and transferred into a fresh tube. Prior analysis the samples were mixed 1:1 (v/v) 
with 1.2 M sodium citrate buffer. 
II.2.10.1 Analysis of free polyamine levels from stable transformed tobacco 
Levels of free polyamines were determined on a Biochrom 20 Amino acid analyser 
(Amersham Pharmacia Biotech) by post-column derivatisation with ninhydrin (Spackman 
et al., 1958). The polyamine sample was loaded onto a 100 x 4 mm cation-exchange 
column (Bio 20 Peek, polyamine column, Amersham Pharmacia Biotech) and polyamines 
eluted according to the manufacturers instructions. The column eluent was mixed with the 
ninhydrin reagent (Amersham Pharmacia Biotech) and passed through a high temperature 
(135oC) reaction coil. In the reaction coil ninhydrin reacts with the polyamines present in 
the eluate to form coloured compounds. The amount of coloured compounds, determined 
by photometric detection at 570 nm, is directly proportional to the quantity of polyamines 
in the eluate. 
After each sample analysis, the column was regenerated with 0.4 M NaOH followed by the 
equilibration with 1.2 M sodium citrate buffer (pH 6.45). 
Evaluation of amino acid analysis data was performed by using Ezchrom V 6.7 chrom data 
system (Scientific Software Inc) (Amersham Pharmacia Biotech). 
Known concentrations of standard: ornithine, putrescine, spermidine and spermine (Sigma) 
were run prior to tobacco plants analysis and a calibration analysis was performed based on 
the manufacturers instructions. 
 
Polyamine buffer: 
                              Tripotassium citrate monohydrate 0.55 M 
                              Sodium chloride anhydrous 0.55 M 
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                              Hydrochloric acid (concentrated) 1.78 % (v/v) 
                              Propan-2-ol 6.5 % (v/v) 
                              80% (v/v) solution phenol 0.12 % (v/v) 
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III Results 
III.1 Cloning of human ornithine decarboxylase (ODC) a key enzyme 
in polyamine biosynthesis 
The gene encoding ODC was amplified from a human prostate cDNA library using 
primers based on the 5' and 3' sequences of human ODC mRNA sequence (Gen-bank 
accession number M16650). Restriction sites EcoRI/NcoI and SalI/HindIII were introduced 
into the forward and reverse primers for subcloning, respectively. 
The ∼1.5 kb PCR product (Figure III-1) was ligated into the NcoI/SalI sites of pGEM-3zf 
vector and the sequence verified from the clone pGEM-3zf-ODCL. A single point mutation 
(highlighted in the sequence, please refer to the appendix VII.2) changing glutamic acid to 
glutamine (Glu417→Gln417) was observed. To investigate if the original gene from the 
cDNA library already showed this mutation or if it has been introduced by PCR the ODC 
gene was amplified from the prostate library using expand high fidelity Taq polymerase 
and ligated into pCR2.1 (TOPO vector). The sequence analysis of six independent 
transformants confirmed the amino acid change from glutamine to glutamic acid at 
position 1246. The nucleic acid and the amino acid sequence of amplified ODC gene from 
clone #103 (ODCL/TOPO) are presented in appendix VII.2. The ODC fragment of clone 
#103 was used for subcloning into bacteria (III.2) and plant expression vectors (III.4.1.1). 
 
 
 
 
 
 
 
Figure III-1 PCR amplification and cloning of human ODC gene. 
Nucleic acids were separated on a 1.2% (w/v) agarose gel. A: 5 µl of PCR amplified ODC gene 
from human prostate c-DNA library (1 and 2). B: double digestion of the pGEM-3zf-ODC plasmid 
with NcoI/SalI restriction enzymes (1 and 2). M: 1kb ladder. 
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III.2 Expression and purification of ADC, ODC and PAO from 
bacterial cultures 
In order to obtain polyamine proteins for immunization, panning and scFv characterization, 
the amplified human ODC (III.1), oat ADC and maize PAO genes (Dr. Bernd Schneider, 
RWTH Aachen, Institut für Biologie VII, Germany) were ligated into NcoI/SalI sites of 
pGEX-5x-3 bacterial expression vector. The polyamine genes were fused to the C-terminus 
of GST and expressed in E. coli BL21λDE3 (II.2.3.1). The GST fusion proteins contained 
a Factor Xa cleavage site for removal of the GST fusion part. When protein expression was 
induced with 1 mM IPTG at 30°C 95% of the fusion proteins were produced as insoluble 
inclusion bodies (data not shown). The following modifications were employed to obtain 
improved solubility. First the growth and induction temperatures were lowered from 30°C 
to 16°C, second the IPTG concentrations were reduced to 0.01-0.1 mM, third longer 
induction periods, and fourth different induction time (3-12 hr) were tested. 
The best parameters to obtain larger quantities of soluble ADC-GST and ODC-GST fusion 
protein were obtained by increasing the culture volume, decreasing the IPTG concentration 
to 0.05 mM, reducing the temperature to 18°C after induction and increasing the induction 
time to 8 hrs.  
Cleavage of the polyamine fusion protein from the GST domain with Factor Xa was only 
successful for ADC (Figure III-2).  
 
 
Figure III-2 SDS-PAGE analysis of affinity purified GST fusion proteins.  
ADC (A) and ODC-GST (B) fusion proteins were affinity purified using glutathione sepharose 
matrix (II.2.3.1). Purified proteins were separated on 12% (w/v) SDS-PAA gels then stained with 
Coomassie brilliant blue (II.2.4.2). A: affinity purified ADC protein after cleavage with Factor Xa; 
B: affinity purified ODC-GST fusion protein. 1; 2: 5 µl of the first and the second elution fractions 
of ADC protein after cleavage with Factor Xa; 3: 5 µl of the boiled glutathione sepharose matrix 
sample after elution of the ADC protein; 4; 5: 5 µl of the first and the second elution fractions of 
ODC-GST fusion proteins; M: Mark12 protein marker.  
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Following the elution steps, a significant amount of ADC protein remained bound to the 
matrix (Figure III-2, line 3). Affinity purified fusion proteins showed high purity in 
Coomassie-stained SDS-polyacrylamide gels (Figure III-2). 
The yields of purified ADC and ODC-GST fusion proteins were 2.0 and 1.5 mg per litre 
culture medium, respectively. The sizes of the ADC and ODC-GST proteins corresponded 
with the expected molecular weights of 63 and 78 kDa, respectively. 
Attempts to purify soluble PAO fusion protein (MW 83 kDa) with the above mentioned 
parameters gave no improvements (Figure III-3). The yield of affinity purified PAO-GST 
was 0.07 mg per litre culture medium. These results suggested that the formation of the 
PAO-GST inclusion bodies was not affected by the expression conditions used. Efforts for 
solubilization using 4-8 M urea and N-lauroylsarcosine resulted in low yield of PAO-GST. 
 
 
 
 
 
 
 
Figure III-3 SDS-PAGE analysis of purified PAO proteins. 
Affinity purified PAO-GST fusion protein obtained from the GST expression system was resolved 
on 12% (w/v) SDS-PAA gel then stained with Coomassie brilliant blue (II.2.4.2). 1: 5 µl of 
sonicated E. coli BL21(λDE3) cells containing the pGEX-5x-3 plasmid that codes for PAO-GST. 
2: 5 µl of flow through; 3: 5 µl of wash fraction; 4-6: 10 µl of the first, second and third elution 
fractions of PAO-GST fusion protein; M: Mark12 protein marker.  
 
Purified ADC, ODC-GST fusion protein and PAO-GST inclusion bodies after suspension 
in PBS were used as antigens for immunization of mice (III.7) and antibody selection by 
phage display (III.9.1). 
 
III.3 Cloning of ODC in bacteria expression vector pET22b and 
purification of the expressed protein via IMAC 
To avoid the cross reaction of antibodies against the GST domain during the antibody titer 
determination of mice immunized with ODC-GST fusion proteins (III.7) the ODC gene 
was cloned into NcoI/SalI sites of pET22b bacterial expression vector and purified via 
IMAC (II.2.3.2). The pET22b vector contains the IPTG inducible T7 promoter and the 
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pelB leader sequence to enable recombinant protein targeting into the periplasm. The target 
protein was engineered to contain a C-terminal His tag sequence for Ni-NTA affinity 
purification. Protein expression was induced with 1 mM IPTG for 4 hr at 37°C. Under 
these conditions ODC was expressed as insoluble aggregates. The recombinant protein was 
purified from inclusion bodies via the C-terminal his6 tag under denaturating conditions 
(II.2.3.2) and stored in 8M urea. The purity was verified on SDS-PAGE. Only about 45% 
of purified protein showed the expected size of 53 kDa (Figure III-4). Another protein 
migrating at 37 kDa was observed on SDS-PAGE gels in addition to the full length ODC 
protein. Both proteins were present in about the same quantity. Immunoblot analysis 
showed that both purified proteins were recognized by the anti-His6 antibody, indicating 
that the 37 kDa protein is a truncated form of ODC (data not shown). 
The purified 53 kDa and 37 kDa ODC proteins were used in ELISA tests for determination 
of antibody titer from mice immunized with ODC-GST fusion protein (III.7). 
 
 
 
 
 
 
 
 
Figure III-4 SDS-PAGE analysis of purified ODC protein from pET22b vector via IMAC. 
The affinity purified ODC protein was separated on a 12% (w/v) SDS-PAA gel and stained with 
Coomassie brilliant blue (II.2.4.2). 1: 5 µl elution fraction; M: Mark12 protein marker. The MW of 
ODC (53 kDa) and the C-terminal truncated form of ODC (37 kDa) are indicated.  
 
III.4 Generation and characterization of transgenic plants 
III.4.1 Engineering of constructs for targeting of human ODC to different 
plant cell compartments. 
III.4.1.1 Cloning of ODC into plant expression vector pSSH1 
The human ODC gene was cloned into three plant expression cassettes that enable 
targeting of expressed recombinant protein to the plant cytosol, secretion to the apoplast 
and retention in the ER. The strategy for cloning of ODC into the plant expression pSSH1 
vector is shown Figure III-5. Direct ligation of DNA fragments into plant vector pSSH1 
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was not possible due to an internal NcoI restriction site in the pSSH1 vector. Therefore the 
ODC gene (III.1) had to be subcloned into the NcoI/SalI sites of modified pGEM-3zf 
vector downstream from the 5' untranslated region (UTR) of the chalcone synthase (CHS) 
and the plant codon-optimized leader peptide derived from the light chain (LPL) of the 
murine mAb24 (Voss et al., 1995), and upstream from a sequence encoding a his6 tag and 
the 3' UTR from tobacco mosaic virus (TMV). 
 
 
Figure III-5 Strategy for cloning of human ODC gene into pSS plant expression vector for 
cytosolic, apoplastic expression and ER retention. 
P35S: 35SS promoter from CaMV; Ω: omega leader region of TMV RNA; CHS: 5' untranslated 
region of chalcon synthase; LPL: plant codon optimized leader peptide derived from murine light 
chain of TMV-specific mAb24; Pw: 3' UTR of TMV RNA: scFv24: TMV specific single chain 
antibody 24; c-myc: myc epitope for detection; His6: his-6 tag for purification and detection.  
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For generation of pSS: ODC-apo construct the cassette containing the 5' UTR of CHS, the 
LPL and ODC gene was excised with EcoRI/SalI from ODC-pGEM-3zf vector and cloned 
downstream of the enhanced 35S promoter and upstream of c-myc/his6 tags and the 3' 
UTR of tobacco mosaic virus RNA (Pw) of the pSS plant expression vector. 
For cytosolic targeting the ODC gene (III.1.1) was cloned via NcoI and SalI restriction 
sites in the SCA24OmW cassette in pUC 18 downstream of an omega leader (Ω) region of 
TMV, and upstream of the c-myc/his-6 tags. Then, the cassette containing the Ω leader, 
ODC gene and c-myc/his6 tags was excised with EcoRI and XbaI and cloned between the 
enhanced 35S promoter and Pw untranslated region of pSS vector resulting in the pSS: 
ODC-cyt construct. 
To retain the ODC in the lumen of the ER the cassette containing the 5' UTR of CHS, the 
LPL and ODC gene was excised with EcoRI/SalI from pGEM-3zf vector and cloned 
upstream of the C-terminal KDEL tag (Munro and Pelham, 1987; Nilsson and Warren, 
1994) into a modified pGEM-3zf vector. The expression cassette together with the KDEL 
tag were subcloned into pSS vector via the EcoRI and XbaI restriction sites resulting in the 
pSS: ODC-ER construct.  
The constructs pSS: ODC-apo, pSS: ODC-cyt and pSS: ODC-ER were transformed into 
Agrobacterium by electroporation (II.2.1.6). Seven independent recombinant colonies from 
each transformation were screened for the presence of insert by PCR (II.2.1.13). 
Recombinant Agrobacterium cultures were prepared from single colonies of each construct 
(II.2.1.9) and used for transient expression (III.4.1.2) and stable transformation of N. 
tabacum (III.4.2). 
III.4.1.2 Transient expression of ODC in different plant cell compartments 
Transient expression experiments were performed for the initial analysis because the 
procedure is fast and not affected by position effects (Kapila et al., 1996). Four leaves were 
infiltrated with recombinant agrobacteria. After three days of incubation soluble proteins 
were extracted and detected by Immunoblot analysis to verify expression rate and integrity 
of the recombinant protein in these compartments.  
Time-course analyses showed that maximum accumulation of ODC protein was reached at 
50-60 h postinfiltration (data not shown). Immunoblot analyses showed a distinct band of 
approximately 51 kDa, corresponding to the molecular weight of ODC for both, cytosolic 
and apoplastic constructs (Figure III-6). 
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Figure III-6 Transient expression of cytosolic and apoplastic ODC. 
Total soluble leaf proteins were extracted by grinding tobacco leaf tissue in two volumes extraction 
buffer (II.2.2.1), separated by SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose membrane 
(II.2.4.3). Immunodetection was carried out with 9E10 as primary antibody in dilution 1:5000, 
followed by alkaline phosphatase conjugated goat anti mouse as secondary antibody in dilution 
1:5000 (II.2.4.3). Detection was performed with NBT/BCIP for 1 min at RT. 
1-4: 5 µl of total soluble protein extracted from individual tobacco leaves expressing ODC in the 
cytoplasm; 5-8: 5 µl of total soluble protein extracted from different infiltrated tobacco leaves 
secreting ODC into apoplastic space. M: prestained protein marker; C: 1 µg of scFvODC3 carrying 
c-myc tag used as positive control. 
 
The level of expression of the recombinant protein varied considerably between the 
constructs. Higher level of expression was shown in cytosol. No size difference was 
observed between the ODC accumulated in apoplast and cytosol indicating cleavage of the 
LPL signal peptide for the apoplastic construct pSS: ODC-apo. 
ER retained ODC was not detectable by immunoblot analyses although the DNA sequence 
of the pSS: ODC-ER construct was confirmed (data not shown). RNA extracts of leaves 
carrying gene constructs for apoplastic and ER retained ODC were analysed by Northern 
blotting (Figure III-7). 
The analysis demonstrated that in both vacuum-infiltrated plants a transcript of about 1.5 
kb was synthesized which, hybridized with the human ODC gene used as a probe. This 
band was absent in the RNA extract of wild type tobacco leaves used as control (Figure III-
7, line 3). Although, similar transcript levels were observed for apoplastic and ER 
constructs, protein expression levels did not correlate with the steady state levels of 
mRNA. 
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Figure III-7 Northern blot analysis of transcript levels of apoplastic and ER retained ODC. 
Total RNA was isolated from infiltrated leaves expressing ODC in the apoplast (1), ER (2) and 
from wild type tobacco plants (3) (II.2.2.7). Per line 10 µg RNA was loaded and separated on a 1% 
(w/v) agarose gel containing 2.4 M formaldehyde prior to blotting onto a nylon membrane 
(II.2.2.8). The RNA marker (not shown in the figure) was run simultaneously. DIG labeled 1.5 kb 
human ODC gene was used as probe for hybridization (II.2.2.8). Detection of dioxigenin labeled 
ODC was performed by DIG luminescent detection kit for 2 min at RT. 
 
III.4.2 Generation and screening of stable transformed tobacco plants 
expressing human ODC 
Following the transient expression results, pSS: ODC-apo and pSS: ODC-cyt constructs 
were stably transformed into tobacco plants by Agrobacterium-mediated transformation 
(II.2.2.4). Twenty-five regenerated plants (labeled ODC-apo-1→25) from the 
transformation experiments with pSS: ODC-apo and 19 plants (labeled ODC-cyt-1→19) 
expressing pSS: ODC-cyt were planted and screened for accumulation of recombinant 
protein (Figure III-8/A, C). None of the transformed plants exhibited altered morphology 
and all set seed normally upon self-fertilization. Recombinant accumulated proteins in 
tobacco leaves were analyzed by immunoblot using crude extracts of total soluble leaf 
protein. Immunoblot experiments revealed that 18 out of 25 and 16 out of 19 T0 
transformed plants accumulated the ODC in apoplast and cytosol, respectively (Figure 
III-8/A, C).  
These T0 plants segregated in a Mendelian manner into siblings with the ODC transgene 
and those without it. The ODC migrated according to its predicted molecular weight.  
Higher expression was observed in tobacco plants accumulating the ODC in cytosol 
(Figure III-8/C). For apoplasmic ODC the expression was lower. The lines with the highest 
level of accumulation in the apoplasm (ODC-apo-7; ODC-apo-10) and the cytosol (ODC-
cyt-4; ODC-cyt-8; ODC-cyt-10; ODC-cyt-13) (highlighted in the Figure III-8) were 
selected and self pollinated for establishment of homozygous lines. 
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Figure III-8 Screening of stable transgenic tobacco plants expressing apoplastic and 
cytosolic ODC. 
Total soluble leaf proteins were extracted by grinding tobacco leaf tissue in two volumes extraction 
buffer (II.2.2.6). 5 µl of total soluble protein from each sample was separated by 12% SDS-PAGE 
(II.2.4.2) and blotted onto a nitrocellulose membrane (II.2.2.3). Immunodetection was carried out 
with anti-c-myc antibody (1:5000), followed by 1 hr incubation with goat anti-mouse antibody 
conjugated to alkaline phosphatase (1:5000) and NBT/BCIP detection for 5 min at RT. 
A: 1-17: ODC-apo-1→17 T0 transgenic lines from the transformation experiments expressing 
apoplasmic ODC. W: 5µl of total soluble protein extracted from wild type fresh leaves; M: 
prestained protein marker. B: 1-8: T2 transgenic lines (labeled ODC-apo-7/3-1→8) expressing 
apoplasmic ODC generated from the T1 generation of the ODC-apo-7 tobacco plant indicated in the 
Figure III-8/A; C: 1µg of scFvODC7 carrying the c-myc tag sequence used as positive control; M: 
prestained protein marker. C: 1-19: ODC-cyt-1→19 T0 stable transformed tobacco lines expressing 
cytosolic ODC. Tobacco lines selected for establishment of homozygous lines are indicated by *. 
 
The accumulated levels of the recombinant ODC protein in the T1 generation of the 
tobacco plants expressing the ODC in apoplast were similar with the parental T0 ODC-apo-
7 and GR1-10 selected lines (data not shown). The line ODC-apo-7/3 was chosen for 
further crossing experiments. The T2 generation of line ODC-apo-7/3 expressing 
apoplasmic ODC (Figure III-8/B) showed higher level of expression than the T0 and T1 
generation. 
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The T1 generation of ODC-cyt-4; ODC-cyt-8; ODC-cyt-10; ODC-cyt-13 tobacco lines 
expressing the human ODC in cytosol accumulated comparable levels of the recombinant 
ODC protein with the T0 lines (data not shown). Expression levels of the T2 generation of 
the ODC-cyt-4; ODC-cyt-8; ODC-cyt-10; ODC-cyt-13 selected lines expressing cytosolic 
ODC were comparable with the accumulation levels of parental T0 and T1 generation (data 
not shown). 
The T2 generation of tobacco lines overexpressing apoplastic ODC (ODC-apo-7/3) were 
further analyzed for free polyamine levels (III-5). 
 
III.4.3 Generation of transgenic tobacco plants co-expressing human ODC 
and chimeric mouse/human SDE enzymes 
Non-segregating transgenic lines co-producing apoplasmic ODC and SDE were generated. 
It was expected that stable transgenic lines coexpressing both polyamine enzymes show an 
increase in putrescine and spermidine levels. Two T2 tobacco plants with a high expression 
of apoplastic SDE (SDE-11/1-2; SDE-11/1-1) (kindly provided by Dr. B. Schneider) were 
pollinated with two T2 tobacco plants expressing apoplastic ODC (ODC-apo-7/3-2; ODC-
apo-7/3-4). 11 plants of the T1 generation of each crossing were grown under identical 
conditions. All plants appeared healthy and there was no noticable change in growth and 
phenotype compared to wild type plants. Crossed plants were analysed for the expression 
of ODC and SDE by immunoblots using antibody 9E10 as primary antibody (Figure III-9).  
 
 
 
 
 
 
 
Figure III-9 Analysis of ODC-apo-7/3-2 x SDE-11-1/1 or (ODC x SDE/1→11) stable 
transformed tobacco plants co-expressing apoplasmic ODC and SDE.  
Total soluble leaf proteins were extracted by grinding leaf tissue in two volumes extraction buffer 
(II.2.2.6), separated by SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose membrane (II.2.4.3). 
Immunodetection was carried out with anti-c-myc antibody, followed by goat anti-mouse 
antibodies conjugated to alkaline phosphatase and NBT/BCIP detection. 1-11: ODC x SDE/1→11 
different lines co-expressing both enzymes; M: prestained protein marker. Tobacco lines selected 
for establishment of homozygous lines are indicated by *. 
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Non transgenic and ‘‘single transgenic’’ plants were distinguished from ‘‘double 
transgenic’’ by the absence, by one or both protein band. Immunoblot analyses revealed 
that more then 80% of the lines tested co-expressed both enzymes. However, as shown in 
Figure III-9 the expression levels of both enzymes differed significantly, ODC (51.2 kDa) 
being produced much higher. The enzyme levels were also compared between the T1 
offspring and the parental lines (data not shown). Higher expression of SDE enzyme (33.8) 
was observed in parental lines, while for ODC similar levels of expression were observed. 
Lines ODC x SDE/6 and ODC x SDE/8 (indicated in figure III-9) that showed the 
strongest signals for both enzymes in immunoblot analysis was kept to establish double 
transgenic homozygous lines. Analysis of recombinant protein accumulation levels and the 
free polyamine levels are planned with the T2 generation of both selected transgenic lines 
co-expressing both proteins. 
 
III.5 Polyamine analysis 
III.5.1 Polyamine levels in stable transformed plants overexpressing ODC 
In order to examine if transgenic tobacco plants expressing ODC in apoplast affect the 
polyamine metabolism, transgenic plants were analyzed for increased levels of putrescine, 
spermidine and spermine. Polyamine levels were analyzed in transgenic plants in parallel 
with the immunoblot analyses and ODC enzyme activity measurements. Leaves for 
polyamine analysis were collected from all transgenic lines at the same time, because 
abiotic and biotic factors effect the polyamine metabolism and could influence the results. 
In Figure III-10 the profile of free polyamine levels determined by the amino acid analyser 
by post-column derivatisation with ninhydrin is presented. The following retention times in 
minutes were determined: putrescine-17.2; spermidine: 24.1 and spermine: 35.9. The 
regression curves for each polyamine were calculated using the peak area values and 
standard concentrations of polyamines (II.2.9.1). 
The polyamine profile in Figure III-10 indicates that two transgenic T2 lines ODC-apo-7/3-
3 and GR1-7/3-4 showed 17-20 % higher level of putrescine compared to wild type plants. 
The levels of free polyamines were measured in vegetative tissue from six independent 
transgenic tobacco lines (ODC-apo-7/3-1→6). To exclude errors due to different extraction 
efficiencies three repetitions for each sample were analyzed. 
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Figure III-10 The polyamine profiles of the two T2 transgenic lines (ODC-apo-7/3-3 and 
ODC-apo-7/3-4) compared to wild type tobacco plants.  
Free polyamines were extracted by grinding leaf tissue in the presence of 10% TCA (1:3 w/v) 
(II.2.10). The levels of free polyamines were determined on a Biochrom 20 Amino acid analyser by 
post-column derivatisation with ninhydrin. Putrescine, spermidine and spermine were eluted after 
17.2, 24.1 and 35.9 min retention times, respectively. ODC-apo-7/3-3, ODC-apo-7/3-4: T2 
transgenic lines expressing apoplasmic ODC; C: Wild type SR1 tobacco plants. 
 
There was a significant difference (P< 0.05) in the putrescine levels between all 
transformed lines expressing apoplastic ODC and the wild type SR1 control plants (Figure 
III-11). There is no difference in the spermidine and spermine levels. 
A 5.6-fold increase in putrescine levels was observed in ODC-apo-7/3-3 line (622 nmol/g 
fresh weight, compared to 110 nmol/g fresh weight in the control (P<0.05). 
The line ODC-apo-7/3-4 exhibited a 4.5 fold increase (520 nmol/gfresh weight; P<0.05), 
while line ODC-apo-7/3-2 showed a 4-fold (462 nmol/g fresh weight; P<0.05) increase in 
putrescine levels, compared to control. No significant variation (P> 0.05) was detected in 
the levels of spermidine and spermine compared to control plants. 
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Figure III-11 Analyses of polyamine levels in T2 generation of transgenic plants expressing 
human ODC.  
Free polyamines were extracted by grinding leaf tissue in the presence of 10% TCA (1:3 w/v) 
(II.2.10). The levels of free polyamines were determined on a Biochrom 20 Amino acid analyser by 
post-column derivatisation with ninhydrin. Values are mean ± SE for three replicates for every 
transgenic plant. Control values were determined by analysing 4 different plants. 1-6: ODC-apo-
7/3-1→6 different T2 transgenic lines. C: wild type tobacco plant SR1. 
 
 
III.5.2 Polyamine levels in transgenic plants co-expressing apoplasmic ODC 
and SDE enzymes 
To investigate the effect of co-expressed ODC and SDE on the polyamine pool the levels 
of free polyamines were analyzed. Five transgenic T1 lines (ODC x SDE/4; 6; 8; 9 and 11, 
please refer to the Figure III-9) showing the highest expression of both enzymes in 
immunoblot were examined (Figure III-12). A significant increase in the levels of 
putrescine and spermidine was measured in all transgenic lines. Putrescine levels ranged 
from 250-341 nmol per gram fresh weight. These values differed significantly from the 
non-transgenic control (P<0.05), which showed only 70 nmol/g fresh weight. Spermidine 
levels varied from 199 to 370nmol/g fw, representing an up to 4.5 fold increase (P<0.05) 
compared to the wild type control (82 nmol/g fw). Spermine levels did not show any 
significant change (P>0.05). 
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Figure III-12 Analyses of polyamine levels in T1 generation of transgenic plants co-
producing ODC and SDE in the apoplast.  
Free polyamines were extracted by grinding leaf tissue in the presence of 10% TCA (1:3 w/v) 
(II.2.10). The levels of free polyamines were determined on a Biochrom 20 Amino acid analyzer by 
post-column derivatisation with ninhydrin. Values are mean ± SE for three replicates for every 
transgenic plant. Control values were determined by analyzing 4 different plants. 1-5: ODC x 
SDE/4; 6; 8; 9 and 11, different transgenic lines. C: wild type tobacco plant SR1. 
 
 
III.6 Enzymatic activity of ODC in stable transformed plants 
overexpressing human ODC 
To investigate whether the apoplastic human ODC is a functional and active enzyme in 
leaf extracts from T2 transgenic plants were assays for ODC activity. The ODC activity 
was measured in 30-40 days old leaves of ODC-apo-7/3-1, -4, -5, -6, -7, -10 transgenic 
plants that showed high expression levels of ODC protein in western blot (Figure III-13). 
Wild type tobacco plants were assayed for intrinsic plant ODC activity. 
All the plants overexpressing ODC showed elevated ODC activity that was 1.6 to 32.8 fold 
greater than that of wild type plant (Figure III-14). 
The highest increase of enzymatic activity, up to 32-fold, was found in line 1 (481 nmol 
14CO2 released per hour per mg total soluble protein; P<0.001) when compared to controls 
(14 nmol 14CO2 / mg total soluble protein /hr). A 19-fold increase in activity was detected 
in line O6 (P<0.005). 
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Figure III-13 Immunoblot analysis of 30-40 days old ODC-apo-7/3-O1-O10 transgenic T2 
plants. 
Total soluble leaf proteins were extracted by grinding leaf tissue in two volumes extraction buffer 
(II.2.2.4), separated by SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose membrane (II.2.4.3). 
Immunodetection was carried out with anti-c-myc antibody (1:5000), followed by goat anti-mouse 
antibody conjugated to alkaline phosphatase (1:5000) and NBT/BCIP detection for 1 min at RT. 
Lines 1-10: ODC-apo-7/3-1→10 individual T2 transgenic lines. M: prestained protein marker. 
Lines that were analyzed for the ODC enzymatic activity are indicated by *. 
 
  
 
 
 
 
 
 
 
 
 
Figure III-14 ODC enzymatic activity analyses of T2 generation of stable transformed 
tobacco plant with apoplastic ODC.  
Tobacco leaf tissue was extracted in HEPES extraction buffer at ratio 500 mg/ml and the 
determination of ODC activity was performed as described previously (please refer to II.2.9). The 
control values are mean ± SE for four replicates from five wild type SR1 plants. The values for 
transgenic lines are mean ± SE (n=4). The indicated mean value of the ODC activity is expressed in 
nmol of CO2/mg total soluble protein /h. Determination of plant total soluble protein was 
performed using BCA assay. Buffer: HEPES extraction buffer pH 7.0; NC: boiled plant extract 
used as negative control; SR1: wild type tobacco plant; 1, 4, 5, 6, 7, 10: stable transformed T2 
tobacco lines (ODC-apo-7/3-1; 4; 5; 6; 7; 10) (Figure III.13) expressing human ODC in apoplast. 
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III.7 Immunization of mice with recombinant ADC, ODC and PAO 
Mice were immunised three times with the recombinant proteins ADC, ODC-GST and 
PAO-GST inclusion bodies at two week intervals (II.2.5). After the third boost, polyclonal 
antibodies were obtained from mouse blood serum and the titer was determined by direct 
ELISA (Figure III-15). To avoid cross reaction of antibodies against the GST domain, 
ELISA tests (II.2.5.1) were performed with ADC protein cleaved from GST moiety with 
Factor Xa (III.2), or ODC and PAO proteins purified from pET22b vector (III.3). GST was 
used as a control. 
The antibody titer refers to the highest dilution at which antigen-specific binding was 
detectable above background binding to the GST. Titer of polyclonal mouse antibody 
specific for ADC and PAO ranged between 1:120,000-150,000, while the anti-ODC 
antiserum titer ranged between 1:60,000-70,000 indicating that ODC-GST triggered a 
lower immune response then ADC protein and PAO-GST inclusion bodies. 
No cross reactivity of polyclonal antibodies with GST was observed for mice immunized 
with ADC, indicating the successful cleavage of the protein from GST with factor Xa. A 
reactivity to GST was observed for mice immunized with ODC-GST and PAO-GST fusion 
proteins. 
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Figure III-15 Determination of polyclonal antibody titers from mouse antiserum by direct 
ELISA.  
The ADC cleaved from GST with Factor Xa (II.2.3), ODC and PAO proteins purified from pET 
vector (II.2.3.2) (10 µg/ml each) were coated to ELISA plates (II.2.5.1). Serial dilutions of sera 
were added to the coated plates and incubated for 1.5 hours. Bound antibodies were detected by 
addition of GAMAP polyclonal antibody (1:5000). ELISA readings were performed at OD405 nm after 
1 h min incubation with pNPP substrate at 37°C. A: Antisera from mice immunized with protein 
ADC cleaved from GST with Factor Xa. B: Antisera from mice immunized with ODC-GST fusion 
protein. C.: Antisera from mice immunized with PAO-GST inclusion bodies. Antigens used in 
ELISA for titer determination are indicated. 
 
III.8 Construction of phage displayed libraries 
III.8.1 Isolation of total RNA from mouse spleen cells 
Total RNA was isolated from spleen cells of mice immunized with ADC, ODC-GST and 
PAO-GST inclusion bodies (II.2.6.1). The RNA concentration and the purity of isolated 
total RNA was determined by spectrophotometry. The yield of total RNA isolated from an 
individual mouse ranged between 1-1.5 mg, regardless of the antigen used for 
immunization. The integrity of the RNA was checked on a 1.2% (w/v) agarose gel (Figure 
III-16). 
The 28S and 18S ribosomal RNA were visible as distinct bands whereas the mRNA was 
present as background smear indicating the quality and integrity of the isolated total RNA. 
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Figure III-16 Analysis of total RNA isolated from mouse spleen cells (II.2.6.1).  
Total RNA was isolated from spleen cells of immunized mice (II.2.6.1) and separated on a 1% 
(w/v) agarose gel containing 2.4 M formaldehyde. The major ribosomal RNA species (28S and 18S 
rRNA) are indicated. 1: 1 µg total RNA isolated from ADC immunized mice; 2: 1 µg total RNA 
isolated from ODC-GST immunized mice; 3: 1 µg total RNA isolated from PAO-GST immunized 
mice 
 
 
III.8.2 cDNA synthesis and PCR amplification of variable heavy and light 
chain fragments 
Total RNA was used for PCR amplification of variable heavy (VH) and light (VL) chain 
fragments. Five µg RNA was reverse transcribed to synthesise first strand cDNA, using 
primers (II.1.8/3) binding to the constant regions of mouse heavy and light chains. Mouse 
IgG1 and IgG2a/b heavy chain variable region and variable fragments from the λ and κ 
light chain were amplified with primer combinations listed in Materials and Methods 
(II.1.8).  
47 individual PCR reactions were performed to amplify VH and VL fragments for each 
library. From ADC, ODC and PAO cDNA 15 out of 16 primer combinations amplified a 
product for the heavy chain subclass IgG1. 14 primer combinations out of 16 amplified a 
product for subclass IgG2a/b. From the ADC cDNA PCR products were amplified from 12 
out of 13 primer combinations for the κ light chain (Figure III-17).  
The same procedure was applied for cDNA amplification of ODC-GST and PAO-GST 
immunized mice. All PCR products had the expected size of 400 to 450 bp. No visible 
band was detected when λ primers were used. Reamplification of λ variable domains failed 
to amplify a PCR product.  
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Figure III-17 Amplification of variable heavy and light chain fragments from ADC 
immunized mice using primers specific for murine: IgG1 (A); Ig2a/2b (B); κ (C).  
Nucleic acids were separated on a 1.2% (w/v) agarose gel. M=1 kb DNA ladder. Lines 1-15 (A); 1-
14 (B) and 1-13 (C) indicate the different MPDV forward primers used for the amplification of the 
IgG1, IgG2a/2b and κ, respectively (II.1.8). 
 
Table III-1 summarizes the results of amplified variable light and heavy chain fragments 
from mice immunized with ADC, ODC-GST and PAO-GST antigens. 
 
Table III-1 Summary of amplified variable heavy and light chain fragments from cDNAs of 
ADC, ODC-GST and PAO-GST immunized mice. Amplification was performed using primers 
specific for IgG1, Ig2a/2b, kappa (κ) and lambda (λ). ‘++’: strong band; ‘+’ band present; ‘(+)’ 
faint band’; ‘-‘: no band visible. 1-16; 1-13 and 14-15 represent the different MPDV forward 
primers used for the amplification of the IgG1 (IgG2a/2b), κ and λ respectively (II.1.8). 
 
IgG1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
ADC ++ + - + + + + + ++ + + + + + + + 
ODC ++ ++ - ++ ++ ++ ++ ++ ++ + ++ ++ ++ ++ ++ + 
PAO + (+) - + ++ ++ + + ++ (+) ++ + + + ++ + 
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IgG2a/b 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
ADC ++ ++ - ++ ++ ++ ++ (+) (+) + (+) ++ - ++ + (+) 
ODC ++ ++ - ++ ++ ++ ++ (+) + ++ ++ ++ ++ ++ - ++ 
PAO ++ + - ++ ++ ++ + + + ++ + ++ ++ ++ - ++ 
 
 κ λ 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
ADC ++ - ++ ++ (+) ++ + ++ + + ++ ++ + - - 
ODC ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - - 
PAO + + + + + + + + + (+) + ++ (+) - - 
 
III.8.3 Construction of phagemid-scFv libraries 
The strategy shown in Figure III-8 was used to establish the scFv libraries expressing 
recombinant antibodies against ADC, ODC and PAO (II.2.6.3). 
 
V  amplification mixH
V  in pHEN4IIH
V  amplification mixL
scFv library in pHEN4II
Sfi BstI / EII Asc NotI / I
SfiI BstEII
pelB VH
Spacer
for VL
c-myc
Gene III pelB
SfiI NotIAscI
Spacer
for VH VL
c-myc
Gene III
SfiI NotI
pelB VH
c-myc
Gene IIIVL
Asc NotI / I
BstEIIAscI NotI
Asc NotI / I
218*
218* 218*
V  in pHEN4IIL
 
 
Figure III-18 Schematic presentation of cloning procedure followed for construction of 
murine scFv libraries.  
The VH and VL amplification mixes were digested with SfiI/BstEII or AscI/ NotI, respectively and 
ligated into the linearized pHEN4II vector. Then the VL was excised with AscI/NotI and subcloned 
into the pHEN4II vector containing the corresponding VH fragment. pelB: pelB leader peptide; c-
myc: myc epitope for the scFv detection; 218*: 218 linker. 
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Gel purified VL fragments were digested with SfiI/BstEII and AscI/NotI, respectively, and 
ligated into pHEN4II vector resulting in construction of variable heavy and light chain 
libraries. The construction of scFv libraries were performed by recovering of VL fragments 
from the VL libraries and cloning them into the linearized pHEN4II vector containing the 
corresponding VH fragment. 
For determination of cloning efficiency 19 individual colonies were randomly selected 
from each scFv library and amplified by PCR using pHEN specific primers (II.1.8/2). The 
amplified PCR products had the expected size of 900-950 bp (Figure III-19). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-19 Analysis of PCR product of randomly selected colonies from murine scFv 
libraries with specificity for ADC (A) and ODC (B).  
1-19: PCR amplification of scFv-fragment of 19 or 15 independent colonies separated on a 1.2% 
(w/v) agarose gel. M: 1 kb ladder. M': 100 bp ladder. 
 
Three final scFv libraries designated HA1LA2; HO1LO2; HP1LP2, were generated for ADC, 
ODC and PAO, respectively. Table III-2 summarizes results obtained from all Fv and scFv 
libraries created. The percentage of positive clones in these final libraries carrying a full 
size scFv fragment were 86.6% for ADC, 87.5% for ODC and 100% for PAO. The library 
size was 3.2x107, 2.6x106 and 1.4x106 for ADC, ODC and PAO, respectively. Biopanning 
was performed with libraries HA1LA2; HO1LO2 only, since purification of soluble PAO 
was unsuccessful (III.2). 
1 kb 
1 kb 
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Table III-2 Summary of constructed murine phage displayed libraries. Library designation and 
their antigen specificity are indicated. The library size and cloning efficiency are indicated for VH, 
VL and scFv libraries generated for each of the three antigens. 
 
Designation Fv-Library size 
(Cloning efficiency %) 
H L 
Antigen 
H L 
scFv-Library size 
(Cloning efficiency %) 
A1 A2 ADC 5.0x105 (75) 9.0x106 (94) 3.2x107 (86.6) 
O1 O2 ODC 5.0x105 (100) 1.2x106 (87) 2.6x106 (87.5) 
P1 P2 PAO 1.2x107 (94) 1.0x106 (100) 1.4x106 (100) 
 
To verify diversity of scFv HA1LA2 and HO1LO2 libraries before panning procedures 
PCR-amplified scFv fragments were subjected to BstNI digestion (II.2.6.4). The RFLP 
analyses indicated that ∼70% and ∼80% of the clones tested from the HA1LA2 and 
HO1LO2 libraries respectively, had different RFLP pattern (Figure III-20). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-20 Analysis of murine scFv fragments after BstNI digestion. 
Samples were analyzed on a 2.3% (w/v) agarose gel. A.: BstNI fingerprinting of 18 randomly 
selected colonies from HA1LA2 scFv library. B.: BstNI fingerprinting of 19 randomly selected 
colonies from HO1LO2 scFv library. M: 100 bp ladder. 10: empty line. 
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III.9 Selection and characterisation of specific scFvs 
III.9.1 Solid phase panning of libraries HA1LA2 and HO1LO2 against 
recombinant fusion proteins ADC and ODC-GST 
The phage libraries HA1LA2 and HO1LO2 were subjected to 3 rounds of panning against 
25 µg/ml ADC and ODC-GST antigens immobilized on the surface of the immuno tubes 
(II.2.7). For each round of panning, 1012 recombinant phages were preabsorbed with GST 
(10 µg/ml) protein to exclude GST specific phages in the subsequent panning rounds. After 
each round the integrity of full size scFv-fragments was verified by PCR amplification 
using vector-specific primers followed by BstNI fingerprinting to visualize diversity of the 
library (data not shown). As shown in Table III-3 there was a 152 and 382-fold enrichment 
of specific phages after the third round of panning of ADC and ODC phage displayed 
libraries, respectively. 
Between the first and the second round of panning of HA1LA2 library an increase of insert 
free-phages from 4.5 x 104  (100% with insert) to 5.4 x 105 (70% with insert) was observed. 
However, the third round of panning led to an enrichment of the eluted phage to a library 
size of 4.7 x 106 (95% with insert). 
 
Table III-3 Enrichment of ADC-GST and ODC-GST binding phage through panning. Fold 
enrichment was calculated by dividing the ratio of recovered number of phage to the input number 
of phage for each round by the same ratio from the preceding round. Total enrichment is obtained 
by dividing the ratio of recovered number of phage to input number of phage of round 3 by the 
same ratio from round 1. Enrichment of round 1 is considered as one. 
scFv 
library 
Panning 
Antigen 
Panning 
rounds 
Input 
phage 
Recovered 
phage 
Recovered to 
input ratio 
Fold-
enrichment
1 2 x 1012 4.5 x 104 2.3 x 10-8 1 
2 2.4 x 1012 5.4 x 105 2.2 x 10-7 9.7 HA1LA2 ADC-GST 
3 1.9 x 1012 6.7 x 106 3.5 x 10-6 15.9 
1 3.1 x 1012 5.3 x 104 1.7 x 10-8 1 
2 2.6 x 1012 6.2 x 105 2.4 x 10-7 14 HO1LO2 ODC-GST 
3 1.3 x 1012 8.4 x 106 6.5 x 10-6 27 
 
For the HO1LO2 library there was a significant increase in phage titer after each round of 
panning. The presence of insert-free phage during panning rounds was not observed for 
this library. The BstNI fingerprinting performed with 20 randomly selected colonies from 
the HO1LO2 library after the third round of panning indicated four unique fragment profiles 
suggesting the enrichment of at least four distinct antibody clones. This observation was 
confirmed by DNA sequencing (III.9.3). 
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III.9.2 Screening and characterisation of scFv-fragments against ODC-GST 
fusion protein 
After the third panning round of HO1LO2 phage display library 120 colonies were 
randomly selected and grown in microtiter plates. Expression of soluble scFv-fragments 
was induced by 1 mM IPTG. The specificity of scFv-fragments was tested in direct ELISA 
experiments against bacterially expressed ODC-GST. More than 60% of analyzed clones 
(Figure III-21) showed a specific binding to the ODC-GST antigen. To verify the presence 
of full size scFv-fragments, the DNA inserts of 30 clones that showed a high reactivity to 
ODC-GST were PCR-amplified followed by BstNI fingerprinting. All clones analyzed 
showed an insert of about 1 kb and BstNI digestion indicated the presence of four different 
band patterns (data not shown). 
 
 
 
 
 
 
 
 
 
Figure III-21 Screening of selected clones from the library HO1LO2 in soluble ELISA.  
Binding activity of 60 randomly selected soluble murine scFv binding to ODC-GST protein after 
the third round of panning was revealed by direct ELISA (II.2.8.1). 10µg/ml of ODC-GST was 
coated on microtiter plates. Bacterial supernatant was added in 2% (w/v) MPBS to a final volume 
of 100µl. Bound scFvs were detected by addition of 1:5000 diluted 9E10 monoclonal antibody, and 
goat-anti mouse polyclonal antibodies conjugated to alkaline phosphatase as secondary antibody 
(1:5000). ELISA readings (OD405 nm) were performed after 10 min incubation with pNPP substrate 
at 37°C 
 
15 clones with the highest absorbance and with different RFLP patterns were subjected to 
medium scale periplasmic expression to overcome the differences based on expression in 
microtiter plates. Their reactivity to the ODC protein purified from pET vector, to ODC-
GST fusion protein, and GST was evaluated in direct ELISA. All scFv-fragments reacted 
specifically to ODC and/or ODC-GST (Figure III-22). No cross reactivity to GST was 
observed. Clone number 3 and clone number 14 (Figure III-22) reacted only specifically to 
the ODC-GST fusion protein and could recognize a conformational epitope, which is not 
present in the denaturated form of ODC. 
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Figure III-22 Reactivity of selected murine scFv-fragments with ODC, ODC-GST and GST 
in direct ELISA.  
10µg/ml of ODC-GST, ODC purified via IMAC under denaturated conditions and GST were 
coated on microtiter plates (II.2.8.1). Periplasmic supernatant (II.2.3.3) was added in 2% (w/v) 
MPBS to a final volume of 100 µl. Bound scFvs were detected by addition of 1:5000 diluted 9E10 
monoclonal antibody, and GAMAP polyclonal antibody (1:5000). ELISA readings (OD405 nm) were 
performed after 10 min incubation with pNPP substrate at 37°C. 
 
To avoid false positives, and to insure that the engineered scFvs were specific for epitopes 
in ODC and not against GST or the linker present in the fusion protein, the reactivity of the 
15 selected clones was analysed against ODC-GST, SME-GST and GST fusion proteins. 
None of the fifteen clones showed a reaction with GST and SME-GST, indicating that 
these clones bind specifically to ODC (data not shown). 
 
 
 
 
 
 
 
 
Figure III-23 Reactivity of selected murine scFv fragments to ODC-GST and GST in 
capture ELISA. 
Chicken IgY’s specific to ODC-GST fusion protein were coated o/n in dilutions 1:1000 (blue) and 
1:5000 (red, yellow) (II.2.8.2). The ELISA plate was blocked for 2 h at RT, and then incubated 
with 10 µg/ml of ODC-GST and GST. Supernatant from the periplasmic expression of 15 selected 
scFvs (II.2.8.1) was added followed by addition of 1:5000 diluted 9E10 monoclonal antibody and 
GAMAP polyclonal antibody (1:5000). ELISA readings (OD405 nm) were performed after 10 min 
incubation with pNPP substrate at 37°C 
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The capture ELISA (II.2.8.2) performed with the same 15 selected scFv fragments (Figure 
III-23) showed that the selected murine scFvs show a high specificity and reactivity for 
ODC-GST and a low reactivity to GST. 
The clone Nr. 3 showed a relatively high signal in the indirect ELISA (Figure III-23) 
compared to the direct ELISA readings (Figure III-22), confirming that this scFv-fragment 
could recognize a conformational epitope in ODC. 
 
III.9.3 Sequence analysis of scFv fragments specific to ODC clones 
The fifteen scFv fragments selected from the library were sequenced. The 15 scFv 
fragments belonged to four different sequence groups. The most abundant sequence was 
represented by clone scFvODC1 (8/15) followed by scFvODC3 (3/15), scFvODC15 (3/15) 
and scFvODC7 (1/15). 
One representative clone of each group named scFvODC1, scFvODC3, scFvODC7 and 
scFvODC15 was further analyzed. All scFv-fragments had open reading frames encoding 
proteins of about 28 kDa. The sequence alignment of the four scFv-fragments with the 
consensus sequence of Kabat database indicated that variable heavy and light chain 
fragments belong to murine IgG. Amino acid comparison of the selected scFv showed 
differences in the framework and CDR regions of both heavy and light chain fragments. 
The deduced amino acid alignment of four scFv is presented in Figure III-24.  
Except for four amino acid differences (Ile54→ Val54; Ser58 → Asn58; Gly69 → Asp69 and 
Met84 → Ile84) the scFvODC7 and scFvODC15 have the same heavy chain, but two 
different light chains. In addition, scFv3 and scFv7 share the same light chain sequence 
(expect for two amino acid change: Try244 → Leu244, Gly248 → Ala248,) with two different 
variable heavy chains. Table III-5 summarizes the sequencing results of the four selected 
scFvODCs. 
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Figure III-24 Alignment of the deduced amino acid sequences of selected murine scFv-
fragments with specificity for ODC: scFvODC1, scFvODC3, scFvODC7 and scFvODC15. 
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Framework regions and complementary determining regions (CDRs) were determined according to 
Kabat and Wu, (1991). ‘*’: the same amino acid; ‘-‘: no amino acid at this position; ‘:’ or ‘.’ 
different amino acid. The complementary determining regions and the 218* linker have been 
indicated. 
 
Table III-4 Summary of sequence analysis of murine derived scFvs with specificity for ODC. 
Deduced molecular weight is indicated. 
Designation 
of scFv 
Nucleotide 
length (bp) 
Deduced 
MW (Da) CDRH3 sequence 
scFvODC1 759 26921  - - - -  -  S - -  LSY 
scFvODC3 765 27666 RDGDYGKWFAY 
scFvODC7 765 27457 KGEDYDVRFAY 
scFvODC15 777 28199 KGEDYDVRFAY 
 
Sequence alignment with the nearest germline V-gene segments listed in the IMGT 
database indicated that the heavy and light chain variable domains of selected scFvODCs 
were members of the family I of murine VH and family I and 10 of the κ light chain 
respectively. Several differences were observed from the nearest germline V-gene 
segments both in the nucleotide and amino acid level as indicated in Table III-5. 
 
Table III-5 V-gene family, germline deviation and extent of somatic hypermutation of four 
scFvs specific for ODC. Numbers in brackets indicate the nucleotide and amino acid differences 
observed in the primer region of scFv-fragments. The alignment of the four selected scFvODCs to 
their closest germline gene sequences was performed using the IMGT database 
(http://imgt.cnusc.fr:8104/). 
 Differences from germline 
scFvs Mouse IgG Family 
Closest germline 
gene sequences Nucleotides Amino acid 
 H L H L H L H L 
scFvODC1 IGHV1 IGKV1 X02459 D00080 49(4) 5(2) 22(2) 2(2) 
scFvODC3 IGHV1 IGKV10 AF304556 M15520 13(5) 4(2) 10(4) 2(1) 
scFvODC7 IGHV1 IGKV10 AF304556 M15520 7(4) 3(2) 6(3) 2(0) 
scFvODC15 IGHV1 IGKV1 AF304556 D00081 11(4) 8(1) 9(3) 3(1) 
 
III.9.4 Screening and characterisation of scFv-fragments against ADC-GST 
fusion protein 
After the third round of panning the HA1LA2 phage display library against purified ADC 
protein, 120 colonies were randomly selected and grown in microtiter plates. Expression of 
soluble scFv fragments was induced by IPTG. The specificity of scFv-fragments was 
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tested in ELISA experiments against ADC-GST. 40% of the analysed clones showed a 
specific binding to the antigen (data not shown). To examine the presence of full size scFv-
fragments inserts from 15 clones that showed a high reactivity to ODC-GST in soluble 
ELISA were PCR-amplified followed by BstNI fingerprinting. All clones analysed had an 
insert of about 1 kb and BstNI digestion showed the presence of two RFLP patterns. 14 
clones were subjected to periplasmic expression. Their reactivity to the ADC-GST fusion 
protein and to GST was reevaluated by direct ELISA (Figure III-25). The results indicated 
that all selected scFv-fragments reacted specifically to ADC and there was no cross 
reactivity to GST. 
 
 
 
 
 
 
 
 
Figure III-25 Reactivity of selected murine scFv-fragments to ADC-GST and GST in direct 
ELISA. 
10µg/ml of ADC-GST, and GST were coated on microtiter plates (II.2.8.1). Periplasmic 
supernatant (II.2.3.3) was added in 2% (w/v) MPBS to a final volume of 100 µl. Bound scFvs were 
detected by addition of 1:5000 diluted 9E10 monoclonal antibody, and GAMAP polyclonal antibody 
(1:5000). ELISA readings (OD405 nm) were performed after 30 min incubation with pNPP substrate 
at 37°C. 
 
The capture ELISA (II.2.8.2) was performed with the periplasmic preparation of the same 
14 scFv fragments. Capture antibodies used for ELISA were IgY’s from chickens 
immunized with ADC-GST protein cleaved off from GST with Factor Xa. Results 
presented in Figure III-26 indicated that there was a high specificity and reactivity of the 
scFv to the ADC-GST and the reactivity to the GST are significantly lower, but higher 
when compared to the reactivity of the ODC specific clones (refer to Figure III.23). 
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Figure III-26 Reactivity of selected murine scFv fragments to ADC-GST and GST in 
capture ELISA.  
Chicken IgY’s specific to ADC protein were coated o/n in dilutions: 1:1000 (blue) and 1:5000 (red, 
yellow) (II.2.8.2). The ELISA plate was blocked for 2 h at RT, and then incubated with 10 µg/ml of 
ADC-GST and GST. Supernatant from the periplasmic expression of 14 selected scFvs (II.2.8.1) 
was added followed by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMAP 
polyclonal antibody (1:5000). ELISA readings (OD405 nm) were performed after 10 min incubation 
with pNPP substrate at 37°C 
 
 
III.9.5 Sequence analysis of selected scFv-ADC clones 
The scFv inserts of 14 clones that showed the highest reactivity to the antigen in direct and 
capture ELISA were sequenced. All scFv-fragments had open reading frames comprising 
two different sequences (confirmation of RFLP pattern). The most abundant scFv fragment 
was present in thirteen of the 14 clones sequenced. Two clones showing a different 
sequence, named scFvADC3 and scFvADC7 were analysed further. Amino acid alignment 
(Figure III-27) showed that the selected scFvs share 55.9% identity and 65% similarity. 
Analysis of the amino acid sequence revealed significant differences in the framework and 
CDR regions of both, heavy and light chain fragments. Sequence alignment with the Kabat 
database showed that VH of the scFvADC3 and 7 belonged to the murine V1 and V5 
family. The VL is member of V4 and V9 of murine κ light chain respectively. Table III-7 
present a short summary of sequence analyses of scFvADC3 and scFvADC7. The 
comparison with the closest germline V-gene segments indicated large differences both in 
nucleotide and amino acid levels (Table III-7). 
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Table III-6 Summary of sequence analysis of murine derived scFvs with specificity for ADC. 
The deduced molecular weight is indicated. Matching amino acid is indicated in red. 
Designation 
of scFv 
Nucleotide 
length (bp) 
Deduced 
MW (Da) CDRH3 sequence 
scFvADC3 759 27160 R - - DYYYAMDY 
scFvADC7 762 27039 KGENYGNYFYV 
 
 
Table III-7 V-gene family, germline deviation and extent of somatic hypermutation of two 
scFvs specific for ADC. Numbers in brackets indicate the nucleotide and amino acid differences 
observed in the primer region of scFv-fragments. The alignment of the four selected scFvADCs to 
their closest germline gene sequences was performed using the IMGT database 
(http://imgt.cnusc.fr:8104/). 
 
 Differences from germline 
scFvs Mouse IgG Family 
Closest germline gene 
sequences 
Nucleotides Amino acid 
 H L H L H L H L 
scFvADC3 IGHV5 IGKV9 AF120474 V00804 >40(2) 6(4) 37(2) 1(1) 
scFvADC7 IGHV1 IGKV4 AF304556 AJ231224 14(4) 5(3) 9(3) 2(1) 
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Figure III-27 Alignment of the deduced amino acid sequences of two selected murine scFv-
fragments with specificity for ADC: scFvADC3 and scFvADC7. 
Framework regions and complementary determining regions (CDRs) were determined according to 
Kabat and Wu, (1991). ‘*’: the same amino acid as above; ‘-‘: no amino acid at this position; ‘:’ or 
‘.’ different amino acid. The complementary determining regions and the 218* linker have been 
indicated.  
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III.10 Characterization of biological and physical features of the ODC-
specific scFv antibodies 
III.10.1 Cloning and expression of scFvODC1, scFvODC3, scFvODC7 and 
scFvODC15 in E. coli 
Up scaled expression of scFvODC1, scFvODC3, scFvODC7 and scFvODC15 was 
performed using pSyn vector (III.10.1). Protein expression into the periplasmic space was 
achived by 1 mM IPTG at 30°C (II.2.8). scFvODC1 and scFvODC3 were subcloned 
downstream of the pelB leader peptide of pSyn vector using NcoI and NotI restriction sites. 
Because of an internal NcoI site at base pair position 125 of the VH chains of the 
scFvODC7 and scFVODC15 SfiI and NotI restriction enzymes were used for subcloning. 
Correct insertion was confirmed by sequencing (data not shown). Soluble expression of 
recombinant proteins was performed using E. coli strain HB2151. 
The His6 tagged scFvs were purified by IMAC from the culture medium (III.10.1). SDS-
PAGE analysis of the affinity purified scFvs’ revealed the presence of a single band of 
approximately 30 kDa for all four scFvs (Figure III-28).  
 
 
 
 
 
 
 
 
 
 
Figure III-28 SDS-PAGE analysis of affinity purified scFvODC1, scFvOSC3, scFvODC7 
and scFvODC15. 
Selected scFvODCs (1, 3, 7 and 15) were subcloned into the pSyn vector and expressed in the E. 
coli strain HB2151 upon induction with IPTG. The periplasmic expressed scFvs were purified by 
IMAC (II.2.8.1). Proteins were separated on 12% (w/v) SDS-PAGE and stained with Coomassie 
brilliant blue (II.2.4.2). O: 10 µl of osmotic fraction; F1: 10 µl of the first flow through; F2: 10 µl of 
the second flow through; W: 10 µl of washing fraction; E1, E2, E3, E4, E5: 5 µl of five elution 
fractions; M Mark12 protein marker. 
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Pilot experiment showed that washing steps with 30 mM imidazol led to losses of 
recombinant protein (data not shown). This was avoided by increasing the matrix volume 
and decreasing the imidazol concentration to 10 mM in the wash buffer (data not shown). 
After purification the purified scFv were dialysed overnight in 1xPBS buffer pH 7.4 and 
the final concentration determined by either Bradford or BCA assay using BSA as a 
standard. The yield of purified scFvs ranged between 1.5-2.7 mg/L culture volume. Slight 
deviations were observed depending on the batch of preparation. All clones expressed a 
functional scFv as shown by their ability to bind specifically to ODC-GST in ELISA 
(III.10.3). 
 
III.10.2 Stability of affinity purified scFvODCs 
To generate more information about the stability of affinity purified scFvODC1, 3 and 
scFvODC7 and to ascertain whether scFvs were present as monomeric or dimeric forms, 
gel filtration analysis was performed (II.2.8.6). Proteins with known molecular weight 
were run as standards. A calibration curve was prepared by plotting the logarithms of the 
known molecular weights of protein standards versus their respective Ve/Vo values (Ve is 
the elution volume and Vo is the void volume). Molecular weight determination of scFvs 
was made by comparing the ratio Ve/Vo of the scFvs to the Ve/Vo of the protein standards 
of known molecular weight. Elution was monitored by UV absorption at 280 nm. 
Figure III-29 shows results from gel filtration analysis of the scFvODC1, 3 and 7. Analyses 
of the scFvODC1 after 3-6 months storage at 4°C revealed that more than 80% of the 
scFvODC1 eluted as a 16 kDa degradation product. Degradation of scFvODC1 was 
confirmed by SDS-PAGE (data not shown). However, the degraded scFvODC1 retained 
50% binding activity compared to the fresh purified scFvODC1 (data not shown). The 
scFvODC1 stored at -20°C for about 3-months was stable and eluted as a monomeric scFv 
form. 
The elution profile from the scFvODC3 and scFvODC7 showed two peaks (Figure III-29) 
with a retention volume of 14.54 ml and 16.2 ml; the second peak corresponded to a 
molecular weight of 27-28 kDa, as determined from the standards, representing a 
monomeric scFv. The first peak (retention volume 14.54 ml) corresponded with 66 kDa to 
dimeric forms of scFvODC3 and 7. About 35% of scFvODC3 and 20% of the scFvsODC7 
were present as dimers. The immunoblot analysis confirmed the monomeric and dimeric 
forms of scFvODC3 and 7 by showing the presence of 28 and 66 kDa protein bands (data 
not shown). The scFvODC7 used for this analysis was stored at -20°C for about 1 month. 
The scFvODC3 was analyzed directly after a fresh purification indicating that the dimer 
formation is a scFv property.  
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Figure III-29 Gel filtration chromatography of affinity purified ODC-specific scFvs.  
scFv were purified via IMAC (II.2.3.3) and analyzed after dialyses by gel filtration on a Sephadex 
200 column (II.2.8.6). Affinity purified scFvs were loaded and run at 1 ml/min after calibration 
with the MW standards (II.2.8.6). The scFvODC1 stored at 4°C eluted as a 16 kDa degradation 
product. The mobility of the scFv3 and 7 were consistent with a molecular mass of 27-28 kDa. 
Dimers of both scFvs were present (retention volume 14.54 ml). 
 
III.10.3 Reactivity of ODC-specific scFvs with ODC-GST and GST 
Direct ELISA was performed to examine the reactivity of the purified scFvODC1, 3, 7, 
and 15 to the ODC-GST and GST antigens. Several dilutions of purified scFvODCs were 
incubated on high binding ELISA plates coated with ODC-GST and GST (5µg/ml). The 
slope determined by linear regretion was taken as reactivity (Figure III-30).  
The slope of the curves in the Figure III-30/B, D is a direct indication of reactivity of these 
scFv to their antigens. The results indicate that scFvODC1, scFvODC3 and scFvODC7 
have a high, specific reactivity to ODC-GST and do not cross-react to GST. The signal to 
noise ratio indicated in Figure III-30/D presents the ratio between the scFv reactivity of 
ODC-GST antigen and GST. Even though the scFvODC15 did not show a high reactivity 
to the antigen, its signal to noise ratio (482.1) indicated a high specificity to ODC-GST. 
The specific binding of scFv was further assessed using surface plasmon resonance 
analysis (III.2.8.7). 
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Figure III-30 Reactivity of affinity purified scFvODC1, 3, 7 and 15 to ODC-GST and GST. 
1 µg/ml of ODC-GST and GST were coated on microtiter plates (II.2.8.1). Serial dilutions 
(concentrations) of affinity purified ODC specific scFvs were added in 1xPBS to a final volume of 
100 µl. Bound scFvs were detected by using 9E10 monoclonal antibody (1:5000), and GAMAP 
polyclonal antibody (1:5000). ELISA readings were performed at OD405 nm after 30 min incubation 
with pNPP substrate at 37°C and presented in A, C. Using the Origin software the slope was 
determined by linear regression and then presented as the arbitrary reactivity of the scFvODC1 
(green) and scFvODC3 (yellow) to the ODC-GST and GST (B), or as the molar reactivity of the 
scFvODC7 (green) and 15 (yellow) (D) to the ODC-GST and GST. The signal to noise ratio is 
calculated for all scFvs specific to ODC. 
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III.10.4 Epitope mapping of scFvODC1, scFvODC3 and scFvODC7 by 
surface plasmon resonance 
Epitope mapping of affinity purified scFvs to ODC-GST was performed by surface 
plasmon resonance (BIAcore) using pair-wise epitope mapping analysis (II.2.8.5). In pair-
wise epitope mapping assays the ability of two scFv to bind simultaneously to the same 
antigen is tested. One scFv ‘‘the ligand’’ is covalently bound to the sensor surface using 
amine-specific coupling. Then the antigen is passed over the prepared surface under flow 
to bind to the ligand, followed by the injection of the second scFv.  
If the second scFv binds to the antigen, the two scFv recognize different epitopes. If two 
scFvs have identical or overlapping epitopes they compete for the binding site. Any 
interaction between proteins is recorded as a function of time in resonance units (RU). RU 
are arbitrary units that reflect the changes in refractive index (a function of mass) at the 
sensor surface as a result of the binding of solution-phase analyte to (or its release from) 
surface-bound ligand. 
scFvODC1 was immobilized in the flow cell 1 (Fc1). In the second flow cell (Fc2) rabbit 
anti GST monoclonal antibody (Rα-GST) that does not have identical or overlapping 
epitopes with any of the scFvODCs was immobilized. The Rα-GST was used as positive 
control because it recognized an epitope present in GST part of the ODC-GST fusion 
protein. The scFvODC3 and 15 were immobilized in the Fc3 and Fc4 respectively. After 
immobilization the ODC-GST antigen was injected in the four flow cells at a concentration 
of 0.15 µM. Then, either scFvODC1 (Figure III-31/A) or scFvODC3 (Figure III-31/B) was 
injected to the flow cells after immobilization with ODC-GST and the changes in the RU 
was studied on the sensogram. Figure C, D represents the binding activity of the second 
injected scFv (scFvODC1 or scFvODC3) to the antigen bound in the four flow cells. The 
binding activity of the second scFv to the Fc2 where the rabbit anti GST has been 
immobilized was taken as 100% because the scFvODCs do not have identical or 
overlapping epitope with the R-α-GST antibody. Binding activity of scFvODC1 to Fc1 
(Figure III-31/C) was taken as negative control. The binding activity of scFvODC1 in Fc3 
and Fc4 ranged between 75-85% indicating that scFvODC1 did not have overlapping 
epitopes with scFv3 and 15. 
In Figure III-31/B, D the pair wise epitope mapping of scFvODC3 with the scFvODC1 and 
scFvODC15 is analysed. The low binding activity of the scFvODC3 to the ODC-GST 
antigen in the Fc3 (negative control) and Fc4 indicated that scFvODC3 has an overlapping 
epitope with scFvODC15. scFvODC1 recognized a distinct epitope different to 
scFvODC3, 7 and 15. 
 
 
Chapter III Results 
 88
scFvODC1 scFvODC15 scFvODC3 R a-GST
0
20
40
60
80
100
 %
 B
in
di
ng
 a
ct
iv
ity
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
-100 0 100 200 300 400 500 600 700 800 900
Time s
R
es
po
ns
e
RU
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
-400 -200 0 200 400 600 800 1000 1200 1400
Time s
R
es
po
ns
e
RU
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-31 Epitope mapping of scFvODC to ODC-GST by surface plasmon resonance. 
0.3 µM scFvODC1, 3 and 15 were immobilized in flow cells 1, 3 and 4 (Fc1, Fc3 and Fc4) (II.2.8). 
Rabbit anti GST antibody was immobilized in the Fc2 at a concentration of 0.35 µM. First injection 
was performed by 0.15 µM ODC-GST antigen. After surface regeneration the second scFvODC 
(scFvODC1 (A) or scFvODC3 (B) were injected. The changes in the RU were measured after 800 
(A) and 1200 (B) seconds of the second injection. C: binding activity of scFvODC1 to the ODC-
GST antigen bound in the four flow cells. D: binding activity of scFvODC3 to the ODC-GST 
antigen bound in the four flow cells. 
 
III.10.5 Comparative analysis of binding activity of scFvODC1 preincubated 
with ODC-GST 
To analyze the binding activity of scFvODC1 to soluble ODC-GST a BIAcore assay was 
performed. The ODC-GST antigen was immobilized to a BIAcore CM5 sensor chip 
surface at a concentration of 0.15 µM. Constant concentrations of scFvODC1 (750 nM) 
were incubated with different molar ratio of soluble ODC-GST for 1 h at RT. Controls 
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without ODC-GST and scFvODC1 alone were prepared and analysed under the same 
conditions. Each sample was passed over the chip and the response units monitored. The 
obtained BIAcore curves shown in Figure III-32 indicate that the highest binding activity 
of scFvODC1 to the immobilized ODC-GST antigen was achieved in the sample without 
ODC-GST. Addition of increasing concentration of antigen from 0 to 7.5 µM reduced the 
binding activity of scFvODC1 to the immobilized antigen. The ratio of observed to 
maximal response units was calculated and plotted against the logarithmic concentration of 
soluble ODC-GST (Figure III-32). The graph shows that addition of soluble ODC-GST 
inhibits the interaction of scFvODC1 to the immobilized antigen in a dose-dependent 
fashion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-32 Inhibition of scFvODC1 binding to immobilized ODC-GST by addition of 
soluble antigen.  
The binding curves representing scFvODC1 binding to the immobilized ODC-GST in the absence 
of soluble ODC-GST (upper curve), or increasing amounts of up to 7.5 µM (lower curve) are 
shown in the inset figure. The changes in the RU were measured after 240 seconds of sample 
injections. One site competition model expressed the function between the Robs/Rmax ratio and the 
logarithmic concentration of soluble ODC-GST antigen. Rmax reflect the response units measured 
after 240 seconds of the scFvODC1 (without soluble ODC-GST antigen) injection. Robs reflect the 
RU measured after 240 seconds of any sample (scFvOSC1 + soluble ODC-GST) analyzed. 
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III.10.6 Electrophoretic mobility shift assay (EMSA) 
The functionality of the affinity purified scFvODC1 and scFvODC3 to the ODC-GST 
antigen was confirmed by electrophoretic mobility shift assay (EMSA). EMSA is based on 
the observation that stable antibody-antigen complexes migrate slower through 
polyacrylamide gels than free antigen and antibody fragments (II.2.8.5). Two µg of the 
purified scFvODC1 and scFvODC3 were incubated for one h at RT with ODC-GST 
starting with a 1:1 molar ratio of antigen:scFv up to a 30:1 ratio. Incubation of the antigen 
with the scFv formed complexes that migrated slower than the ODC-GST and the scFv 
fragments alone (Figure III-33). Samples containing the scFvODC1, scFvODC3 and ODC-
GST antigen were loaded in parallel. 
 
 
 
 
 
 
 
 
Figure III-33 The functionality analysis of the scFvODC1 (A) and scFvODC3 (B) to ODC-
GST antigen by EMSA. 
scFvODC1-ODC-GST complex formation was analyzed on a nondenaturating 12% (w/v) PAA-gel 
electrophores at RT for 5 h at 100 V. A-1: 1.5 µg ODC-GST; 2: 2 µg scFvODC1; 3: 0.16 µg ODC-
GST + 2 µg scFvODC1; 4: 0.33 µg ODC-GST + 2 µg scFvODC1; 5: 0.5 µg ODC-GST + 2 µg 
scFvODC1; 6: 1 µg ODC-GST + 2 µg scFvODC1; 7: 1.5 µg ODC-GST + 2 µg scFvODC1; 8: 5 µg 
ODC-GST + 2 µg scFvODC1. 
B- 1: 1.5 µg ODC-GST; 2: 2 µg scFvODC3; 3: 4 µg ODC-GST + 2 µg scFvODC3; 4: 2 µg ODC-
GST + 2 µg scFvODC3; 5: 1 µg ODC-GST + 2 µg scFvODC3; 6: 0.5 µg ODC-GST + 2 µg 
scFvODC3; 7: 0.25 µg ODC-GST + 2 µg scFvODC3; 8: 0.125 µg ODC-GST + 2 µg scFvODC3. 
The scFvODC3-ODC-GST complex formation was separated on a nondenaturating PAA-gel run at 
4°C for 5 h at 100 V and blotted onto a nitrocellulose membrane (II.2.2.3). Immunodetection was 
carried out by addition of 1:5000 diluted 9E10 mAb, and goat-anti mouse polyclonal antibodies 
conjugated to alkaline phosphatase as secondary antibody (1:5000). Detection was carried out with 
NBT/BCIP for 1 min at RT. 
 
As indicated in Figure III-33/A the scFvODC1 (red arrow) migrated faster than the ODC-
GST antigen (blue arrow). Although the concentration of scFvODC1 was kept constant in 
the assay, scFv band intensity decreased with increasing concentration of ODC-GST 
(Figure III-33/A lines 3-8) resulting in formation of higher MW complexes. These results 
scFvODC1 + ODC-GST scFvODC3 + ODC-GST 
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indicate that scFvODC1 and ODC-GST interacted and formed stable complexes. Thus, 
confirming the functionality of the scFvODC1 to the antigen. 
Also scFvODC3 caused a band shift (Figure III-33/B lanes 3-6) when incubated with 
ODC-GST. Lanes 3, 4, 5 and 6 in Figure III-32/B show clearly the band shift resulting 
from addition of increasing amounts of ODC-GST using the constant scFvODC3 
concentrations versus the scFvODC3 alone (lane 2). In lanes 3, 4, 5 and 6 two bands are 
observed, an intense band with decreased mobility (black arrow) corresponding to the 
scFvODC3-ODC-GST complex and a faint band corresponding to the free scFvODC3 
(green arrow). The intensity of the scFvODC3-ODC-GST complex decreases with 
decreasing amounts of the antigen indicating that scFvODC3-ODC-GST complex 
formation is a dose dependent process. 
 
III.10.7 In vitro effect of scFvODC1 and scFvODC3 on the enzymatic activity 
of bacterial purified ODC-GST  
In order to examine the effect of ODC-specific murine scFvODC1 and scFvODC3 on the 
ODC enzymatic activity, radioactive assays were performed using bacterial purified ODC-
GST (II.2.3.1). Prior to in vitro analyses the binding of freshly purified scFvODC1 and 
scFvODC3 with affinity purified bacterial ODC-GST was tested by direct ELISA 
(II.2.8.1). Both scFvs exhibited high binding activity to ODC (data not shown). 
Serial dilutions of bacterial purified ODC-GST were analysed for ODC enzymatic activity, 
to determine the enzyme concentrations resulting in a significant signal in the assay. The 
ODC-GST concentration chosen was 13 nM (data not shown) and used as the 100% value.  
The antibody concentration chosen for the in vitro enzyme assay was determined 
theoretically as indicated in the formula below based on the law of mass action, since it 
was crucial to be in the range giving inhibition effect. 
 








−

 ++±

 ++=
−





 ++±

 ++=
ß
Ac
Kß
Ac
KßAc
Ac
Ac
K
Ac
Ac
K
AcAB
DD
DD
*4
)(
1
)(
1*)(*
2
1
)(*
)(
1*)(*
2
1
)(
1*)(*
2
1][
2
00
0
20
2
0
0
0
0
2,1 βββ
 
 
where, [AB]1,2 = complexed ODC-GST 
 c0(A)  = ODC-GST molar concentration 
 c0(B)  = scFv molar concentration 
β = c0(B) / c0(A) 
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KD  = 500 nM (estimated by BIAcore experiments) 
 
Five different concentrations of scFvODC1 and scFvODC3 (3.4 µM; 1.7 µM; 850 nM; 425 
nM; 212 nM) were chosen for in vitro enzyme analyses (Figure III-34). The scFv4813 (in 
the same molar concentrations) was used as a negative control. 
 
              I                                                                      II 
 
 
 
 
 
Figure III-34 In vitro effect of scFvODC1 (A) and scFvODC3 (B) on the enzymatic activity 
of ODC. 
ODC-GST fusion protein was affinity purified using glutathione sepharose matrix (II.2.3.1). 13 nM 
of the ODC-GST were diluted in HEPES buffer (pH 7.5) and mixed with different concentrations 
of scFvODC1 and scFvODC3 (3.4 µM; 1.7 µM; 850 nM; 425 nM; 212 nM). Determination of 
ODC activity was performed as described (II.2.9). All the values indicated are mean ±SE (n=4). 
The indicated mean value of the ODC activity are expressed in µmol CO2 mg-1 protein h-1. The % 
change of the ODC activity after addition of scFvODc1 and scFvODc3 is indicated. 
I: B: Hepes buffer pH 7.5; C1: 13 nM of heat inactivated ODC-GST enzyme; C2: 1.7 µM of 
scFvODC1; C3: 13 nM ODC-GST ≡100% value; C4: 13 nM ODC-GST + 3.4 µM scFv4813; S1: 
13 nM ODC-GST + 3.4 µM scFvODC1; S2: 13 nM ODC-GST + 1.7 µM scFvODC1; S3: 13 nM 
ODC-GST + 850 nM scFvODC1; S4: 13 nM ODC-GST + 425 nM scFvODC1; S5: 13 nM ODC-
GST + 212 nM scFvODC1. 
II: B: Hepes buffer pH 7.5; C1: 13 nM of heat inactivated ODC-GST enzyme; C2: 1.7 µM of 
scFvODC3; C3: 13 nM ODC-GST; C4: 13 nM ODC-GST + 3.4 µM scFv4813; S1: 13 nM ODC-
GST + 3.4 µM scFvODC3; S2: 13 nM ODC-GST + 1.7 µM scFvODC3; S3: 13 nM ODC-GST + 
850 nM scFvODC3; S4: 13 nM ODC-GST + 425 nM scFvODC3; S5: 13 nM ODC-GST + 212 nM 
scFvODC3. 
 
 
Results presented in Figure III-34 clearly indicate that addition of different of scFvODC1 
and scFvODC3 concentrations stabilized the enzymatic activity of bacterial purified ODC 
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in a dose dependent manner. Addition of 3.4 µM scFvODC1 and scFvODC3 increased the 
enzymatic activity of ODC by 75% and 92%, respectively, indicating that the scFvODC3 
could have a stronger stabilizing effect. In future experiments it would be interesting to 
invenstigate the additive effect of both scFvODC1 and scFvODC3 to 13 nM ODC. 
 
III.10.8 Transient expression of scFvODC1, 3, 7 and 15 in vacuum-infiltrated 
tobacco leaves 
To study recombinant antibody expression in tobacco plants scFvODC1, 3, 7 and 15 were 
subcloned into plant expression vector pTRA using NcoI/NotI restriction sites. Leader 
peptides or tags were added for either secretion into the apoplasmic space or retention in 
ER. Eight different plant expression constructs were generated and their sequences 
verified. Transient assays were performed and the scFv expression levels in the apoplast 
and ER were analysed by immunoblot analysis (Figure III-35). 
The immunoblot analyses of the total soluble protein extracted from infiltrated leaves 
showed a distinct, single band of about 30 kDa for all four ODC-specific scFvs. No 
difference in expression level was observed among four leaves of the same construct. The 
constructs that retained the scFv in ER, carrying His6 and KDEL detection tags, were 
analyzed in parallel (Figure III-35). The immunoblot analyses revealed that all four scFvs 
specific to ODC had higher levels of expression in the ER than in the apoplast (Figure III-
35/C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
   1   2   3    4    5    6    7    8   C  M 
#1-apo #3-apo 
 1   2    3    4 
#15-apo 
A B 
47.5 
32.5 
25 scFvODC1 
83.5 
Chapter III Results 
 94
 
 
 
 
 
 
 
 
 
Figure III-35 Transient expression of ODC specific scFvs in tobacco leaves.  
Four tobacco leaves were infiltrated for each construct either for retention of scFv in ER or for 
secretion of scFvs into apoplastic space. Total soluble leaf proteins were extracted by grinding 
tobacco leaf tissue in two volumes of extraction buffer (II.2.2.6). 5 µl of total soluble protein from 
each sample was separated by 12% SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose 
membrane (II.2.2.3). Immunodetection was carried out with anti-his6 antibody (1:5000), followed 
by 1 hr incubation with goat anti-mouse antibody conjugated to alkaline phosphatase (1:5000) and 
NBT/BCIP detection for 1 min at RT. 
A: 1-4: different infiltrated leaves expressing scFvODC1 in apoplast. B: 1-4: different infiltrated 
leaves expressing scFvODC3 in apoplasm; 5-8: different infiltrated leaves expressing scFvODC15 
in apoplasm. C: 1-3: different infiltrated leaves expressing scFvODC7 in ER; 4-7: different 
infiltrated leaves expressing scFvODC7 in apoplasm; M: prestained protein marker; C: 1 µg anti 
HCG diabody. 
 
 
III.10.9 Functional analyses of cytosolic expressed scFvODC1 and scFvODC3 
To study the accumulation level and the functionality of ODC-specific murine scFv 
fragments in the plant cytosol, the scFvODC1 and scFvODC3 that were fully functional in 
EMSA assays and recognized different epitopes in the ODC protein were chosen for 
cytosolic targeting. 
The scFvODC1 and scFvODC3 were cloned via NcoI and SalI restriction sites in the 
SCA24OmW cassette in pUC 18 downstream of the TMV 5′ UTR (omega (Ω) leader), and 
upstream of the c-myc/his-6 tags (Figure III-36). Then, the cassette containing the Ω 
leader, scFvODC cDNAs and c-myc/his6 tags was excised with EcoRI and XbaI and 
cloned between the enhanced 35S promoter and Pw untranslated region of pSS vector 
resulting in the pSS: scFvODC1-cyt and pSS: scFvODC3-cyt constructs (Figure III-36). 
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Figure III-36 Strategy for cloning of ODC specific murine scFvs into pSS plant expression 
vector for cytosolic targeting. 
P35S: 35S promoter from CaMV with duplicated 35S enhancer; Ω: omega leader region of TMV 
RNA; Pw: 3' UTR of TMV RNA: scFv24: TMV specific single chain antibody 24; scFvODC: 
ODC specific murine scFv antibody (scFvODC1 or scFvODC3); c-myc: myc epitope for detection; 
His6: his-6 tag for purification and detection. 
 
Transient expression experiments were performed. Four leaves for each construct were 
infiltrated with recombinant agrobacteria. After three days of incubation at 26°C total 
soluble proteins were extracted and detected by immunoblot analyses to verify 
accumulation and integrity of the recombinant proteins in the plant cytosol. Immunoblot 
analyses (Figure III-37) showed a distinct band of approximately 30 kDa, corresponding to 
the molecular weight of scFvODC1 and scFvODC3. No significant difference in 
accumulation level was observed among four leaves of the same construct. The 
immunoblot analyses revealed that scFvODC1 and scFvODC3 accumulated to high levels 
in the plant cytosol (~50-70 µg/g fresh weight), as indicated by comparison of band 
intensity with several concentrations of scFv standard (data not shown). 
The total soluble protein extracts were analyzed for antigen-binding activity of cytosolic 
expressed scFv fragments. The binding of scFvODC1 and scFvODC3 to ODC-GST was 
analysed by direct ELISA (Figure III-38). 
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Figure III-37 Transient expression of cytosolic scFvODC1 and scFvODC3 
Total soluble proteins were extracted by grinding tobacco leaf tissue (II.2.2.6) in two volumes 
extraction buffer, separated by SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose membrane. 
Immunodetection was carried out with 1:5000 diluted 9E10 as primary antibody, followed by 
1:5000 diluted alkaline phosphatase conjugated goat anti mouse as secondary antibody. Detection 
was performed with NBT/BCIP for 1 min at RT.  
Lane 1: 7 µl PPM; 2-4: 5 µl of total soluble protein extracted from individual leaves expressing 
scFvODC1 in the cytosol; 5-7: 5 µl of total soluble protein extracted from individual leaves 
expressing scFvODC3 in the cytosol; W: 5 µl of total soluble protein extracted from wild type 
tobacco leaves; C: 1 µg of bacterial purified scFvODC3. 
 
To confirm the specific reactivity of the scFvs to the ODC antigen SME-GST and GST 
were coated onto ELISA plates as control. The reactivity of the wild type tobacco plant 
extract to ODC-GST was analysed as well. 
ELISA results presented in Figure III-38 showed that the cytosolic expressed scFvODC1 
and scFvODC3 had a high binding reactivity with ODC compared to the wild type tobacco 
extract. No cross reactivity with the GST and SME-GST was observed for both scFvs, 
indicating the ODC-specificity and functionality of the cytosolic expressed scFvODC 1 
and scFvODC3.  
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Figure III-38 ELISA analyses of cytosolic expressed murine scFvODC1 (A) and scFvODC3 
(B) to ODC-GST, SME-GST and GST antigens. 
Analyses of cytosolic expressed scFvODC1 to ODC-GST (black), SME-GST (green) and GST 
(red). The reactivity of wild type SR1 tobacco extract to ODC-GST is indicated (blue). 
2.5 µg/ml of ODC-GST, GST and SME-GST were coated on microtiter plates. Wild type and 
transient infiltrated tobacco leaves accumulating the scFvODC1 and scFvODC3 in the plant cytosol 
were extracted 1:2 into protein extraction buffer. Plant extract was serially diluted into protein 
extraction buffer in a siliconized plate. After 3x washing with PBST 100 µl of the serially diluted 
plant extract was added into ELISA plates. The plates were incubated at 37°C for 1.5 h. Bound 
scFvs were detected by addition of 1:5000 diluted 9E10 mAb and GAMAP secondary antibody 
(1:5000). ELISA readings (OD405 nm) were performed after 30 min incubation with pNPP substrate 
at 37°C. 
 
 
III.10.10 Generation and characterisation of stable transformed plants 
overexpressing scFvODCs 
ScFvODC1 and scFvODC3 recognize different epitopes in the ODC protein (III.10.4) and 
shown to be fully functional in EMSA assays (III.10.6) were chosen for generation of 
stable transformed plants accumulating ODC-specific scFvs in the plant apoplast and 
cytosol. 
Stable transformed tobacco plants expressing apoplasmic scFvODC1 and scFvODC3 were 
generated for crossing experiments with stable transformed tobacco plants overexpressing 
recombinant human ODC into the apoplast (III.4.2). Transgenic plants accumulating  the 
scFvODC1 and scFvODC3 in the apoplast were regenerated after leaf disc transformation 
of N. tabacum cv. Perite Havana SR1. The resulting transformed tobacco plants (T0) were 
selected for kanamycin resistance. Nineteen regenerated T0 plants (labeled scFvODC1-apo-
1→19) from the transformation experiments with pTRA: scFvODC1-apo and 18 T0 plants 
(labeled scFvODC3-apo-1→18) expressing pTRA: scFvODC3-apo were planted and 
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screened for expression of the recombinant protein. None of the transformed plants 
exhibited an altered morphology and all set seed normally upon self-fertilization. The 
presence of recombinant proteins in tobacco leaves was analysed by immunoblot using 
crude extracts of total soluble protein. Immunoblot experiments revealed that 16 out of 19 
and 12 out of 18 T0 plants accumulating scFvODC1 or scFvODC3 in the apoplast (Figure 
III-39). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-39 Immunoblot analysis of stable tobacco T0 plants producing apoplastic 
scFvODC1 (A) and scFvODC3 (B). 
Total soluble proteins were extracted by grinding tobacco leaf tissue in two volumes extraction 
buffer (II.2.2.6). 5 µl of total soluble protein from each sample was separated by 12% SDS-PAGE 
(II.2.4.2) and blotted onto a nitrocellulose membrane (II.2.2.3). Immunodetection was carried out 
with 1:5000 diluted anti-his6 antibody, followed by incubation with 1:5000 diluted goat anti-mouse 
antibody conjugated to alkaline phosphatase and NBT/BCIP detection for 5 min at RT.  
A: 1-13: 7 µl total soluble protein extracted from transgenic T0 tobacco lines (scFvODC1-apo-
1→19) producing apoplastic scFvODC1. M: prestained protein marker. C: 0.46 µg scFv4813 used 
as positive control. 
B: 1-8: 7 µl total soluble protein extracted from transgenic T0 tobacco lines (scFvODC3-apo-
1→18) producing apoplastic scFvODC3. M: prestained protein marker. C: 0.46 µg scFv4813 used 
as positive control.  
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ScFvODC1 and scFvODC3 migrated according to their predicted molecular weight of 30 
kDa (Figure III-39).  
Transgenic T0 lines with the highest level of accumulation of scFvODC1 in apoplast 
(scFvODC1-apo-2; scFvODC1-apo-3; scFvODC1-apo-4; scFvODC1-apo-8 and 
scFvODC1-apo13) and scFvODC3 (scFvODC3-apo-2; scFvODC3-apo-4; scFvODC3-apo-
10; scFvODC3-apo-17; scFvODC3-apo-19) were kept for generation of the homozygous 
lines, that will be used for crossing experiments with the ODC-apo-7/3 lines that showed 
high ODC enzymatic activity (III.6).  
Generation of stable transformed plants accumulating scFvODC1 and scFvODC3 into the 
cytosol is still ongoing. As soon as homozygous transgenic plants are available they will be 
analysed for enzymatic activity of ODC and polyamine levels. 
 
III.11 Cloning and expression of scFvADC3 and scFvADC7 in E.coli 
Large-scale expression of selected scFvADCs was performed using the bacterial 
expression vector pSyn. scFvADC3 was subcloned downstream of the pelB leader peptide 
of pSyn vector using NcoI and NotI restriction sites. Because of an internal NcoI site at the 
126 bp position of VH chain the scFvADC7 was subcloned into pSyn vector using SfiI and 
NotI restriction sites. Correct insertion of the scFvs was confirmed by sequence analysis. 
Both antibody fragments were expressed upon induction with 1 mM IPTG. The His6 
tagged scFvs secreted into the culture medium were purified by IMAC. The affinity 
purified scFvs were analysed by SDS-PAGE (Figure III-40).  
 
 
 
 
 
 
 
Figure III-40: SDS-PAGE analyses of affinity purified scFvADC3 and scFvADC7.  
Two selected scFvADCs (3 and 7) were subcloned into the pSyn vector and expressed in the E. coli 
strain HB2151 upon induction with IPTG. The periplasmic expressed scFvs were purified by 
IMAC (II.2.8.1). Proteins were separated on 12% (w/v) SDS-PAGE and stained with Coomassie 
brilliant blue (II.2.4.2). E1, E2, E3: 5 µl of three 1 ml elution fractions; M: Mark12 protein marker. 
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The purified scFv revealed the presence of a single band of approximately 30 kDa. The 
concentration of purified scFvs was determined by either Bradford or BCA assay using 
BSA as a standard. The yield of purified scFvs ranged between 1-1.5 mg/L culture volume 
with slight deviations depending on the batch of preparation. The purified scFv fragments 
(Figure III-36) retained their functionality as shown in ELISA test (Figure III-41). 
 
III.11.1 Reactivity of purified scFvADC3 and scFvADC7 
Direct ELISA was performed to examine the reactivity of the purified scFvADC3 and 
scFvADC7 to ADC-GST and GST antigens (Figure III-41/A). 
Dilutions of purified scFvADC3 and scFvADC7 were incubated on high binding ELISA 
plates coated with ADC-GST and GST (5µg/ml). Quantitative analysis of the linear fit was 
performed for the data in linear range. The slope, the direct indication of reactivity of these 
scFv to the antigen has been calculated and presented in Figure III-41/B. The results 
indicated that scFvADC3 and scFvADC7 have a high, specific reactivity to ADC-GST and 
no cross-reactivity to GST. 
 
 
  
 
 
 
 
 
 
 
Figure III-41 Reactivity of affinity purified scFvADCs to ADC-GST and GST. 
1 µg/ml of ADC-GST and GST were coated on microtiter plates (II.2.8.1). Serial dilutions of 
affinity purified scFvADCs (3 and 7) were added in 1xPBS to a final volume of 100 µl. Bound 
scFvs were detected by using 9E10 monoclonal antibody (1:5000), and GAMAP polyclonal 
antibody (1:5000). ELISA readings were performed at OD405 nm after 30 min incubation with pNPP 
substrate at 37°C and presented in A. Using the Origin software the slope was determined by linear 
regretion and then presented as the arbitrary reactivity of the scFvADC3 (green) and scFvADC7 
(yellow) to the ADC-GST and GST (B). The signal to noise ratio is calculated for scFvADC3 and 
scFvADC7. 
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III.12 Epitope mapping of scFvADC3 and scFvADC7 
Epitopes of the two scFvADC3 and scFvADC7 were analysed by competition to the ADC-
GST antigen in ELISA experiment. In order to verify independent or overlapping epitopes 
the biotinylation of one scFv was necessary since both scFvs carried the same detection 
tags. scFvADC3 was biotinylated using biotin disulfide N-hydroxysuccinimide ester 
(II.2.8.3). Biotinylation efficiency of the scFvADC3 was determined by immunoblot 
analysis using non-biotinylated scFvADC3 and another biotinylated scFv with known 
concentration as standard (Figure III-42). The reactivity and functionality of the 
biotinylated scFvADC3 was analysed in the direct ELISA. Serial dilutions of biotinylated 
scFvADC3 were incubated on ELISA plates coated with a constant concentration of ADC-
GST (1.5 µg/ml). 
For the competition ELISA experiments the concentration of biotinylated scFvADC3 was 
chosen, which gave an OD405 nm of one (Figure III-42) after 30 min incubation. 
The scFvADC3 and scFvADC7 were serially diluted in a constant concentration of 
biotinylated scFvADC3 (1:80) determined by the direct ELISA and incubated for 2 hrs on 
ELISA plates coated with ADC-GST. Bound scFvADC3-bio was detected with AP-labeled 
Streptavidin. 
 
 
 
 
 
 
 
 
 
 
 
Figure III-42 Reactivity of biotinylated scFvADC3 to the ADC-GST antigen.  
ADC-GST (1.5 µg/ml) was immobilised on ELISA plates and several dilutions of biotinylated 
scFvADC3 were added to the plate. Bound scFvs were detected with 1:3000 diluted AP-labeled 
Streptavidin. ELISA readings (OD405 nm )were performed after 30 min incubation with pNPP 
substrate at 37°C. 
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Results presented in Figure III-43 showed the ability of non-biotinylated scFvADC3 to 
inhibit the binding scFvADC3-bio to the antigen.  
This indicated competition between biotinylated and not biotinylated scFvADC3 and 
proofed the correct set-up of the competition ELISA. Conversely, increasing amounts of 
scFvADC7 did not inhibit the binding of scFvADC3-bio to the ADC-GST antigen. Thus, 
no competition between scFvADC3 and scFvADC7 existed indicating that scFvs binds to 
two nonoverlapping epitopes. 
 
 
 
 
 
 
 
 
 
 
Figure III-43 Epitope mapping of scFvADC3 and scFvADC7.  
ADC-GST fusion protein was coated to a microtiter plate at a concentration of 1 µg/ml (II.2.8.4). 
scFvADC3 and scFvADC7 were serially diluted in 1:80 dilution of biotinylated scFvADC3. Bound 
scFvADCs were detected with 1:3000 diluted AP-labelled Streptavidin. ELISA readings were 
performed at OD405 nm after incubation at 37oC with pNPP for 1 h. One site competition model was 
performed by Origin program indicating the function between the scFvADC3 or scFvADC7 and 
the biotinylated scFvADC3. 
 
III.13 Transient expression of scFvADC3 in tobacco plants 
To examine the expression of scFvADC3 in N. tabaccum, scFvADC3 was subcloned into 
plant expression vector pTRA. Plant expression constructs were generated for targeting of 
expressed recombinant protein to the plant cytosol, secretion into the apoplast and 
retention in the ER. Transient assay experiments were performed, total soluble proteins 
extracted as described (II.2.2.6) and the presence of scFv fragments analysed by 
immunoblot analysis. 
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In immunoblots (Figure III-44) a distinct band of the expected molecular size of 30 kDa 
were detected in all analysed plant cell compartments. The level of expression of the ADC-
specific murine scFvADC3 varied between the constructs. Higher level of expression was 
shown in ER.  
Generation of stable transformed plants accumulating scFvADC3 in the cytosol is still on 
going. 
 
 
 
 
 
 
 
 
Figure III-44 Transient expression of scFvADC3 in tobacco plants.  
Total soluble leaf proteins were extracted by grinding tobacco leaf tissue in two volumes of 
extraction buffer (II.2.2.6). 5 µl of total soluble protein from each sample was separated by 12% 
SDS-PAGE (II.2.4.2) and blotted onto a nitrocellulose membrane (II.2.2.3). Immunodetection was 
carried out with anti-his6 antibody (1:5000), followed by 1 h incubation with goat anti-mouse 
antibody conjugated to alkaline phosphatase (1:5000) and NBT/BCIP detection for 5 min at RT. A- 
1-2: different infiltrated leaves expressing scFvADC3 in apoplast. B- 1-4: different infiltrated 
leaves expressing scFvADC3 in ER. C- 1-4: different infiltrated leaves expressing scFvADC3 in 
cytosol; W: wild type SR1 tobacco plant. 
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IV Discussion 
The polyamine biosynthetic pathway has been the subject of intensive study for several 
decades (Smith, 1985; Pegg, 1986). All genes of the enzymes involved in the polyamine 
biosynthesis pathway are cloned permitting its manipulation. Strategies to manipulate the 
pathway are based on the overexpression of key anabolic enzymes in concert with the 
down regulation of catabolic enzymes such as diamine oxidase (DAO) and polyamine 
oxidase (PAO) (DeScenzo and Minocha, 1993; Bastola and Minocha, 1995; Kumar et al., 
1996; Burtin and Michael, 1997; Capell et al., 1998; Malmberg et al., 1998; Noury et al., 
2000). Conversely, Burtin and Michael (1997) speculate that the plant polyamine pathway 
is so rigidly controlled that changes in polyamine levels cannot be achieved by over-
expressing key enzymes. The immunomodulation is an alternative approach for 
manipulating plant metabolism to change agronomic traits, ‘immunize’ the plants against 
pathogens, or blocking regulatory factors, such as immunomodulation of enzyme or signal 
molecule activity (De Jaeger et al., 2000; Giddings et al., 2000; Cattaneo and Biocca, 
1997). The idea of this work was to achieve changes in the polyamine pathway by over-
expression of ODC and SDE enzymes combined with the expression of recombinant 
antibodies to immunommodulate key enzymes. So far no data are available for modulation 
of the biosynthesis pathway by expressing specific scFv fragments binding to key 
enzymes. 
Human ODC, a key enzyme of polyamine biosynthesis was overexpressed in different 
plant cell compartments. Stable transformed tobacco plants were generated and the effect 
of the recombinant protein on the polyamine metabolism investigated. Stable transformed 
tobacco plants co-expressing ODC and SDE were generated and the effect of the 
recombinant proteins investigated. Three phage display libraries were constructed from 
spleen cells of immunized mice with polyamine GST fusion proteins. Four scFv-fragments 
specific to ODC and two scFv fragments specific to ADC were selected from phage 
display libraries. Then, fully active scFvs were expressed in Escherichia coli and 
characterized for their reactivity and functionality to antigens by ELISA, EMSA and 
surface plasmon resonance analysis. In vitro assays were performed to analyse the effect of 
ODC-specific scFvs on the enzymatic activity of ODC. Transient expression experiments 
were performed with all selected scFvs to analyse their intracellular performance. In 
addition, stable transformed plants expressing two scFv-fragments specific to ODC were 
generated and characterized for scFv expression. 
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IV.1 Generation and characterization of transgenic plants 
The human ODC gene was amplified from a prostate cDNA library (III.1) using gene 
specific primers (Gen-bank accession number M16650) The ODC-PCR product was 
cloned into pGEM-3zf vector and the sequence was verified. A single point mutation 
changing glutamic acid to glutamine (Glu417 →Gln417) in the position 417 was observed. 
An amino acid change in the protein sequence could be critical for the correct folding and 
may abolish the enzymatic activity especially when present in the catalytic site. Therefore 
it was important to investigate if this point mutation is an alternative form of the ODC gene 
(allele) or was introduced during PCR and RT-PCR amplification steps. The sequence 
analyses of six independent transformants carrying the ODC gene amplified from the 
human prostate c-DNA library using Expand high fidelity polymerase showed that the 
Glu417 →Gln417 change was not introduced during PCR amplification steps. Alignment of 
the ODC gene with database human ODC sequences confirmed that the amplified gene is 
an allele of ODC. In addition the most important residues for ODC activity are Lys69, 
Cys360 and Asp361 (Tobias and Kahana, 1993; Osterman et al., 1995; Almrud et al., 2000). 
Variants mutated in these amino acids revealed that each one is required for full catalytic 
activity (Osterman et al., 1995; Toney and Kirsch, 1993; Coleman et al., 1993). The Glu417 
is not involved in the catalytic site of the ODC enzyme suggesting that this point mutation 
does not abolish the enzymatic activity. Therefore the amplified human ODC gene was 
considered for further analyses. The analysis of ODC enzymatic activity in T2 stable 
transformed plants overexpressing human ODC in apoplast showed that this point mutation 
did not affect the enzymatic activity. 
The plant ODC is localized in cytosol, but has also been reported to be present in the 
nucleus, vacuole and mitochondria. Nevertheless, these data have to be interpreted with 
caution, because of the limitations of the subcellular fractionation studies and the electron 
microscopic autoradiography methods (Slocum, 1991). So far, overexpression of ODC has 
been only reported in plant cytosol (Bastola and Minocha, 1995; Andersen et al., 1998; 
Lepri et al., 2001). To investigate the stability and the activity of ODC in different plant 
cell compartments the human ODC gene was cloned into different pSS vector constructs 
suitable for expressing the recombinant protein in the plant cytosol, the apoplast and 
endoplasmic reticulum (ER) (III.4.1.1). Successful overexpression of functional enzymes 
in ‘‘non native’’ compartments may provide an additional alternative for polyamine 
pathway manipulation. Taking into consideration that ODC is a cytosolic protein the pSS: 
ODC-cyt construct was generated assuming that this would be the best environment for 
high level of accumulation and activity. Immunoblot analysis showed expression of human 
ODC protein in the plant cytosol and apoplasm with higher levels in the cytosol, while ER 
targeted ODC was not detected in Western blot assays. Northern blot analyses, however, 
showed that the level of ODC mRNA was similar for apoplastic and ER transcripts 
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demonstrating that transcript stability is not the reason for the observed difference. The 
failure to detect the ER targeted ODC could be the lower sensitivity of the anti-KDEL 
antibody compared to the anti-c-myc antibody. This assumption could be investigated by 
adding a tag to the ER construct for which a more sensitive detection antibody is available. 
Alternatively the stability of the protein in the ER might be lower than in the apoplast 
leading to low accumulation levels. 
The transient state of transgene accumulation in vacuum-infiltrated leaves may not be fully 
comparable to results after stable integration into tobacco chromosomes and extended 
screening of different individual lines. However, data from transient and stable 
transformation experiments of different recombinant proteins indicate that the 
accumulation levels observed in agrobacterium-infiltrated leaves correlate to those 
obtained in best expressing lines. In addition, transient expression is not influenced by 
positional effects that potentially bias gene expression levels in stable transformed plants 
(Kapila et al., 1996; Schalthof et al., 1996). Therefore, transient gene expression seems 
particularly suited for rapidly verifying a gene construct and the gene product before 
moving into transgenic plants (Kapila et al., 1996; Fischer et al., 1999c).  
Stable transgenic tobacco plants were generated only for the cytosolic and apoplastic 
targeted ODC. Generation of stable plants retaining the ODC in ER was not considered 
since the ER accumulation of ODC in transient assays was below the detection limit. 
Western blot analyses showed that 15 out of 22 and 16 out of 23 independent transgenic 
lines expressed the human ODC in the apoplast and cytosol, respectively. Higher 
expression was observed in tobacco plants expressing the ODC in cytosol, the native 
compartment of ODC. Two ‘‘apoplastic’’ and four ‘‘cytosolic’’ lines with the highest level 
of expression were selected and self pollinated for establishment of homozygous lines. 
Further screening was carried out in the T1 and T2 generation to identify the lines with the 
highest accumulation levels. 
The accumulation levels of the best expressing lines correlated with the accumulation 
levels obtained in the transient agroinfiltration thereby corroborating the suitability of 
transient expression to indicate the levels obtained in stable transformants. 
 
IV.2 Enzymatic activity and polyamine analyses of stable 
transformed plants overexpressing human ODC 
Seeds of the ODC-apo-7/3-T1-line that showed the highest level of ODC protein 
accumulation in apoplast were selected on kanamycin and six resistant, individual T2-
plants were tested for ODC activity. For analysing enzymatic activity young leaves were 
chosen because it was reported that ODC expression is low in mature leaves (Kwak and 
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Lee, 2001). To exclude errors due to assay variation four replicates were analyzed. The 
control values were determined by analyzing 4 different SR1 wild type tobacco plants 
grown under the comparable conditions. The ODC enzymatic activity of the transgenic 
lines was 1.6- to 32-fold higher than in wild type plants. Although significantly higher 
amounts (P<0.05) of ODC activity were observed in all transgenic plants compared to the 
wild type controls, the enzyme activity varied significantly in different transgenic lines 
(Figure III-14). No variation was observed between the four different control plants. Such 
variations in transgene activity regulated by the CaMV 35S promoter are quite common 
(Nagata et al., 1987; Hamill et al., 1990; Fecker et al., 1993; Bastola and Minocha, 1995; 
Noury et al., 2000). Variations of ODC activity in different transgenic lines could also be 
due to different sites of integration of the foreign gene in the plant genome and its copy 
number. Therefore, Southern analyses may be necessary to determine the gene copy 
number. 
The 1.6- to 32-fold increase of the enzymatic activity proofs that the mutation is not 
compromising the enzymatic activity. In addition the C-terminal addition of the c-myc 
epitope and hexa histidine tag for detection and/or purification does not interfere with 
enzymatic activity. However no studies have been done to investigate if these 
modifications affect the stability and/or activity of human ODC. A detailed analysis of the 
properties of the recombinant plant-expressed human ODC could be done after purification 
of his-tagged protein using IMAC. 
To investigate if overexpression of human ornithine decarboxylase in a ‘‘non native 
compartment’’ affects the polyamine pools free levels of putrescine, spermidine and 
spermine were analysed. Six individual T2 plants of the GR1-7/3 line were analysed. As 
observed for the enzyme activities the levels of free polyamines varied significantly among 
individual transgenic plants. In addition polyamine levels were slightly dependent on the 
developmental stage of the tissues with higher amounts in young leaves. There was a 
significant 4-5.6 fold increase (P<0.05) of putrescine levels in all transgenic lines 
expressing apoplastic ODC compared to wild type SR1 control plants (III.5.1).  
Elevated levels of ODC activity and putrescine were caused by the presence of the 
transgene indicating that the polyamine biosynthesis machinery was functional at the 
DNA, RNA and enzymatic level. However a direct correlation of enzyme activity to 
putrescine levels could not be done because it was not possible to analyse the same 
individual plants for both parameters. Nevertheless the results and the model of the 
polyamine biosynthesis strongly suggest that this correlation exist. 
However, the increased putrescine levels did not result in elevated spermidine and 
spermine accumulation. 
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The results of this study are in line with results from the overexpression experiments of 
human ODC in mouse (Halmekytö et al., 1991), yeast ODC in hairy root cultures of N. 
hesperis (Hamill et al., 1990) and mouse ODC in tobacco (DeSenzo and Minocha, 1993). 
None of the ODC overexpressing systems produced a significant change in spermidine and 
spermine accumulation. Increased ODC activity in transgenic mice overexpressing human 
ODC did i.e. not result in a general increase in putrescine levels except in testes and brain 
(Halmekytö et al., 1993). Similarly, overexpression of yeast ODC in N. hesperis did not 
significantly increase putrescine levels (Hamill et al., 1990) and overexpression of mouse 
ODC in tobacco increased putrescine accumulation 2.5-fold in the most extreme case 
(DeSenzo and Minocha, 1993). Conversely, Lepri et al. (2001) reported that 
overexpression of a cDNA for human ODC gene in transgenic rice plants under the control 
of Ubi-1 exhibit significant changes in the levels of all three major polyamines in seeds 
and also in vegetative tissues. Increased ODC activity and putrescine levels might result in 
an increase in alkaloid production via putrescine. Nicotine is synthesized in the roots and 
transported to the leaves (Hibi et al., 1994). Hamill et al. (1990) reported that 
overexpression of yeast ODC in hairy root cultures of Nicotiana hesperis resulted in a 
slight increase (less then 2-fold) in nicotine accumulation.  
 
IV.3 Polyamine analyses of transgenic tobacco plants co-expressing 
apoplasmic ODC and SDE enzymes 
Previous studies (Hamill et al., 1990; DeSenzo and Minocha, 1993; Bastola and Minocha, 
1995) indicated that increased ODC activity by overexpression of recombinant ODC gene 
is apparently not adequate to increase spermidine and spermine levels. It was then 
concluded that the polyamine pathway is tightly controlled and the system adjusts by 
regulation of other parts. 
For this reason stable transformed lines co-expressing human ODC and chimeric human-
mouse SDE enzymes were generated (III.4.3). Up to date this is the first study attempting 
to modulate the polyamine pathway by simultaneous expression of two enzymes involved 
in polyamine synthesis. Western blot analyses revealed that more than 80% of the lines 
tested co-expressed both enzymes. Despite the expression of both enzymes no change in 
growth and phenotypic appearance was observed compared to wild type plants. When free 
polyamine levels in four transgenic plants were measured, significantly higher (P<0.05) 
putrescine and spermidine levels were observed compared to SR1 control plants. 
The parental transgenic plants overexpressing SDE were not analysed for their spermidine 
levels. However, Western blot experiments verified high SDE accumulation levels in the 
parental lines. In contrast the level of SDE in the crossed lines (ODCxSDE) was 
significantly lower than in the parental lines. 
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It is reasonable to postulate that increase in ODC and SDE enzyme activity cause this 
significant increase in putrescine and spermidine levels. However, spermine values were 
not altered. This could either indicate that catabolic enzymes such as PAO were activated 
to keep spermine levels low compensating accumulation of putrescine and spermidine or 
higher levels of spermine synthase is needed to bring the reaction forward. 
The polyamine pathway is tightly regulated and it is very sensitive to changes in end 
product accumulation (Burtin and Michael, 1997). Consequently, there is a general notion 
that it is unlikely that any major changes in PA accumulation can be achieved. Previous 
experiments have indicated that a key element for changing polyamine levels in transgenic 
tissues is the strength of the promoter used to drive expression of transgenes (Capell et al., 
1998; Bassie et al., 2000). The CaMV 35S promoter used in this study is a strong promoter 
for driving heterolous transgene expression in tobacco (Töpfer et al., 1988; Kay et al., 
1987; Becker, 1990). The constitutive overexpression of the human ODC in apoplast 
appears to be sufficient to increase the putrescine pool, but a tight control of the polyamine 
pathway on the rate of spermidine and spermine synthesis does not lead to an accumulation 
of spermidine and spermine. The constitutive co-expression of ODC and SDE enzymes 
results in increased levels of putrescine and spermidine suggesting that the pathway can be 
brought ‘‘forward’’ by increasing the levels of subsequent enzymes. Due to time constrains 
no further crossing of stable transformed plants could be performed. However, in the future 
a cross between the stable transformed tobacco lines expressing SME and stable 
transformed tobacco co-expressing ODC and SDE is suggested. In case the spermine levels 
will be increased, this would indicate that the polyamine levels are not as tightly controlled 
as thought or that metabolic pathways cannot respond to an increase of polyamines. 
This study shed further light on the complexity of polyamine biosynthesis in intact plants 
providing a basis for further manipulations of the pathway using additional genes of the 
pathway. 
 
IV.4 Generation and Characterization of scFv-fragments specific to 
ADC, ODC and PAO 
In this study arginine decarboxylase (ADC), ornithine decarboxylase (ODC) and 
polyamine oxidase (PAO) were chosen as antigens for generation of specific scFv antibody 
fragments. These proteins were chosen because they present key enzymes of the polyamine 
pathway. ADC and ODC convert L-arginine and L-ornithine, respectively to putrescine. 
The flavoprotein PAO deaminates oxidatively the higher polyamines such as spermidine 
and spermine. The idea was to immunomodulate ADC and ODC which might then result 
in increased levels of putrescine by improving their stability and catalytic activity. 
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Antibodies that inhibit PAO function might, on the other hand, increase spermidine and 
spermine levels by blocking their degradation. 
So far, almost all antibodies that have been used for intracellular immunization derived 
from classical hybridoma technology. However, this technology is expensive and time-
consuming resulting in scFv that express badly in the cytosol (McCafferty et al., 1990; 
Hoogenboom et al., 1991). Phage display technology, on the other hand allows the 
isolation of recombinant antibodies of the desired specificity in vitro directly from 
established libraries or from the spleen of immunized mice, thus obviating the need for 
hybridoma production. In this study, the phage display technology was used to provide 
high affinity antibodies against the above mentioned enzymes from antibody libraries of 
immunized mice.  
Important for immunomodulation is the targeting of the recombinant antibody to the right 
subcelluar compartment were it should retain antigen binding activity. Therefore, the 
antibody has to be co-localised where the antigen is residing. Because ODC is localised in 
the cytosol, PAO in the cell walls and ADC in the chloroplast, scFv fragments (Bird et al., 
1988; Huston et al., 1988) were chosen as recombinant antibody format. ScFv-fragments 
have lesser requirements for folding and assembly and have successfully been expressed in 
the reducing environment of the plant cytosol (Fecker et al., 1996; De Jaeger et al., 1999; 
Zimmermann et al., 1998) while accumulation of larger fragments like Fab or full size 
antibodies is not possible. Moreover, scFv-fragments can also be easily expressed in E. coli 
and are suitable for phage display, facilitating selection, identification and characterization 
of potential binding molecules. 
 
IV.4.1 Expression and purification of recombinant antigens 
To obtain polyamine proteins for immunization, panning and scFv characterization the 
ADC, ODC and PAO cDNAs were genetically fused to the carboxyl-terminal end of GST 
(III.2). Using GST as fusion partner allowed one step affinity purification of the fusion 
proteins under native conditions (Frangioni and Neel, 1993). Overexpression of all GST-
fusion proteins resulted in formation of inclusion bodies. Thus, for altering amounts of 
soluble and correctly folded protein the culturing and induction conditions had to be 
optimized. Larger quantities of soluble ADC-GST and ODC-GST fusion proteins were 
obtained by increasing the culture volume, decreasing the IPTG concentration to 0.05 mM, 
increasing the induction time to 8 hrs and reducing the temperature to 18°C after induction. 
The positive effect of low temperature to reduce inclusion body formation has been 
demonstrated in many studies (Bishia et al., 1987; Schein, 1989; Burton et al., 1991). The 
rationale behind was based on the assumption that the rate of protein folding is only 
slightly affected at temperatures between 15 to 20°C, whereas the rates of transcription and 
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translation, being biochemical reactions, is substantially decreased. This, in turn provided 
sufficient time for protein folding, yielding active proteins and avoiding the formation of 
inactive protein aggregates, i.e., inclusion bodies, without reducing the final yield of the 
target protein (Oppenheim et al., 1996). The yields of purified ADC cleaved from GST 
domain with Factor Xa and ODC-GST fusion proteins after optimization were 2.0 and 1.5 
mg per liter culture, respectively. Affinity purified proteins showed high purity in SDS-
PAGE. In contrast, no soluble PAO fusion could be obtained even after optimizing the 
conditions suggesting that the formation of PAO inclusion bodies was not affected by the 
expression conditions used. The large size of the PAO-GST (83 kDa) could effect the 
proper refolding of the fusion protein as reported in other studies (Hackenbeck et al., 
1998). 
In some cases the change of expression vector or compartment can lead to soluble 
expression. Therefore the PAO gene was cloned into pET22b vector for periplasmic 
expression. Since the periplasm contains only 4% of the total cell protein (Nossal and 
Heppel, 1966) the target protein is effectively concentrated, and could be purified with less 
contaminants. In addition the oxidizing environment of the periplasm facilitates the proper 
folding of proteins. In vivo cleavage of the signal peptide during translocation to the 
periplasm is more likely to yield the authentic N terminus of the target protein. Protein 
degradation in the periplasm is also less extensive (Talmadge and Gilbert, 1982). However, 
attempts to express PAO in a soluble form failed, presumably via the aggregation of a 
folding intermediate. The yield of IMAC purified PAO under native conditions was very 
low. No reports so far are published describing a successful expression and purification of 
recombinant PAO. 
 
IV.4.2 Immunization of mice with ADC, ODC-GST and PAO-GST inclusion 
bodies 
The isolation of specific antibodies from a cloned immunological repertoire requires a 
large, diverse library, as well as an efficient selection procedure. The key to achieve this 
goal is the generation of a good immune response, isolation of high quality RNA and 
efficient cDNA synthesis from which the library is constructed. 
Mice were immunized with ADC, ODC fusion proteins and PAO-GST inclusion bodies. A 
high serum antibody titer against the injected antigen usually indicates enrichment of an 
antigen-specific cell clone. Serum titers from immunized mice against ADC and PAO 
ranged between 1:120,000-150,000, while the anti-ODC antisera titer ranged between 
1:60,000-70,000. The ODC protein is highly conserved in mammalians showing more than 
90% homology between human and mouse. This could render a limited immune response 
in mouse due to immunologic tolerance invoked during fetal development (Barbas et al., 
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2001) which would explain the low immunogenicity of human ODC in mice. The oat ADC 
and maize PAO were more immunogenic because they have a low homology with 
mammalian enzymes (Li et al., 1994; Tavladoraki et al., 1998; Bagni and Tassoni, 2001). 
Serum from mice immunized with ADC exhibited no cross reactivity against GST, 
indicating complete cleavage of the fusion partner by Factor Xa. Cross reactivity with GST 
was observed for serum from mice immunized with ODC-GST fusion protein and PAO-
GST inclusion bodies. However, as shown in the ELISA experiments with the recombinant 
proteins expressed from pET22b vector the immune response against the ODC and PAO 
domain were greater than against GST carrier protein. 
 
IV.4.3 Phage displayed antibody selection 
For each target antigen a complex scFv-phage display library was generated from the 
spleen cells of immunized mice. The library sizes were 3.2x107, 2.6x106 and 1.4x106 for 
ADC, ODC and PAO respectively (III.8.3). Previous studies have shown that the success 
of selection experiments depends to a large extent on the quality of the library. Complexity 
is a major factor determining the quality of a library and its complexity (Rader et al., 
2001). The greater the complexity the higher is the possibility to select scFvs of the 
required affinity and/or specificity. Although the constructed phage display libraries were 
not very large, selection of specific, high affinity binders was anticipated from these 
libraries since: -an immunized source was used for library construction where affinity 
maturation and clonal expansion had already taken place; -the percentage of positive 
clones carrying a full size scFv fragment was high (86.6% for ADC, 87.5% for ODC and 
100% for PAO); -analyses by BstNI fingerprinting showed diverse RFLP pattern for all 
libraries. 
Phage display is most successful when a purified antigen is used for selection. Selections 
on impure antigens are significantly more difficult, due to the problem of the limited 
amount of target antigen present in the mixture, and the enrichment of phage antibodies 
specific to non-relevant antigen (Hoogenboom et al., 1998). Because the purification of 
soluble PAO recombinant protein failed panning of library HP1LP1 was postponed. Work 
was continued with HA1LA2 and HO1LO2 libraries which were panned against purified 
ADC-GST and ODC-GST antigens.  
Phage antibody library selection was carried out using antigens directly coated on a plastic 
surface (immunotubes). This method was chosen since it is easy to perform, has been 
shown to be very successful for a diverse set of antigens (for review see Winter et al., 
1994) and does not require antigen biotinylation. The biotin is attached to the functional 
groups that are surface exposed and often reside in selection of binders that recognize only 
the biotinylated protein. Liquid phase panning using delayed infectivity panning selection 
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(DIP), biotinylated antigen and indirect coating (Dierks et al., 1986; Hawkins et al., 1992; 
Grob et al., 1998; Benhar et al., 2000; Chames et al., 2001) was regarded as an alternative 
backup strategy if no enrichment of specifically binding phages or/and characterization of 
isolated candidates would indicate the need for isolating higher affinity binders. Since 
suitable candidates have been successfully isolated from these libraries the alternative 
approaches were not performed. 
For both libraries three rounds of selection were performed by panning on immunotubes 
coated with the antigen as recommended by Vaughan et al., (1996). Zhang et al., (2001) 
have reported selection of GST specific binders when using GST as a fusion partner 
Therefore soluble GST was incubated with phage pools before each round of panning. The 
presence of false and low-specificity binders was eliminated by applying more stringent 
washing conditions in panning (De Bruin et al., 1999) and by blocking the phage with milk 
proteins prior to selection.  
The enrichment of ODC and ADC specific binders was followed by monitoring the ratio of 
input/output phage in each cycle. In the third round of panning the number of eluted 
phages was increased 152-fold for library HA1LA1 and 382-fold for library HO1LO1 
compared to the number of phages eluted in the first round indicating enrichment of 
specific binding clones. 
The integrity of the full size insert was verified in both libraries throughout the panning 
process. For the HA1LA1 library an increase of phages without scFv insert was observed 
between the first and the second round of panning. Plasmids carrying nonproductive, 
aberrant or truncated antibody fragments encoding sequences are often preferred by the E. 
coli host and frequently have a growth advantage over the scFv-expressing clones (Seehaus 
et al., 1992; Courtney et al., 1995; Dziegiel et al., 1995). This phenomenon seems to be 
related to the stringency of the washing procedures during the panning. Recovery of insert 
free phages is an indication of too low stringency of the washing procedures (Tur et al., 
2001). Here, such clones were eliminated by applying more stringent washing and elution 
conditions. Therefore 95% of the eluted phages carried a full size insert after the third 
round of panning. 
The diversity of the libraries was determined after each round of panning. The RFLP 
pattern of randomly selected clones revealed the presence of two and four unique patterns 
for ADC and ODC, respectively suggesting the efficient enrichment of specific clones. 
For a first screen, soluble ELISA-based assays were used in combination with PCR and 
BstNI fingerprinting to identify positive scFv-fragments (Marks et al., 1991). As indicated 
previously (Iacono-Connors, 1994; Murthy et al., 1999; Zhang, 2000) the ELISA method 
used for the recombinant phage characterization is critical for excluding false positives. 
Therefore, fifteen scFv-fragments with the highest ELISA readings and with different 
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RFLP patterns were selected for further characterization to increase the likelihood of 
selecting different DNA sequences. Their reactivity and functionality was assayed in direct 
and capture ELISA tests to avoid false positives. All clones analyzed from both libraries 
showed specific binding to ADC-GST and ODC-GST respectively. No cross reactivity to 
GST was observed in direct and capture ELISA tests. These results are in line with results 
from Songsivilai and Dharakul, (1998) who successfully used GST fusion proteins for 
selection of specific scFv against hepatitis C virus nucleocapsid protein by antibody phage 
display technology. Conversely, Zhang et al. (2001) described selection of false positives 
when GST fusion proteins were used for selection of antibodies specific to viral movement 
protein (TSWV). A similar phenomenon was observed by Murthy et al. (1999) while 
identifying a consensus motif specific for the PDZ2 domain of a cytosolic protein tyrosine 
phosphatase by peptide phage display. 
Sequence analyses of fifteen selected mouse derived scFvs specific to ODC showed that all 
scFv-fragments were in frame with the cloning module and belonged to four different 
sequence groups. Four clones scFvODC1, scFvODC3, scFvODC7 and scFvODC15 were 
chosen from each sequence group for further analyses. Sequence alignment with the Kabat 
database showed that the heavy and light chain variable domains of selected ODC-specific 
scFvs were members of the murine family VH1 and Vκ1/Vκ10 light chain respectively 
(Table III-6). 
ScFvODC1-like antibodies dominated the mouse immune response sharing only 72% 
similarity with scFvODC3, 7 and 15. The sequence variation between scFvODC1 and 
scFvODC3, 7 and 15 could be the result of the diversity generated by somatic 
recombination as indicated by alignment of scFvODCs variable sequences with the nearest 
germline V-gene segments listed in the IMGT database. Additionally, some sequence 
variation at the N terminus of both light and heavy chain may have been introduced by 
degenerate primers used for cloning (H5: Val, Gln; L4: Ile, Val; L5: Gln, Leu or Val), 
while the internal variations may have resulted from somatic mutations or from errors 
introduced during PCR amplifications. 
Comparison of the VH sequence of the scFvODC1 with the nearest germline V-gene 
segments (X02459) indicated large differences, both at the nucleotide (49) and amino acid 
(22) level. These amino acid differences were mainly distributed between CDRH1, 
CDRH2, FR2 and FR3 representing an affinity maturated clone that arose through somatic 
mutation/antigen selection. 
The variable heavy chain of the scFvODC3; 7 and 15 were most homologous to the 
AF304556 germline gene segment exhibiting a ratio of replacement to silent substitutions 
ranging from 3:1 to 6:1, respectively. The majority of the replacement substitutions fall 
within CDR1, CDR2 and FR3 with occasional changes in the FR1 and FR2 suggestive of 
an antigen-driven selection of the same maturated B-cell since somatic hypermutation of 
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antibody genes is triggered only after antigen-induced B-cell proliferation (Griffiths et al., 
1984). 
Furthermore, the homology between the scFvODC7 and 15 heavy chains and the 
scFvODC3 and 7 light chains respectively could be explained by mutations on an original 
VH and VL introduced during the PCR since low-fidelity polymerase such as Taq DNA 
polymerase was used to amplify the variable fragments. Although most of the mutations 
were neutral or detrimental, a small fraction could have improved the affinity of the scFvs 
for the target, and/or the folding or stability of a member, thereby yielding an advantage 
for this mutant in the next selection cycle (Schaffitzel and Plückthun, 2001). 
Sequence analyses of fourteen selected scFvs specific for ADC showed that all scFv-
fragments had open reading frames comprising two different sequences (proof by RFLP 
pattern). The most abundant scFv-fragment, was present in thirteen of the clones 
sequenced (13/14). This could be due to its predominant presence in the immune response 
of mouse or to its preferential amplification by PCR or phage multiplication as shown by 
Burmester and Plückthun, (2001) or due to the overselection of the library. Two clones 
scFvADC3 and scFvADC7 that shared 55.9% identity and 65% similarity were selected 
for further analyses. Sequence alignment with the Kabat database showed that VH of the 
scFvADC3 and 7 belonged to the murine V5 and V1 family. The VL is member of V9 and 
V4 of murine κ light chain respectively.  
The comparison of VH fragment of scFvADC3 with its nearest V germline gene fragments 
(AF120474) showed very large differences both in nucleotide and amino acid levels 
mainly distributed in the FR3 region. These mutations that possibly arose through somatic 
hypermutations could have an important positive effect on antibody affinity and stability 
considering that the scFvADC3 was the most abundant scFv specific to ADC selected. 
Most of the differences observed between the VH fragment of scFvADC7 and its closest 
germline gene segments (AF304556) were mainly distributed in CDR1, CDR2 and FR3 
with occasional changes in the FR1. 
The sequence analyses of both scFvADCs suggested the presence of two different affinity 
maturated clones arose by random rearrangment of antibody gene fragments and somatic 
hypermutations. 
 
IV.4.4 Expression and purification of scFvs in E. coli 
Since the production of functional recombinant antibody fragments in E. coli was first 
described (Skerra and Plückthun, 1988) it has become the method of choice in a variety of 
applications, ranging from immunochemical analyses to therapeutic treatment. The 
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bacterial synthesis of antibody fragments provides important advantages mainly due to 
facile handling of the prokaryotic organism (Fiedler and Skerra, 2001).  
An important strategy for production of scFvs-fragments in E. coli is their secretion to the 
periplasmic space as it permits the production of soluble and functional proteins with 
correctly formed disulfide bonds. Therefore the scFvODC1; 3; 7 and 15 and scFvADC3 
and 7 were cloned in pSyn vector preceded by a pelB leader sequence (Lei et al., 1987). 
Soluble scFv fragments were produced by induction with IPTG in E. coli HB2151. 
Immunoblots showed distinct bands with the expected molecular weight of about 28 kDa. 
The yield of purified scFvs was relatively high and ranged between 1.5-2.7 mg/L culture 
volume. Previous studies have indicated that bacterial expression systems secreting scFvs 
into the periplasmic space give typical yields of 0.1-2 mg/l in shake flask cultures for many 
scFv fragments. However, success of expressing antibody fragments in E. coli depends on 
the properties of the variable domain sequences and structure (Plückthun et al., 1996) and 
expression levels can vary widely for different antibody fragments. The relatively high 
yield of the scFvs in this study could be related with the particular amino acids located in 
the positions H6, H7 and H10 (H9) of the FR1 segment of the VH domain. Particularly the 
residue in the position H6, a buried glutamine or glutamate residue, has been found to have 
a strong effect on antibody yield and functionality (Kipriyanov et al., 1997; de Haard et al., 
1998; Langedijil et al., 1998). Honegger and Plückthun (2001) indicated that the mutations 
in the N-terminal part of FR1 of the VH domain introduced by PCR cloning using 
degenerate primers can lead to severe impairment of production yield, stability and antigen 
binding. Gln H6 is relatively permissive concerning the identity of the amino acids in the 
position H7 and H10 (H9), while Glu has more stringent requirements: H7 cannot be a 
proline residue and H10 (H9) requires a positive phi torsion angle compatible only with a 
glycine residue in this position (Honegger and Plückthun, 2001). The PCR-induced 
substitutions of Gln H6 by Glu decreased the production yield of the scFv derived from the 
murine hybridoma OKT3 30-fold, while antigen binding was not affected (Kipriyanov et 
al., 1997). The scFvODCs and scFvADC7 share Gln residues at this position showing a 
high expression levels in bacterial periplasm. The scFvADC3 has Glu residues at the H6 
position revealing a notable difference in the production yields of the scFvADC3 (Glu at 
H6) compare to scFvADC7 (Gln at H6). However, the presence of serine and glycine 
residues at the H7 and H9 position respectively could lead in relatively high expression 
levels. 
 
IV.4.5 Characterization of engineered scFvs 
The reactivity of affinity purified scFvODC1; 3; 7; and 15 with ODC antigen was analysed 
in direct ELISA tests (III.10.3). Comparative analyses of the reactivity of the affinity 
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purified scFvs to ODC-GST and GST indicated that scFvODC1; 3 and 7 had a high 
specific reactivity to the ODC and did not cross react to GST. Although the scFvODC15 
did not show a high reactivity to the antigen, its signal to noise ratio (482) indicated a high 
specificity to ODC. Therefore the four selected scFv specific to ODC were further 
characterized.  
The specific reactivity of scFvADC3 and scFvADC7 to ADC antigen was also directly 
compared indicating that scFvADC7 had a two fold higher reactivity to ADC. 
In EMSA, complex formation with ODC-GST was observed between the scFvODC1 and 
scFvODC3. Both scFvs were completely shifted demonstrating that IMAC purified scFvs 
were fully functional. ELISA assays are not capable of revealing this information unless a 
standard probe is used for calibration and the concentration of the purified scFv’s. 
Unfortunately for the scFvODC7 and scFvODC15 EMSA was not successful so further 
analyses are necessary. Therefore only scFvODC1 and 3 were considered for further in 
vivo analyses. 
The binding properties of the scFvODC1 on the soluble antigen were further verified by 
competition in solution monitored by surface plasmon resonance (III.10.5). Binding of 
soluble scFv to immobilized ODC-GST was completely inhibited by addition of excess 
amounts of soluble ODC-GST confirming the previous EMSA results and clearly proving 
that the scFv recognized the antigen in solution in a dose-dependent fashion. These 
experiments indirectly demonstrated that the scFvODC1 recognize an epitope present in 
the native confirmation of the ODC antigen. This was of special concern since the passive 
adsorption of the antigen to the plastic surface of immunotubes could result in the complete 
denaturation of the bound protein and loss of the conformational epitopes. Under these 
conditions, 95% of adsorbed proteins are not functional (Butler et al., 1992; Davies et al., 
1994) and the phage antibodies binding to epitopes only present in denaturated molecules 
could be selected (Chames et al., 2001). 
The determination of the epitope specificity was an important part of the scFv 
characterization. The selected scFvs were analyzed whether they recognize overlapping 
epitopes by pair wise epitope mapping. Epitopes recognized by the two scFvADC3 and 
scFvADC7 were analysed by competition to ADC-GST antigen in ELISA experiments. 
Because both scFvADCs carried the same detection tags biotinylation of scFvADC3 was 
necessary for discriminating between the different scFvs. No competition was observed 
between the biotinylated scFvADC3 and scFvADC7 and therefore it was concluded that 
they recognize independent epitopes. Thus, without additional information available both 
scFvADCs were considered for further in vivo analyses in transgenic plants. 
The pair wise epitope mapping of four generated scFvs specific to ODC was performed by 
surface plasmon resonance analyzes using immobilized scFv. This approach has the 
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advantage that whenever binding of the antigen to the immobilized scFv occurs this 
particular epitope is blocked. In contrast, a setup where the antigen is immobilized and the 
scFvs are serially injected is not optimal for two reasons. First, high scFv concentration 
have to be used to saturate all binding sites. Second, when the antigen-scFv interaction is 
characterized by fast off-rates, binding sites could become available for the second scFv 
affecting the reliability of the analyses. 
The pair wise epitope mapping revealed that scFvODC3 had an overlapping epitope with 
scFvODC7 and scFvODC15. This may be explained either by the fact that these scFvs may 
belong to the same original B-cell population or their striking homology in the CDR3. 
ScFvODC1 recognized a distinct epitope to scFvODC3, 7 and 15. Further analyses are 
needed to proof whether the scFvODC3, 7 and 15 bind to overlapping or identical epitopes 
and their effect on the enzymatic activity of ODC. 
After selection of high affinity from the low affinity scFv fragments, it was important to 
differentiate their binding kinetic. Preliminary experiments indicated an estimated Kd value 
of 5.0x10-7 M and 2.5x10-7 M for scFvODC1 and scFvODC3, respectively (data not 
shown). Despite several attempts, a precise determination of the affinity constant was not 
possible. Association and dissociation rate determination on the BIAcore device of scFv 
fragments is difficult due to the problem of multimerization behavior inherent to many 
scFv formats which complicates measurements of the antigen binding kinetics of scFv 
fragments as shown for other studies (Plückthun and Pack, 1997). The presence of 
monomeric and dimeric forms in affinity purified ODC-specific scFvs was revealed by gel 
filtration chromatography analyses (III.10.2). scFv fragments can associate to form dimers 
in bacterial supernatants (Griffiths et al., 1993; Holliger et al., 1993), and the dimers have 
higher binding avidity especially to solid phase (immobilized) antigen (Griffiths et al., 
1993). Purification can also lead to the formation of multimers (Nissim et al., 1994). 
Presumably multimerisation is promoted by dissociation of VH and VL chain domains of 
the same chain, followed by pairing with another chain, especially during acid elution and 
neutralization in concentrated solutions. The phenomenon of dimerization or even higher 
oligomerization of scFv fragments has been reported previously (Essig et al., 1993; 
Griffiths et al., 1993; Whitlow et al., 1993; Kortt et al., 1994; Raag and Whitlow, 1995) 
and has been investigated in the context of the linker length and the scFv properties 
(Alfthan et al., 1995; Turner et al., 1997). 
In addition, the affinity measurements are even more complicated when the antigen is 
present in multimeric forms as shown for the ODC-GST protein in the gel filtration 
analyses (data not shown). 
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IV.4.6 Generation of stable transformed tobacco plants overexpressing 
ODC-specific scFvs 
Because of the complexity of the ODC activity regulation, a full understanding of the 
effect of the generated scFvs on the polyamine pathway can only be studied in vivo. 
However, in vitro assays for testing the effect of selected scFv fragments on the ODC 
activity are crucial prior to in vivo experiments. Therefore, scFvODC1 and scFvODC3 that 
recognize different epitopes on the ODC enzyme and shown to be fully functional in 
EMSA were chosen for in vitro assays. Both scFvs stabilized the activity of the human 
ODC in a dose dependent manner. Incubation with scFvODC1 and scFvODC3 increased 
the enzymatic activity of bacterial purified human ODC 16-75% and 25-92%, respectively. 
In vitro results indicated that scFvODC1 and scFvODC3 could be good candidates for the 
immunomodulation approach and further in vivo characterisation. Furthermore, the effect 
upon addition of two scFvs (scFvODC1 and scFvODC3) would be worth invenstigating, as 
well as enzyme crosslinking by bivalent diabodies or bispecific antibodies. 
Since ODC enzyme is localized in the cytosol, co-localization of the scFvODCs in this 
plant cell compartment is necessary for the immunomodulation approach. To 
immunomodulate the ODC activity in the plant cytosol, the scFv fragments must be stable 
and functional in a reducing environment. Accumulation of scFvs in the cytosol is not 
straightforward due to the reducing conditions and the absence of protein disulphide 
isomerase and chaperones. In the majority of reported transgenic plants expressing 
cytosolic scFvs, levels were found to be very low or at the detection limit (Bruyns et al., 
1996; Fecker et al., 1996; Owen et al., 1992; Schouten et al., 1996; Tavladoraki et al., 
1993). Two exceptions were reported by De Jaeger et al. (1999) and Zhang (2000) in 
which cytosolic scFvs have accumulated to levels of up to 1% and 8% of total soluble 
protein, respectively. Preclusion of the scFv intradomain disulfide bridges often results in a 
loss of stability and antigen binding activity of the scFvs in the plant cytosol. However, 
examples of scFv fragments that are stable and able to bind their antigen without disulfide 
bridges have been described. The scFvODC1 and scFvODC3 were tested for their 
accumulation levels and functionality in the plant cytosol. Transient expression 
experiments showed high accumulation levels (50-70 µg/g fresh weight) of the scFvODC1 
and scFvODC3 in the plant cytosol. Furthermore, ELISA results indicated that both scFvs 
retained antigen binding specificity and activity in the reducing environment of the plant 
cytosol. However, these results have to be interpreted carefully. Because ELISA was not 
performed under reducing conditions, it cannot be excluded that binding in ELISA occurs 
upon the formation of disulfide bonds in vitro. Nevertheless, the combined results from the 
in vitro enzyme assay and high accumulation levels of the functional scFvODC1 and 
scFvODC3 in the plant cytosol show that these scFv fragments are possible candidates for 
interfering with in vivo ODC activity and polyamine pathway and will be further 
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characterised in transgenic plants. Additionally, co-expression of cytosolic scFvODC1 and 
scFvODC3 in a monovalent, bivalent or bispecific form may be interesting to invenstigate 
their biological effect in planta. 
Since ODC was expressed as an active enzyme in the apoplast, the apoplast was chosen as 
an alternative model to study the in vivo activity of scFvsODC. This experimental setup 
will indicate if any of the generated scFvODCs is capable of inhibiting or stabilizing the 
activity of human ODC.  
However, a prerequisite of such a study was the generation of stable transformed tobacco 
plants targeting the scFvODC fragments to the apoplast. Therefore a straightforward 
approach was pursued to generate transgenic tobacco plants co-expressing both the 
polyamine enzymes and scFv fragments. Two scFvODC fragments (scFvODC1 and 
scFvODC3) that recognize different epitopes in ODC enzyme and shown to be fully 
functional in EMSA assays were targeted to the apoplast under control of the *35S* 
enhanced cauliflower mosaic virus promoter. Constructs retaining the scFvs in ER were 
generated in parallel and used as control. Transient expression method was used to quickly 
assess the scFv accumulation in tobacco plants before establishing transgenic plants. 
Western blot analyses confirmed the high levels of accumulation of scFvODC1 and 
scFvODC3 in the apoplast and ER. Following transient expression experiments stable 
transformed tobacco plants overexpressing the scFvODC1 and scFvODC3 in the apoplast 
were regenerated. The effect of the scFv expression on the immunomodulation of ODC 
will be studied by analyses of ODC enzymatic activity and free polyamine levels. 
Functional studies with stable transformed plants are ongoing. 
In recent years, several reports have proven the value of the immunomodulation in plant 
research to modulate phytohormone activity and to block plant pathogen infection (De 
Jaeger et al., 2000; Conrad and Manteuffel, 2001). However, successful trials of 
immunomodulation of enzyme activity in plants have not yet reported, despite the success 
of this approach in mammalian cells (Marasco, 1995; Lener et al., 2000). Furthermore, 
only a few articles have been published dealing with the modulation of protein function in 
transgenic plants. One example is phytochrome, a plant regulatory receptor protein, whose 
activity has been changed by immunomodulation (Owen et al., 1992). Seeds of one 
homozygous transgenic tobacco line displayed an aberrant phytochrome mediated 
photocontrol of germination. On the other hand immunomodulation of flower pigment 
synthesis in Petunia hybrida was not successful (De Jaeger et al., 1999), although five 
different murine scFv against dihydroflavonol-4-reductase (DFR) were accumulated in the 
cytosol of transgenic plants. Recently, a specific scFv has been produced using phage 
display technology against CDC2a of Arabidopsis (Eckhout et al., 2000), which is a key 
regulator of the cell cycle in plants. This specific scFv against CDC2a was transiently 
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expressed in the cytosol of tobacco leaves and could recognize the antigen in vitro. 
Functional studies with stable transformed plants are still ongoing. 
 
IV.5 Conclusion and future prospects 
Data presented in this study demonstrated that the human ODC cDNA can be stably 
integrated in the tobacco genome. It is successfully expressed and produces an active 
human ODC enzyme in the apoplast, a non-native compartment of ODC. The increased 
enzymatic activity resulted in increased cellular levels of putrescine. Spermidine and 
spermine levels were unchanged. In transgenic tobacco lines co-expressing human ODC 
and chimeric human/mouse SDE putrescine and spermidine levels increased. Despite the 
co-expression of both enzymes spermine values did not show a significant increase.  
Previous studies indicated that the polyamine pathway is sensitive to changes in end 
product accumulation. It has also been reported that the cellular content of spermidine and 
spermine in plants are much more tightly regulated than those of putrescine (Hiatt and 
Malmberg, 1988; Minocha et al., 1995; Minocha and Minocha, 1995). The question arises 
whether the tight regulation of the spermidine and spermine biosynthesis was due to the 
pathway compensating in some undetected manner for the increased putrescine and/or 
spermidine level. Therefore, to explore if the polyamine flux may have been channelled 
into other polyamine-derived metabolites, the rates of methylation, ethylene synthesis and 
nicotine production could be analysed in the stable transformed tobacco plants. 
To further our understanding about the role of the anabolic and catabolic enzymes on the 
tight regulation of polyamine synthesis the enzymatic activity of PAO, SDE, SME and 
SAMDC could be investigated. This work will be carried out with selected progenies of 
transgenic tobacco plants overexpressing human ODC and co-expressing ODC and SDE 
enzymes. 
Furthermore, analyses of transgenic plants overexpressing ODC in its native compartment 
could help understanding whether the putrescine and/or spermidine were not accessible to 
the rest of the pathway because of the rapid degradation or sequestration by 
compartmentation. This work is currently in progress. 
In an alternative approach highly specific scFvs were generated by phage display 
technology for immunomodulation of ADC and ODC key enzymes in the polyamine 
biosynthesis. Transiently expressed scFvs were accumulated at high levels in the plant 
cytosol, apoplast and ER. The scFvODC1 and scFvODC3 stabilized the ODC activity of 
the bacterial purified human ODC in a dose dependent manner in an in vitro assay. In 
further experiments, transgenic tobacco plants expressing the scFvs in apoplast and/or 
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cytosol could be generated and characterized for their effect in the polyamine pathway by 
analysing changes in the ODC, ADC and PAO enzymatic activities and polyamine levels.  
De Jaeger et al., (2000) suggested that applying antibodies with the same target specificity 
but with different binding affinities might permit different levels of epitope blocking and 
different effects on the protein enzymatic activity. As proteins often interact with more 
than one other protein, it is possible that blocking a signal epitope may leave other protein 
protein interaction intact, resulting in less pleiotropic effect than a total gene knock out. 
Studies have indicated that successful immunomodulation depends not only on the 
expression of high affinity recombinant antibodies in a specific compartment and organ at 
the appropriate time but also on system-intrinsic factors, such as the sensitivity of a cellular 
process to the degree of inhibition of activities to be modulated (Conrad and Manteuffel, 
2001). The ability to modulate levels of enzyme activity and end product accumulation by 
heterologous transgene expression suggested that the polyamine pathway can exhibit 
plasticity. Therefore, immunomodulation could be a promising approach for analysis and 
manipulation of metabolic polyamine pathway, including polyamine biosynthesis.  
Optimized antibody gene isolation and expression, especially in reducing subcellular 
environments should turn immunomodulation into a powerful and attractive tool for gene 
inactivation, complementary or even as replacement to classical antisense and co-
supression approaches. 
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V Summary 
Polyamines are ubiquitous low-molecular weight polycationic compounds found in all 
living organisms and involved in crucial developmental, physiological and metabolic 
processes. The majority of information available about the polyamine pathway was 
obtained by using a wide range of metabolic inhibitors (Evans and Malmberg, 1989; 
Tiburcio et al., 1990) and modulation of specific enzymatic activities via heterologous 
gene expression in transgenic plants. Previous studies have indicated that the polyamine 
pathway is tightly controlled in the end product accumulation. The objective of this study 
was to achieve changes in the pathway by combining genetic engineering and antibody 
technology approaches.  
ODC a key enzyme in the polyamine biosynthesis, was amplified from a human prostate 
cDNA library and subcloned into plant expression vector for transient expression in the 
apoplast, cytosol and endoplasmatic reticulum. ODC was accumulated to higher levels in 
plant cytosol and apoplast, while ODC targeted to ER was not detected in immunoblots. 
Stable transformed tobacco plants overexpressing heterolougs ODC in cytosol and apoplast 
were generated. Lines with the highest accumulation levels were selected for establishment 
of homozygous lines. The T2 generation of transgenic plants overexpressing human ODC 
in apoplast, ‘‘non-native compartment’’ of ODC revealed up to 32-fold elevated levels of 
ODC activity and accumulated significantly higher levels of putrescine. Additionaly, stable 
transformed tobacco plants co-expressing human ODC and chimeric human mouse SDE in 
apoplast were generated. Immunoblot analyses revealed that more than 80% of the lines 
tested co-expressed both enzymes. The best expressers showed significantly increased 
levels of putrescine (up to 5-fold) and spermidine (up to 4.5-fold). No increased levels of 
spermine were observed. 
The ADC, ODC and PAO key enzymes in polyamine pathway were chosen as a target for 
generation of specific scFv recombinant antibody fragments by phage display technology. 
Mice were immunized with the bacterial produced and affinity purified ADC, ODC-GST 
fusion protein and PAO-GST inclusion bodies. High antibody titers showed successful 
immunization. Three phage display libraries were constructed using the immunized mice 
repertoire. Recombinant antibodies were isolated by solid phase panning using bacterial 
ADC- and ODC-GST fusion proteins. Their specific reactivity to ADC and ODC was 
analysed by direct and capture ELISA. Sequence analyses revealed selection of two and 
four scFvs specific to ADC and ODC, respectively. Electromobility shift assays confirmed 
the functionality of the affinity purified scFvODC1 and scFvODC3. The binding properties 
of scFvODCs on soluble antigen were further verified by solution competition as 
monitored by surface plasmon resonance. The epitope specificity of selected scFvs was 
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determined in ELISA and BIAcore assays. The pairwise epitope mapping indicated that 
scFvADC3 and scFvADC7 recognize independent epitopes in ADC, while scFvODC1 
recognize a distinct epitope to scFvODC3, 7 and 15. Gel filtration assays indicated the 
presence of monomeric and dimeric forms of scFvODC3 and scFvODC7. In vitro assays 
indicated increase of the human ODC activity after addition of 3.4 µM of scFvODC1 and 
scFvODC3 of 75% and 92%, respectively. 
All selected scFvs were cloned into pTRA plant expression vector and analysed for their 
stability and accumulation levels in the plant cytosol, apoplast and ER. Immunoblot 
analyses of tobacco leaves demonstrated accumulation of scFvs in apoplast and ER with 
higher levels in ER. Moreover, scFvODC1 and scFvODC3 accumulated in high levels (up 
to 50-70 µg/g fresh weight) in the plant cytosol retaining the antigen binding specificity 
and activity in the reducing environment of the plant cytosol. Stable transformed plants 
expressing scFvODC1 and scFvODC3 specific to ODC in the apoplast and cytosol were 
generated. More than 67% of the regenerated plants expressed the apoplastic scFvODC1 
and scFvODC3. 
The data presented in this study demonstrated changes in the polyamine pathway by 
constitutive expression of heterologous ODC and co-expression of ODC and SDE enzymes 
indicating that the polyamine pathway exhibit plasticity. Up to date this is the first study 
attempting to modulate the polyamine pathway by simultaneous expression of two 
enzymes involved in the polyamine synthesis. Moreover, generation of the scFvs specific 
to ADC and ODC key enzymes in the polyamine biosynthesis could be a valuable 
molecular tool for altering the pathway by using immunomodulation approaches and 
crossing experiments with the homozygous transgenic lines overexpressing ADC and/or 
ODC. 
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VII Appendices 
VII.I Abbreviations 
 
ABTS 2,2’-Azino-di-(3-ethylbenzthiazoline sulphonate) 
Ab Antibody 
ADC Arginine decarboxylase 
Ag Antigen 
Amp  Ampicillin 
AP  Alkaline phosphatase 
AZ  Antizyme 
B cell  Bone-marrow-derived lymphocyte 
BCIP  5-bromo-4-chloro-3-indolyl phosphate 
bp  Baise pair 
BSA Bovine serum albumin 
CaCl2  Calcium chloride 
CaMV  Cauliflower mosaic virus 
Carb  Carbenicillin 
CB  Cleavage buffer 
CDR  Complementarity determining region 
cDNA  Complementary DNA 
cfu  Colony-forming units 
CHS  Chalcone synthase 
CI  Chloroform/isoamyl alcohol (24:1) 
CH/CL  Heavy/Light constant domains 
CLB  Cell lysis buffer 
Cys  Cysteine 
cv.  Cultivar 
D  Diversity gene segments 
DAO  Diamine oxidase 
DEAE  Diethylaminoethyl 
DFMO  Difluoromethylornithine 
DEPC  Diethylpyrocarbonate 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
dNTP  Deoxyribonucleoside triphosphate 
DTT  1,4-dithiothreitol 
E. coli  Escherichia coli 
EDC/NHS  N-Ethyl-N′-(Dimethylaminopropyl) 
EDTA  Ethylenediamine tetraacetic acid 
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ELISA  Enzyme-linked immunosorbent assay 
EMSA  Electrophoretic mobility shift assay 
ER  Endoplasmatic reticulum 
EtOH  Ethanol 
Fab  Fragment antigen binding 
Fc  Fragment crystalline 
FRs  Framework regions 
FV channels fast-activating vacuolar channel 
g  Relative centrifugal force (RCF) 
GABA  Gamma-aminobutiric acid 
gIII  Gene III (encoding minor coat protein III) 
gVIII  Gene VIII (encoding major phage coat protein VIII) 
GST  Glutathione S-transferase 
GSM  Agrobacteria glycerol stock media 
h  Hour(s) 
HCl  Hydrochloride 
his  Histidine 
HRP  Horse radish peroxidase 
IPTG  Isopropyl B-D-thiogalactopyranoside 
IMAC  Immobilized metal ion affinity cgromatography 
J  Joining gene segments 
Lys  Lysine 
kb  Kilobase pair 
kDa  Kilodalton 
KDEL  ER retention signal 
Km  Kanamycin 
M  Molarity 
MES  2-(N-morpholino)-ethanesulphonic acid 
min  Minute(s) 
MPBS  Non-fat skrim milk powder in PBS 
MgSO4  Magnesium sulfate 
MOPS  3-(morpholino)propanesulfonic acid) 
mRNA  Messenger RNA 
NaCl  Sodium chloride 
OD  Optical density 
ODC  Ornithine decarboxylase 
o/n  Overnight 
ORF  Open reading frame 
Ori  Origin of replication 
PAO  Polyamine oxidase 
PBS  Phosphate buffered saline 
PBST  0.1% Tween-20 in PBS 
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PCI  Phenol/chloroform/isoamyl alcohol (25:24:1) 
PCR  Polymerase chain reaction 
PEG  Polyethylene glycol 
PLP  pyridoxal 5′-phosphate 
poly A  Polyadenylation signal 
pH  A logarithmic measure of hydrogen ion concentration 
pIII  Phage minor protein III 
pVII  Phage minor coat protein VII 
pVIII  Phage major protein VIII 
pIX  Phage minor coat protein VII 
pNPP  p-nitrophenyl phosphate 
PVDF  Polyvinylidene fluoride 
Pw  Tobacco mosaic virus RNA termination sequence 
Rif  Rifampicilin 
RNA  Ribonucleic acid 
RNase  Ribonuclease 
rpm  Rounds per minute 
RT  Reverse transcription 
S  Segment; small 
SAM  S-adenosynmethgionine 
SAMDC  S-adenosynmethionine decarboxylase 
SB  Stripping buffer 
scFv  Single-chain variable fragment 
SDE  Spermidine synthase 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SME  Spermine synthase 
SV channels Slow vacuolar channels 
TBE  Tri- buffered saline electrophoresis buffer 
TEMED  N,N,N′, N′-tetramethylene-ethylenediamine 
TMV  Tobacco mosaic virus  
UTR  untranslated region 
Ω  Omega leader region  of TMV 
V  Volt; variable region 
VH/VL  Heavy/Light chain variable region 
v/v  Volume per volume 
w/v  Weight per volume 
w/w  Weight per weight 
 
 
 
 
Chapter VII Appendices 
 148
VII.2 Nucleic acid and amino acid sequence of amplified human ODC 
• Alignment between database entry M16650 (HSODC) and #103, ODCL/TOPO 
(ODC) 
Percent Similarity: 100.000   Percent Identity: 99.783 
                  .         .         .         .         . 
ODC     4 NNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKK 53 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC   2 NNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKK 51 
                  .         .         .         .         . 
ODC    54 HLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSL 103 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC  52 HLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSL 101 
 
ODC   104 GVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKL 153 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 102 GVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKL 151 
                  .         .         .         .         . 
ODC   154 VLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSG 203 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 152 VLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSG 201 
                  .         .         .         .         . 
ODC   204 CTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEI 253 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 202 CTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEI 251 
                  .         .         .         .         . 
ODC   254 TGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQT 303 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 252 TGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQT 301 
                  .         .         .         .         . 
ODC   304 GSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYY 353 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 302 GSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYY 351 
                  .         .         .         .         . 
ODC   354 SSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQ 403 
          |||||||||||||||||||||||||||||||||||||||||||||||||| 
HSODC 352 SSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQ 401 
                  .         .         .         .         . 
ODC   404 RPTIYYVMSGPAWQLMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHR 453 
          |||||||||||||:|||||||||||||||||||||||||||||||||||| 
HSODC 402 RPTIYYVMSGPAWELMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHR 451 
                  . 
ODC   454 AACASASINV 463 
          |||||||||| 
HSODC 452 AACASASINV 461 
 
• Length 1394; 364A, 297C, 359G, 374T 
      CCATGGGTAACAACTTTGGTAATGAAGAGTTTGACTGCCACTTCCTCGAT 
      GAAGGTTTTACTGCCAAGGACATTCTGGACCAGAAAATTAATGAAGTTTC 
      TTCTTCTGATGATAAGGATGCCTTCTATGTGGCAGACCTGGGAGACATTC 
      TAAAGAAACATCTGAGGTGGTTAAAAGCTCTCCCTCGTGTCACCCCCTTT 
      TATGCAGTCAAATGTAATGATAGCAAAGCCATCGTGAAGACCCTTGCTGC 
      TACCGGGACAGGATTTGACTGTGCTAGCAAGACTGAAATACAGTTGGTGC 
      AGAGTCTGGGGGTGCCTCCAGAGAGGATTATCTATGCAAATCCTTGTAAA 
      CAAGTATCTCAAATTAAGTATGCTGCTAATAATGGAGTCCAGATGATGAC 
      TTTTGATAGTGAAGTTGAGTTGATGAAAGTTGCCAGAGCACATCCCAAAG 
      CAAAGTTGGTTTTGCGGATTGCCACTGATGATTCCAAAGCAGTCTGTCGT 
      CTCAGTGTGAAATTCGGTGCCACGCTCAGAACCAGCAGGCTCCTTTTGGA 
      ACGGGCGAAAGAGCTAAATATCGATGTTGTTGGTGTCAGCTTCCATGTAG 
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      GAAGCGGCTGTACCGATCCTGAGACCTTCGTGCAGGCAATCTCTGATGCC 
      CGCTGTGTTTTTGACATGGGGGCTGAGGTTGGTTTCAGCATGTATCTGCT 
      TGATATTGGCGGTGGCTTTCCTGGATCTGAGGATGTGAAACTTAAATTTG 
      AAGAGATCACCGGCGTAATCAACCCAGCGTTGGACAAATACTTTCCGTCA 
      GACTCTGGAGTGAGAATCATAGCTGAGCCCGGCAGATACTATGTTGCATC 
      AGCTTTCACGCTTGCAGTTAATATCATTGCCAAGAAAATTGTATTAAAGG 
      AACAGACGGGCTCTGATGACGAAGATGAGTCGAGTGAGCAGACCTTTATG 
      TATTATGTGAATGATGGCGTCTATGGATCATTTAATTGCATACTCTATGA 
      CCACGCACATGTAAAGCCCCTTCTGCAAAAGAGACCTAAACCAGATGAGA 
      AGTATTATTCATCCAGCATATGGGGACCAACATGTGATGGCCTCGATCGG 
      ATTGTTGAGCGCTGTGACCTGCCTGAAATGCATGTGGGTGATTGGATGCT 
      CTTTGAAAACATGGGCGCTTACACTGTTGCTGCTGCCTCTACGTTCAATG 
      GCTTCCAGAGGCCGACGATCTACTATGTGATGTCAGGGCCTGCGTGGCAA 
      CTCATGCAGCAATTCCAGAACCCCGACTTCCCACCCGAAGTAGAGGAACA 
      GGATGCCAGCACCCTGCCTGTGTCTTGTGCCTGGGAGAGTGGGATGAAAC 
      GCCACAGAGCAGCCTGTGCTTCGGCTAGTATTAATGTGGTCGAC 
 
Figure VII-1 Nucleic acid and amino acid sequences of human ornithine decarboxylase (ODC) 
amplified from prostate cDNA library. Plasmid ODCL/TOPO reference number #103. Sequences 
were compared to the database entries M16650 (HSODC) from which the primers for PCR 
amplification were derived. The single point mutation is highlighted in the sequence. Comparison 
was performed with program GAP or Pileup of the GCG sequence analysis software package. 
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VII.3 Schematic presentation of vector maps 
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Figure VII-2 Schematic presentation of the vector maps. A: pGEM 3zf; B: pTRA; C: pHEN 4II; 
D: pSynI; E-pET22b(+) vector map. The nucleotide sequence of the expression region is indicated. 
F- pGEX-5x-3. 
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